Necrotizing fasciitis associated with acupuncture: A case report

Article Type
Changed
Display Headline
Necrotizing fasciitis associated with acupuncture: A case report

Presentation

An 84 year‐old male with past history of osteoarthritis, extensive degenerative spine disease with spinal stenosis presented to the emergency room with left groin pain accompanied by a foul‐smelling discharge from the acupuncture site. He had been receiving regular physical therapy and acupuncture sessions for the past 6 months prior to his presentation. One and a half weeks prior to presentation, needles were inserted over the left groin as part of his acupuncture regimen. The patient described the acupuncture needles originating from a single use, unopened package. Additionally, the patient states his skin was cleaned with an antiseptic solution prior to insertion. Within 3 days, he developed generalized weakness, malaise with localized swelling, erythema, and warmth over the left groin area. His primary care physician performed an incision and drainage and prescribed ciprofloxacin. The patient continued to experience worsening fatigue, difficulty ambulating, ongoing purulent drainage, and consequently presented to the hospital for further evaluation. The patient has an allergy to penicillin but no history of diabetes. He quit smoking 40 years ago and has occasional alcohol intake. Surgical history includes bilateral knee replacement 15 years ago for osteoarthritis and right inguinal hernia repair and appendectomy 60 years ago.

On physical examination the patient had a temperature of 96.8F, pulse of 88 beats per minute, blood pressure of 97/63 mm Hg, and an oxygen saturation of 98% on room air. There was extensive swelling, erythema, and induration of the left anterior and proximal inguinal area, with a 2‐cm malodorous ulcer over the midline thigh. No crepitation or mass was palpable. Range of motion at the hip on the affected limb was limited due to pain. Distal pulses on the lower extremity were present and equal bilaterally. Laboratory examination revealed white blood cell (WBC) = 16.4 with 41% bands. Blood cultures were sent and intravenous vancomycin, ciprofloxacin, clindamycin, and metronidazole were started. A computed tomography (CT)‐scan of the left lower extremity was performed and revealed skin thickening and reticulation of the subcutaneous tissues edema extending from the left groin to the left buttock. Several foci of gas were present within the soft tissues with the largest in the lateral aspect of the buttocks of gas in the soft tissues (Figure 1). The Laboratory Risk Indicator for Necrotizing Fasciitis, the patient scored a 3 out of a possible 13 points. The diagnosis of necrotizing fasciitis was made based on clinical findings and radiographic imaging.

Figure 1
Computed tomography‐scan of the left lower extremity. The arrow points to several foci of gas present within the soft tissues.

Assessment

Patient became significantly hypotensive which required vasopressor support. He underwent surgical exploration of the left inguinal area. During surgery, tender crepitation of the antero‐lateral aspect of the thigh was noted. Extensive debridement with fasciotomy was performed. Tissue was sent for histopathological analysis and gram‐stain. A negative‐pressure wound dressing was placed over the defect. Post‐operatively, patient required intubation and continued vasopressor support. On post‐operative day 3, patient was extubated. Wound culture report revealed gram negative rods and Enterococcus faecalis which was sensitive to the patients' current antibiotic regimen. Clindamycin was discontinued. The patient was discharged to a subacute rehabilitation facility and returned for a split thickness skin graft 2 months after initial presentation.

Necrotizing fasciitis is a deep‐seated infection of the subcutaneous tissue that results in progressive destruction of fascia and fat. Presenting symptoms include pain, erythema, or bullae formation at the site of infection. Systemic symptoms such as fever, malaise, and myalgias may also be present at the time of presentation. Two types of necrotizing fasciitis are noted to occur. Type 1 is a mixed infection with a predominance of anaerobes1 and carries a 21% mortality.2 It is common post‐operatively and in patients with diabetes. In type 2 necrotizing fasciitis, Group‐A streptococcus was the most common cause of monomicrobial necrotizing fasciitis2 and mortality can be as high as 30%.3 Risk factors for the development of fasciitis include immunosuppression, diabetes, surgery, or penetrating injuries. Gas on soft tissue x‐rays, CT scan, or magnetic resonance imaging (MRI) is a highly specific but insensitive finding and is common in type I necrotizing fasciitis.

The patient in this case likely developed type I necrotizing fasciitis due to the presence of gas on CT scan and polymicrobial culture findings.

Diagnosis

A PubMed search of necrotizing fasciitis and acupuncture reveals only one case report, in which a diabetic patient underwent an unsterile acupuncture consultation.4 To our knowledge, we are the first to describe necrotizing fasciitis occurring in a nondiabetic patient who underwent a sterile acupuncture technique.

Given the lack of an explainable causal relationship regarding the pathogenesis of necrotizing fasciitis in our patient, it appears to be due to the acupuncture needle placement. The patient had no other history of abscesses, trauma and other portals of entry. The patient's presentation, temporal relation of the site of acupuncture, and the development of infection prompted a high index of suspicion as acupuncture as the main etiology.

Management

Treatment of necrotizing fasciitis includes early and aggressive surgical debridement. Multiple antibiotic regimens may be necessary due to the polymicrobial nature of the infection. In our patient, ciprofloxacin was initiated for broadened gram negative coverage, vancomycin for community acquired methicillin‐resistant Staphylococcus aureus (MRSA) and metronidazole for anaerobic coverage. Clindamycin was initiated due to concerns of toxin production, but was discontinued as the patient's condition improved.

Although complications of acupuncture may be rare, there exists the potential to cause life threatening complications. Necrotizing fasciitis has been observed as an adverse effect of acupuncture in a single diabetic patient,4 but can develop in nondiabetic individuals, such as in our patient.

References
  1. Brook I,Frazier EH.Clinical and microbiological features of necrotizing fasciitis.J Clin Microbiol.1995;33(9):23822387.
  2. Wong CH,Chang HC,Pasupathy S,Khin LW,Tan JL.Low CO Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality.J Bone Joint Surg Am.2003;85‐A(8):14541460.
  3. Stevens DL,Tanner MH,Winship J, et al.Severe group A streptococcal infections associated with a toxic shock‐like syndrome and scarlet fever toxin A.N Engl J Med.1989;321(1):17.
  4. Saw A,Kwan MK,Sengupta S.Necrotising fasciitis: a life‐threatening complication of acupuncture in a patient with diabetes mellitus.Singapore Med J.2004;45(4):180182.
Article PDF
Issue
Journal of Hospital Medicine - 5(9)
Page Number
565-566
Legacy Keywords
acupuncture, infection, necrotizing Fasciitis
Sections
Article PDF
Article PDF

Presentation

An 84 year‐old male with past history of osteoarthritis, extensive degenerative spine disease with spinal stenosis presented to the emergency room with left groin pain accompanied by a foul‐smelling discharge from the acupuncture site. He had been receiving regular physical therapy and acupuncture sessions for the past 6 months prior to his presentation. One and a half weeks prior to presentation, needles were inserted over the left groin as part of his acupuncture regimen. The patient described the acupuncture needles originating from a single use, unopened package. Additionally, the patient states his skin was cleaned with an antiseptic solution prior to insertion. Within 3 days, he developed generalized weakness, malaise with localized swelling, erythema, and warmth over the left groin area. His primary care physician performed an incision and drainage and prescribed ciprofloxacin. The patient continued to experience worsening fatigue, difficulty ambulating, ongoing purulent drainage, and consequently presented to the hospital for further evaluation. The patient has an allergy to penicillin but no history of diabetes. He quit smoking 40 years ago and has occasional alcohol intake. Surgical history includes bilateral knee replacement 15 years ago for osteoarthritis and right inguinal hernia repair and appendectomy 60 years ago.

On physical examination the patient had a temperature of 96.8F, pulse of 88 beats per minute, blood pressure of 97/63 mm Hg, and an oxygen saturation of 98% on room air. There was extensive swelling, erythema, and induration of the left anterior and proximal inguinal area, with a 2‐cm malodorous ulcer over the midline thigh. No crepitation or mass was palpable. Range of motion at the hip on the affected limb was limited due to pain. Distal pulses on the lower extremity were present and equal bilaterally. Laboratory examination revealed white blood cell (WBC) = 16.4 with 41% bands. Blood cultures were sent and intravenous vancomycin, ciprofloxacin, clindamycin, and metronidazole were started. A computed tomography (CT)‐scan of the left lower extremity was performed and revealed skin thickening and reticulation of the subcutaneous tissues edema extending from the left groin to the left buttock. Several foci of gas were present within the soft tissues with the largest in the lateral aspect of the buttocks of gas in the soft tissues (Figure 1). The Laboratory Risk Indicator for Necrotizing Fasciitis, the patient scored a 3 out of a possible 13 points. The diagnosis of necrotizing fasciitis was made based on clinical findings and radiographic imaging.

Figure 1
Computed tomography‐scan of the left lower extremity. The arrow points to several foci of gas present within the soft tissues.

Assessment

Patient became significantly hypotensive which required vasopressor support. He underwent surgical exploration of the left inguinal area. During surgery, tender crepitation of the antero‐lateral aspect of the thigh was noted. Extensive debridement with fasciotomy was performed. Tissue was sent for histopathological analysis and gram‐stain. A negative‐pressure wound dressing was placed over the defect. Post‐operatively, patient required intubation and continued vasopressor support. On post‐operative day 3, patient was extubated. Wound culture report revealed gram negative rods and Enterococcus faecalis which was sensitive to the patients' current antibiotic regimen. Clindamycin was discontinued. The patient was discharged to a subacute rehabilitation facility and returned for a split thickness skin graft 2 months after initial presentation.

Necrotizing fasciitis is a deep‐seated infection of the subcutaneous tissue that results in progressive destruction of fascia and fat. Presenting symptoms include pain, erythema, or bullae formation at the site of infection. Systemic symptoms such as fever, malaise, and myalgias may also be present at the time of presentation. Two types of necrotizing fasciitis are noted to occur. Type 1 is a mixed infection with a predominance of anaerobes1 and carries a 21% mortality.2 It is common post‐operatively and in patients with diabetes. In type 2 necrotizing fasciitis, Group‐A streptococcus was the most common cause of monomicrobial necrotizing fasciitis2 and mortality can be as high as 30%.3 Risk factors for the development of fasciitis include immunosuppression, diabetes, surgery, or penetrating injuries. Gas on soft tissue x‐rays, CT scan, or magnetic resonance imaging (MRI) is a highly specific but insensitive finding and is common in type I necrotizing fasciitis.

The patient in this case likely developed type I necrotizing fasciitis due to the presence of gas on CT scan and polymicrobial culture findings.

Diagnosis

A PubMed search of necrotizing fasciitis and acupuncture reveals only one case report, in which a diabetic patient underwent an unsterile acupuncture consultation.4 To our knowledge, we are the first to describe necrotizing fasciitis occurring in a nondiabetic patient who underwent a sterile acupuncture technique.

Given the lack of an explainable causal relationship regarding the pathogenesis of necrotizing fasciitis in our patient, it appears to be due to the acupuncture needle placement. The patient had no other history of abscesses, trauma and other portals of entry. The patient's presentation, temporal relation of the site of acupuncture, and the development of infection prompted a high index of suspicion as acupuncture as the main etiology.

Management

Treatment of necrotizing fasciitis includes early and aggressive surgical debridement. Multiple antibiotic regimens may be necessary due to the polymicrobial nature of the infection. In our patient, ciprofloxacin was initiated for broadened gram negative coverage, vancomycin for community acquired methicillin‐resistant Staphylococcus aureus (MRSA) and metronidazole for anaerobic coverage. Clindamycin was initiated due to concerns of toxin production, but was discontinued as the patient's condition improved.

Although complications of acupuncture may be rare, there exists the potential to cause life threatening complications. Necrotizing fasciitis has been observed as an adverse effect of acupuncture in a single diabetic patient,4 but can develop in nondiabetic individuals, such as in our patient.

Presentation

An 84 year‐old male with past history of osteoarthritis, extensive degenerative spine disease with spinal stenosis presented to the emergency room with left groin pain accompanied by a foul‐smelling discharge from the acupuncture site. He had been receiving regular physical therapy and acupuncture sessions for the past 6 months prior to his presentation. One and a half weeks prior to presentation, needles were inserted over the left groin as part of his acupuncture regimen. The patient described the acupuncture needles originating from a single use, unopened package. Additionally, the patient states his skin was cleaned with an antiseptic solution prior to insertion. Within 3 days, he developed generalized weakness, malaise with localized swelling, erythema, and warmth over the left groin area. His primary care physician performed an incision and drainage and prescribed ciprofloxacin. The patient continued to experience worsening fatigue, difficulty ambulating, ongoing purulent drainage, and consequently presented to the hospital for further evaluation. The patient has an allergy to penicillin but no history of diabetes. He quit smoking 40 years ago and has occasional alcohol intake. Surgical history includes bilateral knee replacement 15 years ago for osteoarthritis and right inguinal hernia repair and appendectomy 60 years ago.

On physical examination the patient had a temperature of 96.8F, pulse of 88 beats per minute, blood pressure of 97/63 mm Hg, and an oxygen saturation of 98% on room air. There was extensive swelling, erythema, and induration of the left anterior and proximal inguinal area, with a 2‐cm malodorous ulcer over the midline thigh. No crepitation or mass was palpable. Range of motion at the hip on the affected limb was limited due to pain. Distal pulses on the lower extremity were present and equal bilaterally. Laboratory examination revealed white blood cell (WBC) = 16.4 with 41% bands. Blood cultures were sent and intravenous vancomycin, ciprofloxacin, clindamycin, and metronidazole were started. A computed tomography (CT)‐scan of the left lower extremity was performed and revealed skin thickening and reticulation of the subcutaneous tissues edema extending from the left groin to the left buttock. Several foci of gas were present within the soft tissues with the largest in the lateral aspect of the buttocks of gas in the soft tissues (Figure 1). The Laboratory Risk Indicator for Necrotizing Fasciitis, the patient scored a 3 out of a possible 13 points. The diagnosis of necrotizing fasciitis was made based on clinical findings and radiographic imaging.

Figure 1
Computed tomography‐scan of the left lower extremity. The arrow points to several foci of gas present within the soft tissues.

Assessment

Patient became significantly hypotensive which required vasopressor support. He underwent surgical exploration of the left inguinal area. During surgery, tender crepitation of the antero‐lateral aspect of the thigh was noted. Extensive debridement with fasciotomy was performed. Tissue was sent for histopathological analysis and gram‐stain. A negative‐pressure wound dressing was placed over the defect. Post‐operatively, patient required intubation and continued vasopressor support. On post‐operative day 3, patient was extubated. Wound culture report revealed gram negative rods and Enterococcus faecalis which was sensitive to the patients' current antibiotic regimen. Clindamycin was discontinued. The patient was discharged to a subacute rehabilitation facility and returned for a split thickness skin graft 2 months after initial presentation.

Necrotizing fasciitis is a deep‐seated infection of the subcutaneous tissue that results in progressive destruction of fascia and fat. Presenting symptoms include pain, erythema, or bullae formation at the site of infection. Systemic symptoms such as fever, malaise, and myalgias may also be present at the time of presentation. Two types of necrotizing fasciitis are noted to occur. Type 1 is a mixed infection with a predominance of anaerobes1 and carries a 21% mortality.2 It is common post‐operatively and in patients with diabetes. In type 2 necrotizing fasciitis, Group‐A streptococcus was the most common cause of monomicrobial necrotizing fasciitis2 and mortality can be as high as 30%.3 Risk factors for the development of fasciitis include immunosuppression, diabetes, surgery, or penetrating injuries. Gas on soft tissue x‐rays, CT scan, or magnetic resonance imaging (MRI) is a highly specific but insensitive finding and is common in type I necrotizing fasciitis.

The patient in this case likely developed type I necrotizing fasciitis due to the presence of gas on CT scan and polymicrobial culture findings.

Diagnosis

A PubMed search of necrotizing fasciitis and acupuncture reveals only one case report, in which a diabetic patient underwent an unsterile acupuncture consultation.4 To our knowledge, we are the first to describe necrotizing fasciitis occurring in a nondiabetic patient who underwent a sterile acupuncture technique.

Given the lack of an explainable causal relationship regarding the pathogenesis of necrotizing fasciitis in our patient, it appears to be due to the acupuncture needle placement. The patient had no other history of abscesses, trauma and other portals of entry. The patient's presentation, temporal relation of the site of acupuncture, and the development of infection prompted a high index of suspicion as acupuncture as the main etiology.

Management

Treatment of necrotizing fasciitis includes early and aggressive surgical debridement. Multiple antibiotic regimens may be necessary due to the polymicrobial nature of the infection. In our patient, ciprofloxacin was initiated for broadened gram negative coverage, vancomycin for community acquired methicillin‐resistant Staphylococcus aureus (MRSA) and metronidazole for anaerobic coverage. Clindamycin was initiated due to concerns of toxin production, but was discontinued as the patient's condition improved.

Although complications of acupuncture may be rare, there exists the potential to cause life threatening complications. Necrotizing fasciitis has been observed as an adverse effect of acupuncture in a single diabetic patient,4 but can develop in nondiabetic individuals, such as in our patient.

References
  1. Brook I,Frazier EH.Clinical and microbiological features of necrotizing fasciitis.J Clin Microbiol.1995;33(9):23822387.
  2. Wong CH,Chang HC,Pasupathy S,Khin LW,Tan JL.Low CO Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality.J Bone Joint Surg Am.2003;85‐A(8):14541460.
  3. Stevens DL,Tanner MH,Winship J, et al.Severe group A streptococcal infections associated with a toxic shock‐like syndrome and scarlet fever toxin A.N Engl J Med.1989;321(1):17.
  4. Saw A,Kwan MK,Sengupta S.Necrotising fasciitis: a life‐threatening complication of acupuncture in a patient with diabetes mellitus.Singapore Med J.2004;45(4):180182.
References
  1. Brook I,Frazier EH.Clinical and microbiological features of necrotizing fasciitis.J Clin Microbiol.1995;33(9):23822387.
  2. Wong CH,Chang HC,Pasupathy S,Khin LW,Tan JL.Low CO Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality.J Bone Joint Surg Am.2003;85‐A(8):14541460.
  3. Stevens DL,Tanner MH,Winship J, et al.Severe group A streptococcal infections associated with a toxic shock‐like syndrome and scarlet fever toxin A.N Engl J Med.1989;321(1):17.
  4. Saw A,Kwan MK,Sengupta S.Necrotising fasciitis: a life‐threatening complication of acupuncture in a patient with diabetes mellitus.Singapore Med J.2004;45(4):180182.
Issue
Journal of Hospital Medicine - 5(9)
Issue
Journal of Hospital Medicine - 5(9)
Page Number
565-566
Page Number
565-566
Article Type
Display Headline
Necrotizing fasciitis associated with acupuncture: A case report
Display Headline
Necrotizing fasciitis associated with acupuncture: A case report
Legacy Keywords
acupuncture, infection, necrotizing Fasciitis
Legacy Keywords
acupuncture, infection, necrotizing Fasciitis
Sections
Article Source
Copyright © 2010 Society of Hospital Medicine
Disallow All Ads
Correspondence Location
100 East 77th Street, New York, New York 10075
Content Gating
Gated (full article locked unless allowed per User)
Gating Strategy
First Peek Free
Article PDF Media

Performance of Dutch hospitals in the management of splenectomized patients

Article Type
Changed
Display Headline
Performance of Dutch hospitals in the management of splenectomized patients

Patients without a spleen have a diminished host immune defense in response to bacteria.1 Especially in the first 2 years after surgery there is a risk for severe infection, mostly with encapsulated bacteria such as Streptococcus pneumoniae.2 This syndrome is called post‐splenectomy sepsis (PSS), and although the incidence is estimated to be low, it is associated with a high mortality of 50% to 70%.2 Importantly, PSS can largely be prevented if protective measures such as immunization and the prescription of antibiotics are taken. Several relevant organizations and committees have developed guidelines for prevention of infections in this group of patients.3 The recommendations by the British Committee for Standards in Haematology are currently considered to reflect best practice4, 5 and consist of the key‐elements shown in Box 1.

Unfortunately, adherence to guidelines is generally considered to be low.6 One of the most consistent findings in health services research is the gap between best practice and actual clinical care.7, 8 We have shown earlier that management of splenectomized patients in the Netherlands is not optimal (Lammers et al., Management of post‐splenectomy patients in the Netherlands, EJCMID, in press, DOI: 10.1007/s10096‐009‐0870‐x).

Several studies demonstrate that performance of hospitals is related to structural characteristics such as teaching status and practice organization.911 A large review showed that teaching hospitals in general offer better care than nonteaching hospitals. Furthermore, major teaching hospitals perform better than minor and nonteaching hospitals.12, 13

The aim of the present study was to investigate whether or not hospital structural characteristics of care delivery are associated with better compliance with best‐practice guidelines for preventing infections in splenectomized patients in Dutch hospitals. Our research questions were two‐fold: (1) are teaching hospitals delivering better quality of care in the prevention of infections in splenectomized patients than nonteaching hospitals and (2) is there an association between characteristics of practice organization (ie, the size of the surgical staff, the availability of a protocol for post‐splenectomy management, and the use of a complication registry by the department of surgery) and quality of care. Quality of care parameters were defined as outcome of adherence to the prevention guidelines of the British Committee for Standards in Haematology.

 

Key Recommendations for the Management of Asplenic Patients by the British Committee for Standards in Haematology

 

  • 1. Splenectomised patients should receive pneumococcal immunization (23‐valent polysaccharide vaccine, PPV‐23) and lifelong revaccination. They should also receive Haemophilus influenzae type B and meningococcal C vaccine. Yearly influenza immunization is recommended.

  • 2. Continuous prophylactic antibiotics are recommended for the first two years after splenectomy. In case of suspected or proven infection during or after these 2 years, patients should be given systemic antibiotics and be admitted to a hospital.

  • 3. All patients should be educated about the risks of infection (PSS) and the risk associated with traveling (such as infection with Plasmodium falciparum) and unusual infections (ie, dog bites).

 

 

Methods

Hospital and Patient Inclusion

This study was approved by the medical ethics committee of the Academic Medical Center, Amsterdam, the Netherlands. After approval, we composed a representative sample out of the total of 93 Dutch hospitals, by including hospitals through a blind drawing. Hospitals were divided into 3 categories: (1) university hospitals, (2) nonuniversity teaching hospitals and (3) nonteaching hospitals. The teaching status of nonuniversity hospitals was based on the (non) presence of an internal or surgical medicine residency training program. After the drawing, each group contained 30% of the total number of Dutch hospitals in its category (source: RIVM, Nationale Atlas Volksgezondheid, 2007).

Subsequently, splenectomized patients were included retrospectively using the Dutch Pathology Registry, since spleens are routinely sent to pathology after removal. In this Registry, a search query *milt* (spleen) was performed, after which all splenectomies performed from 1997 to 2008 were selected and nonrelevant hits such as partial splenectomies or spleen biopsies were removed.

Data Collection

After hospitals and patients were identified, the medical file and all discharge correspondence were assessed on site. All data were collected separately for each hospital by the same 2 investigators (DV, JL) using a standardized survey form. To investigate discharge correspondence, discharge letters as well as all other correspondence up to at least 1 year after splenectomy were included, for example from follow‐up out‐patient visits.

After hospital category was documented, we registered for each hospital the size of the surgical staff at the time of inclusion, the availability of any form of protocol of the surgical department reflecting hospital post‐splenectomy policy, and the practice of systematically registering (surgical) complications by the department of surgery. Patient data included demographics, documentation of vaccine administration and documentation of the prescription of antibiotics. Furthermore, discharge correspondence was checked for mentioning of each of the following: performed splenectomy, vaccination status, the need for revaccination, prescribed prophylactic antibiotics, the need of urgent use of antibiotics in case of suspected infection, and the advice for annual flu‐vaccination.

Data Analysis

When computing vaccination rates, we included only those patients who survived the first 2 weeks after surgery, since correct vaccination is considered by the British Committee to be given 2 weeks prior to or at least 2 or more weeks after surgery. Pneumococcal vaccination was defined as immunization with either the 23‐valent pneumococcal polysaccharides vaccine (PPV‐23, Pneumovax), the 7‐valent pneumococcal conjugate vaccine (PCV‐7, Prevenar), or both.

Prophylactic antibiotics were defined as a prescription of antibiotics for the first 2 years after splenectomy. On demand antibiotics were defined as a prescription to be given to the patient at discharge, to use in case of suspected infection. When investigating prescription rates of prophylactic antibiotics, we excluded patients deceased in the first 2 weeks after surgery, regarding their death as a complication of surgery. In case of on demand antibiotics, patients who died in the hospital before their discharge were excluded as well. When investigating discharge information to the general practitioner (GP), only those patients alive at time of discharge were excluded.

Statistical Analysis

First, we have described the study sample using standard descriptive statistics. Second, to explore differences in performance and calculate P values, we used a chi‐square test between the 3 categories of hospitals (Table 2), between presence or absence of a protocol (Table 3) and complication registry. The influence of surgical staff size (divided into 1‐8 surgeons or >8 surgeons) was calculated using multivariate logistic regression analysis, where surgical staff size and hospital teaching status were used as covariates in the analysis. All statistical analysis of data was performed in SPSS 16.0.

Hospital Demographics
 UniversityNonuniversity TeachingNonteaching
Hospitals, n (number of patients)2 (40)15 (287)11 (209)
Mean number of surgical staff per hospital (range)20 (1822)9.2 (316)5.5 (47)
Presence of splenectomy protocol at surgical department, n (%)2 (100)14 (93)7 (64)
Presence of complication registry at surgical department, n (%)2 (100)15 (100)9 (82)
Guideline Compliance in Relation to Hospital Teaching Status
 Hospital (n = Number of Patients)University (n = 33)Nonuniversity Teaching (n = 268)Nonteaching (n = 197)P Value
  • NOTE: P value calculated by means of chi‐square testing of 3 categories of hospitals.

  • Prophylaxis: prescription of continuous antibiotic therapy for 2 years after surgery.

  • On‐demand: prescription for antibiotics to be used in case of (suspected) infection.

  • Only when pneumococcal vaccination was given.

Immunizations (%)Pneumococcal9085.584.30.559
 H. influenzae B66.740.333.50.001
 Meningococcal C63.630.629.4<0.001
Antibiotics (%)Prophylaxis*21.214.18.60.056
 On‐demand6.38.59.50.812
 Both18.83.60<0.001
 None53.172.681.50.001
Discharge letters mentioning (%)Splenectomy1009896.80.425
 Immunization83.38180.50.609
 Booster immunization40.622.222.80.113
 Influenza vaccination259.814.30.021
 On‐demand antibiotics37.517.723.30.015
Guideline Compliance in Relation to the Availability of a Protocol
 Protocol PresentNo ProtocolP Value
  • NOTE: P value calculated by means of chi‐square testing.

  • Prophylaxis: prescription for continuous antibiotic therapy for 2 years after splenectomy.

  • On‐demand: prescription for antibiotics to be used in case of (suspected) infection.

  • Only when pneumococcal vaccination was given.

Immunizations (%)   
Pneumococcal85.385.90.671
H. influenzae B40.235.30.970
Meningococcal C33.725.90.188
Antibiotics (%)   
Prophylaxis*13.86.3<0.001
On‐demand9.55.50.001
Both3.900.062
None7287.70.230
Discharge letters mentioning (%)   
Splenectomy97.798.80.096
Immunization81.478.60.321
Booster immunization25.513.80.048
Influenza vaccination14.450.024
On‐demand antibiotics23.212.50.213

Results

We included 28 of 93 Dutch hospitals (30%), containing a total of 536 splenectomized patients (Table 1.) Five hospitals were excluded because they refused cooperation, and were subsequently replaced by comparable hospitals in their category.

Differences Between University and Nonteaching Hospitals

Hospital performance of Dutch university, nonuniversity teaching, and nonteaching hospitals is shown in Table 2. Admission to a university hospital is associated with better guideline adherence: 22 of 33 of patients (66.7%) in university hospitals were immunized with H. influenzae B as compared to 108 of 268 patients (40.3%) in nonuniversity teaching and 66 of 197 (33.5%) in nonteaching hospitals. Vaccination with N. meningitidis C occurred in 21 of 33 patients (63.6%) as compared to 82 of 268 patients (30.6%) in nonuniversity teaching and 58 of 197 (29.4%) in nonteaching hospitals. In 53.1% of patients no antibiotics were prescribed in university hospitals, as compared to 72.6% in nonuniversity teaching and 82.5% in nonteaching hospitals. Differences between nonuniversity teaching hospitals and nonteaching hospitals were small.

Presence of a Post‐Splenectomy Protocol

The availability of a protocol at the surgical department was not associated with higher vaccination rates (Table 3). It did however show a positive relation on the prescription of prophylactic antibiotics. The effect of a protocol on the quality of discharge information to the GP was minimal.

Size of Surgical Staff

Performance in relation to the size of surgical staff was determined (data not shown). There were no differences in vaccination rates or quality of discharge information between the groups of different sizes (less or more than 8 surgeons). Larger surgical groups seemed to perform better in prescribing antibiotics, however when adjusting for hospital category in multivariate analysis these differences were not significant.

Complication Registry

Complications were systematically registered by all but 2 surgical departments in nonteaching hospitals, composing a cohort of 27 patients.

Although numbers are low, it demonstrates that in the absence of a registry, the guideline adherence for this group of patients was similar, and only prophylactic antibiotics were significantly less prescribed: 62 of 473 patients (13.1%) in the presence of a registry, as compared to 0 of 27 patients in absence of a registry (P value = 0.044) (data not shown). The precise role of the registry herein remains unclear, since both hospitals also lacked a hospital post‐splenectomy protocol.

Discussion

Main Findings

The aim of the present study was to investigate quality of care for splenectomized patients in Dutch hospitals with different teaching status. In general, beneficial effects of teaching status only extended to university hospitals in the Netherlands. Other teaching hospitals performed similarly to nonteaching hospitals in the Netherlands. Hospitals in which the surgical department developed a local protocol with recommendations for managing patients after splenectomy did not achieve higher vaccination rates. There was, however, an improvement in prescription of antibiotics and in the quality of discharge correspondence from the hospital to the GP. Surgical staff size was not related to hospital performance.

Explanation of Results

In the Netherlands, all categories of hospitals provided over 80% of their post‐splenectomy patients with pneumococcal immunization, reflecting that Dutch physicians in general are aware of the need for pneumococcal protection after splenectomy. However, university hospitals had better performance results regarding immunizing patients with all 3 recommended vaccines, as well as prescribing prophylactic antibiotics in combination with a prescription for on‐demand antibiotics. Collectively, university hospitals offered their patients a more complete post‐splenectomy treatment.

It has been described elsewhere that minor teaching and nonteaching hospitals show small differences, and that nonteaching hospitals even perform better at certain indicators than minor teaching hospitals.13 We indeed found small differences between nonuniversity teaching hospitals and nonteaching hospitals, where nonuniversity teaching hospitals performed better at prescribing antibiotics, and nonteaching hospitals did better at giving recommendations to the GP on booster immunization and use of on‐demand antibiotics.

Hospital characteristics have been shown to have important effects on hospital outcomes.10, 14, 15 We hypothesized this would also be the case regarding the adherence to post‐splenectomy management recommendations. In particular, we were expecting to find that the availability of a protocol at the department of surgery would be associated with better compliance with all key recommendations in the British Standards, however, vaccination rates did not differ form departments without a protocol. The items that were generally most eligible for improvement seemed to benefit most from the presence of a protocol.

Neither the presence of a protocol nor the size of the surgical staff were related to better performance in university hospitals. We can therefore only speculate about the explanation for the differences found between university and other hospitals. Organizational differences may not be disregarded; it has been described elsewhere that better quality and processes of care are delivered in major teaching hospitals.16, 9, 12 Most prior studies have reported a lower risk‐adjusted mortality in major teaching hospitals as compared with minor teaching or nonteaching hospitals.9, 12 It is also possible that residency and fellowship programs contribute to better compliance of guidelines and have a favorable impact on the delivery of patient care in teaching hospitals.12

Limitations

In absence of a Dutch guideline we chose to investigate adherence to the recommendations by the British Committee for Standards in Haematology, assuming that Dutch professionals have some knowledge of these recommendations. Although these recommendations are internationally considered to reflect current best practice and patients should therefore be managed according to at least comparable standards, the extent of familiarity and use of the British standards by Dutch physicians remains to be investigated in the future. Furthermore, we investigated the availability of a locally designed protocol on the management of post‐splenectomy patients by the surgical department. Checking the contents of each of these local protocols was not part of our study and thus we can not exclude that these protocols are lacking certain recommendations. It also remains unclear how hospitals have implemented their protocols.

Implications for Future Research and Policy

In the Netherlands, hospitals could offer better quality of care for hyposplenic and asplenic patients in the prevention of infections by increasing immunization rates. Furthermore, although academic centers performed better than the other hospital categories, only a minority of patients were given or advised to receive on demand antibiotics. Here lies a tremendous opportunity to improve patient care in the prevention of severe infections.

Potential barriers that exist for delivering optimal care to these patients remain to be investigated. Furthermore, although teaching status is related to performance, the explanation for this difference remains unclear. The results of this study suggest that there is a relation between characteristics of practice organization and performance, but these characteristics should be further elucidated.

Conclusion

University hospitals offer higher guideline adherence in preventing infections after splenectomy than other teaching and nonteaching hospitals. For all Dutch hospitals there is room for improving the quality of post‐splenectomy patient care. The results of this study suggest that the difference in performance may be related to several characteristics of hospital practice organization. Future research should further investigate these hospital characteristics and their influence on performance.

Acknowledgements

The authors would like to thank all participating hospitals.

References
  1. Mebius RE, Kraal G.Structure and function of the spleen.Nat Rev Immunol.2005;5:606616.
  2. Holdsworth RJ, Irving AD, Cuschieri A.Postsplenectomy sepsis and its mortality rate: actual versus perceived risks.Br J Surg.1991;78:10311038.
  3. Mourtzoukou EG, Pappas G, Peppas G, Falagas ME.Vaccination of asplenic or hyposplenic adults.Br J Surg.2008;95:273280.
  4. Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen.Working Party of the British Committee for Standards in Haematology Clinical Haematology Task Force.BMJ.1996;312:430434.
  5. Davies JM, Barnes R, Milligan D.Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen.Clin Med.2002;2:440443.
  6. Cabana MD, Rand CS, Powe NR, et al.Why don't physicians follow clinical practice guidelines? A framework for improvement.JAMA.1999;282:14581465.
  7. Grimshaw J, Eccles M, Tetroe J.Implementing clinical guidelines: current evidence and future implications.J Contin Educ Health Prof.2004;24 Suppl 1:S31S37.
  8. Grol R, Grimshaw J.From best evidence to best practice: effective implementation of change in patients' care.Lancet.2003;362:12251230.
  9. Allison JJ, Kiefe CI, Weissman NW, et al.Relationship of hospital teaching status with quality of care and mortality for Medicare patients with acute MI.JAMA.2000;284:12561262.
  10. Chen J, Radford MJ, Wang Y, Marciniak TA, Krumholz HM.Do “America's Best Hospitals” perform better for acute myocardial infarction?N Engl J Med.1999;340:286292.
  11. Lingsma HF, Dippel DW, Hoeks SE, et al.Variation between hospitals in patient outcome after stroke is only partly explained by differences in quality of care: results from the Netherlands Stroke Survey.J Neurol Neurosurg Psychiatry.2008;79:888894.
  12. Polanczyk CA, Lane A, Coburn M, Philbin EF, Dec GW, DiSalvo TG.Hospital outcomes in major teaching, minor teaching, and nonteaching hospitals in New York state.Am J Med.2002;112:255261.
  13. Ayanian JZ, Weissman JS.Teaching hospitals and quality of care: a review of the literature.Milbank Q.2002;80:569593, v.
  14. Thiemann DR, Coresh J, Oetgen WJ, Powe NR.The association between hospital volume and survival after acute myocardial infarction in elderly patients.N Engl J Med.1999;340:16401648.
  15. Yuan Z, Cooper GS, Einstadter D, Cebul RD, Rimm AA.The association between hospital type and mortality and length of stay: a study of 16.9 million hospitalized Medicare beneficiaries.Med Care.2000;38:231245.
  16. Kupersmith J.Quality of care in teaching hospitals: a literature review.Acad Med.2005;80:458466.
Article PDF
Issue
Journal of Hospital Medicine - 5(8)
Page Number
466-470
Legacy Keywords
hospital, management, performance, post‐splenectomy, teaching status
Sections
Article PDF
Article PDF

Patients without a spleen have a diminished host immune defense in response to bacteria.1 Especially in the first 2 years after surgery there is a risk for severe infection, mostly with encapsulated bacteria such as Streptococcus pneumoniae.2 This syndrome is called post‐splenectomy sepsis (PSS), and although the incidence is estimated to be low, it is associated with a high mortality of 50% to 70%.2 Importantly, PSS can largely be prevented if protective measures such as immunization and the prescription of antibiotics are taken. Several relevant organizations and committees have developed guidelines for prevention of infections in this group of patients.3 The recommendations by the British Committee for Standards in Haematology are currently considered to reflect best practice4, 5 and consist of the key‐elements shown in Box 1.

Unfortunately, adherence to guidelines is generally considered to be low.6 One of the most consistent findings in health services research is the gap between best practice and actual clinical care.7, 8 We have shown earlier that management of splenectomized patients in the Netherlands is not optimal (Lammers et al., Management of post‐splenectomy patients in the Netherlands, EJCMID, in press, DOI: 10.1007/s10096‐009‐0870‐x).

Several studies demonstrate that performance of hospitals is related to structural characteristics such as teaching status and practice organization.911 A large review showed that teaching hospitals in general offer better care than nonteaching hospitals. Furthermore, major teaching hospitals perform better than minor and nonteaching hospitals.12, 13

The aim of the present study was to investigate whether or not hospital structural characteristics of care delivery are associated with better compliance with best‐practice guidelines for preventing infections in splenectomized patients in Dutch hospitals. Our research questions were two‐fold: (1) are teaching hospitals delivering better quality of care in the prevention of infections in splenectomized patients than nonteaching hospitals and (2) is there an association between characteristics of practice organization (ie, the size of the surgical staff, the availability of a protocol for post‐splenectomy management, and the use of a complication registry by the department of surgery) and quality of care. Quality of care parameters were defined as outcome of adherence to the prevention guidelines of the British Committee for Standards in Haematology.

 

Key Recommendations for the Management of Asplenic Patients by the British Committee for Standards in Haematology

 

  • 1. Splenectomised patients should receive pneumococcal immunization (23‐valent polysaccharide vaccine, PPV‐23) and lifelong revaccination. They should also receive Haemophilus influenzae type B and meningococcal C vaccine. Yearly influenza immunization is recommended.

  • 2. Continuous prophylactic antibiotics are recommended for the first two years after splenectomy. In case of suspected or proven infection during or after these 2 years, patients should be given systemic antibiotics and be admitted to a hospital.

  • 3. All patients should be educated about the risks of infection (PSS) and the risk associated with traveling (such as infection with Plasmodium falciparum) and unusual infections (ie, dog bites).

 

 

Methods

Hospital and Patient Inclusion

This study was approved by the medical ethics committee of the Academic Medical Center, Amsterdam, the Netherlands. After approval, we composed a representative sample out of the total of 93 Dutch hospitals, by including hospitals through a blind drawing. Hospitals were divided into 3 categories: (1) university hospitals, (2) nonuniversity teaching hospitals and (3) nonteaching hospitals. The teaching status of nonuniversity hospitals was based on the (non) presence of an internal or surgical medicine residency training program. After the drawing, each group contained 30% of the total number of Dutch hospitals in its category (source: RIVM, Nationale Atlas Volksgezondheid, 2007).

Subsequently, splenectomized patients were included retrospectively using the Dutch Pathology Registry, since spleens are routinely sent to pathology after removal. In this Registry, a search query *milt* (spleen) was performed, after which all splenectomies performed from 1997 to 2008 were selected and nonrelevant hits such as partial splenectomies or spleen biopsies were removed.

Data Collection

After hospitals and patients were identified, the medical file and all discharge correspondence were assessed on site. All data were collected separately for each hospital by the same 2 investigators (DV, JL) using a standardized survey form. To investigate discharge correspondence, discharge letters as well as all other correspondence up to at least 1 year after splenectomy were included, for example from follow‐up out‐patient visits.

After hospital category was documented, we registered for each hospital the size of the surgical staff at the time of inclusion, the availability of any form of protocol of the surgical department reflecting hospital post‐splenectomy policy, and the practice of systematically registering (surgical) complications by the department of surgery. Patient data included demographics, documentation of vaccine administration and documentation of the prescription of antibiotics. Furthermore, discharge correspondence was checked for mentioning of each of the following: performed splenectomy, vaccination status, the need for revaccination, prescribed prophylactic antibiotics, the need of urgent use of antibiotics in case of suspected infection, and the advice for annual flu‐vaccination.

Data Analysis

When computing vaccination rates, we included only those patients who survived the first 2 weeks after surgery, since correct vaccination is considered by the British Committee to be given 2 weeks prior to or at least 2 or more weeks after surgery. Pneumococcal vaccination was defined as immunization with either the 23‐valent pneumococcal polysaccharides vaccine (PPV‐23, Pneumovax), the 7‐valent pneumococcal conjugate vaccine (PCV‐7, Prevenar), or both.

Prophylactic antibiotics were defined as a prescription of antibiotics for the first 2 years after splenectomy. On demand antibiotics were defined as a prescription to be given to the patient at discharge, to use in case of suspected infection. When investigating prescription rates of prophylactic antibiotics, we excluded patients deceased in the first 2 weeks after surgery, regarding their death as a complication of surgery. In case of on demand antibiotics, patients who died in the hospital before their discharge were excluded as well. When investigating discharge information to the general practitioner (GP), only those patients alive at time of discharge were excluded.

Statistical Analysis

First, we have described the study sample using standard descriptive statistics. Second, to explore differences in performance and calculate P values, we used a chi‐square test between the 3 categories of hospitals (Table 2), between presence or absence of a protocol (Table 3) and complication registry. The influence of surgical staff size (divided into 1‐8 surgeons or >8 surgeons) was calculated using multivariate logistic regression analysis, where surgical staff size and hospital teaching status were used as covariates in the analysis. All statistical analysis of data was performed in SPSS 16.0.

Hospital Demographics
 UniversityNonuniversity TeachingNonteaching
Hospitals, n (number of patients)2 (40)15 (287)11 (209)
Mean number of surgical staff per hospital (range)20 (1822)9.2 (316)5.5 (47)
Presence of splenectomy protocol at surgical department, n (%)2 (100)14 (93)7 (64)
Presence of complication registry at surgical department, n (%)2 (100)15 (100)9 (82)
Guideline Compliance in Relation to Hospital Teaching Status
 Hospital (n = Number of Patients)University (n = 33)Nonuniversity Teaching (n = 268)Nonteaching (n = 197)P Value
  • NOTE: P value calculated by means of chi‐square testing of 3 categories of hospitals.

  • Prophylaxis: prescription of continuous antibiotic therapy for 2 years after surgery.

  • On‐demand: prescription for antibiotics to be used in case of (suspected) infection.

  • Only when pneumococcal vaccination was given.

Immunizations (%)Pneumococcal9085.584.30.559
 H. influenzae B66.740.333.50.001
 Meningococcal C63.630.629.4<0.001
Antibiotics (%)Prophylaxis*21.214.18.60.056
 On‐demand6.38.59.50.812
 Both18.83.60<0.001
 None53.172.681.50.001
Discharge letters mentioning (%)Splenectomy1009896.80.425
 Immunization83.38180.50.609
 Booster immunization40.622.222.80.113
 Influenza vaccination259.814.30.021
 On‐demand antibiotics37.517.723.30.015
Guideline Compliance in Relation to the Availability of a Protocol
 Protocol PresentNo ProtocolP Value
  • NOTE: P value calculated by means of chi‐square testing.

  • Prophylaxis: prescription for continuous antibiotic therapy for 2 years after splenectomy.

  • On‐demand: prescription for antibiotics to be used in case of (suspected) infection.

  • Only when pneumococcal vaccination was given.

Immunizations (%)   
Pneumococcal85.385.90.671
H. influenzae B40.235.30.970
Meningococcal C33.725.90.188
Antibiotics (%)   
Prophylaxis*13.86.3<0.001
On‐demand9.55.50.001
Both3.900.062
None7287.70.230
Discharge letters mentioning (%)   
Splenectomy97.798.80.096
Immunization81.478.60.321
Booster immunization25.513.80.048
Influenza vaccination14.450.024
On‐demand antibiotics23.212.50.213

Results

We included 28 of 93 Dutch hospitals (30%), containing a total of 536 splenectomized patients (Table 1.) Five hospitals were excluded because they refused cooperation, and were subsequently replaced by comparable hospitals in their category.

Differences Between University and Nonteaching Hospitals

Hospital performance of Dutch university, nonuniversity teaching, and nonteaching hospitals is shown in Table 2. Admission to a university hospital is associated with better guideline adherence: 22 of 33 of patients (66.7%) in university hospitals were immunized with H. influenzae B as compared to 108 of 268 patients (40.3%) in nonuniversity teaching and 66 of 197 (33.5%) in nonteaching hospitals. Vaccination with N. meningitidis C occurred in 21 of 33 patients (63.6%) as compared to 82 of 268 patients (30.6%) in nonuniversity teaching and 58 of 197 (29.4%) in nonteaching hospitals. In 53.1% of patients no antibiotics were prescribed in university hospitals, as compared to 72.6% in nonuniversity teaching and 82.5% in nonteaching hospitals. Differences between nonuniversity teaching hospitals and nonteaching hospitals were small.

Presence of a Post‐Splenectomy Protocol

The availability of a protocol at the surgical department was not associated with higher vaccination rates (Table 3). It did however show a positive relation on the prescription of prophylactic antibiotics. The effect of a protocol on the quality of discharge information to the GP was minimal.

Size of Surgical Staff

Performance in relation to the size of surgical staff was determined (data not shown). There were no differences in vaccination rates or quality of discharge information between the groups of different sizes (less or more than 8 surgeons). Larger surgical groups seemed to perform better in prescribing antibiotics, however when adjusting for hospital category in multivariate analysis these differences were not significant.

Complication Registry

Complications were systematically registered by all but 2 surgical departments in nonteaching hospitals, composing a cohort of 27 patients.

Although numbers are low, it demonstrates that in the absence of a registry, the guideline adherence for this group of patients was similar, and only prophylactic antibiotics were significantly less prescribed: 62 of 473 patients (13.1%) in the presence of a registry, as compared to 0 of 27 patients in absence of a registry (P value = 0.044) (data not shown). The precise role of the registry herein remains unclear, since both hospitals also lacked a hospital post‐splenectomy protocol.

Discussion

Main Findings

The aim of the present study was to investigate quality of care for splenectomized patients in Dutch hospitals with different teaching status. In general, beneficial effects of teaching status only extended to university hospitals in the Netherlands. Other teaching hospitals performed similarly to nonteaching hospitals in the Netherlands. Hospitals in which the surgical department developed a local protocol with recommendations for managing patients after splenectomy did not achieve higher vaccination rates. There was, however, an improvement in prescription of antibiotics and in the quality of discharge correspondence from the hospital to the GP. Surgical staff size was not related to hospital performance.

Explanation of Results

In the Netherlands, all categories of hospitals provided over 80% of their post‐splenectomy patients with pneumococcal immunization, reflecting that Dutch physicians in general are aware of the need for pneumococcal protection after splenectomy. However, university hospitals had better performance results regarding immunizing patients with all 3 recommended vaccines, as well as prescribing prophylactic antibiotics in combination with a prescription for on‐demand antibiotics. Collectively, university hospitals offered their patients a more complete post‐splenectomy treatment.

It has been described elsewhere that minor teaching and nonteaching hospitals show small differences, and that nonteaching hospitals even perform better at certain indicators than minor teaching hospitals.13 We indeed found small differences between nonuniversity teaching hospitals and nonteaching hospitals, where nonuniversity teaching hospitals performed better at prescribing antibiotics, and nonteaching hospitals did better at giving recommendations to the GP on booster immunization and use of on‐demand antibiotics.

Hospital characteristics have been shown to have important effects on hospital outcomes.10, 14, 15 We hypothesized this would also be the case regarding the adherence to post‐splenectomy management recommendations. In particular, we were expecting to find that the availability of a protocol at the department of surgery would be associated with better compliance with all key recommendations in the British Standards, however, vaccination rates did not differ form departments without a protocol. The items that were generally most eligible for improvement seemed to benefit most from the presence of a protocol.

Neither the presence of a protocol nor the size of the surgical staff were related to better performance in university hospitals. We can therefore only speculate about the explanation for the differences found between university and other hospitals. Organizational differences may not be disregarded; it has been described elsewhere that better quality and processes of care are delivered in major teaching hospitals.16, 9, 12 Most prior studies have reported a lower risk‐adjusted mortality in major teaching hospitals as compared with minor teaching or nonteaching hospitals.9, 12 It is also possible that residency and fellowship programs contribute to better compliance of guidelines and have a favorable impact on the delivery of patient care in teaching hospitals.12

Limitations

In absence of a Dutch guideline we chose to investigate adherence to the recommendations by the British Committee for Standards in Haematology, assuming that Dutch professionals have some knowledge of these recommendations. Although these recommendations are internationally considered to reflect current best practice and patients should therefore be managed according to at least comparable standards, the extent of familiarity and use of the British standards by Dutch physicians remains to be investigated in the future. Furthermore, we investigated the availability of a locally designed protocol on the management of post‐splenectomy patients by the surgical department. Checking the contents of each of these local protocols was not part of our study and thus we can not exclude that these protocols are lacking certain recommendations. It also remains unclear how hospitals have implemented their protocols.

Implications for Future Research and Policy

In the Netherlands, hospitals could offer better quality of care for hyposplenic and asplenic patients in the prevention of infections by increasing immunization rates. Furthermore, although academic centers performed better than the other hospital categories, only a minority of patients were given or advised to receive on demand antibiotics. Here lies a tremendous opportunity to improve patient care in the prevention of severe infections.

Potential barriers that exist for delivering optimal care to these patients remain to be investigated. Furthermore, although teaching status is related to performance, the explanation for this difference remains unclear. The results of this study suggest that there is a relation between characteristics of practice organization and performance, but these characteristics should be further elucidated.

Conclusion

University hospitals offer higher guideline adherence in preventing infections after splenectomy than other teaching and nonteaching hospitals. For all Dutch hospitals there is room for improving the quality of post‐splenectomy patient care. The results of this study suggest that the difference in performance may be related to several characteristics of hospital practice organization. Future research should further investigate these hospital characteristics and their influence on performance.

Acknowledgements

The authors would like to thank all participating hospitals.

Patients without a spleen have a diminished host immune defense in response to bacteria.1 Especially in the first 2 years after surgery there is a risk for severe infection, mostly with encapsulated bacteria such as Streptococcus pneumoniae.2 This syndrome is called post‐splenectomy sepsis (PSS), and although the incidence is estimated to be low, it is associated with a high mortality of 50% to 70%.2 Importantly, PSS can largely be prevented if protective measures such as immunization and the prescription of antibiotics are taken. Several relevant organizations and committees have developed guidelines for prevention of infections in this group of patients.3 The recommendations by the British Committee for Standards in Haematology are currently considered to reflect best practice4, 5 and consist of the key‐elements shown in Box 1.

Unfortunately, adherence to guidelines is generally considered to be low.6 One of the most consistent findings in health services research is the gap between best practice and actual clinical care.7, 8 We have shown earlier that management of splenectomized patients in the Netherlands is not optimal (Lammers et al., Management of post‐splenectomy patients in the Netherlands, EJCMID, in press, DOI: 10.1007/s10096‐009‐0870‐x).

Several studies demonstrate that performance of hospitals is related to structural characteristics such as teaching status and practice organization.911 A large review showed that teaching hospitals in general offer better care than nonteaching hospitals. Furthermore, major teaching hospitals perform better than minor and nonteaching hospitals.12, 13

The aim of the present study was to investigate whether or not hospital structural characteristics of care delivery are associated with better compliance with best‐practice guidelines for preventing infections in splenectomized patients in Dutch hospitals. Our research questions were two‐fold: (1) are teaching hospitals delivering better quality of care in the prevention of infections in splenectomized patients than nonteaching hospitals and (2) is there an association between characteristics of practice organization (ie, the size of the surgical staff, the availability of a protocol for post‐splenectomy management, and the use of a complication registry by the department of surgery) and quality of care. Quality of care parameters were defined as outcome of adherence to the prevention guidelines of the British Committee for Standards in Haematology.

 

Key Recommendations for the Management of Asplenic Patients by the British Committee for Standards in Haematology

 

  • 1. Splenectomised patients should receive pneumococcal immunization (23‐valent polysaccharide vaccine, PPV‐23) and lifelong revaccination. They should also receive Haemophilus influenzae type B and meningococcal C vaccine. Yearly influenza immunization is recommended.

  • 2. Continuous prophylactic antibiotics are recommended for the first two years after splenectomy. In case of suspected or proven infection during or after these 2 years, patients should be given systemic antibiotics and be admitted to a hospital.

  • 3. All patients should be educated about the risks of infection (PSS) and the risk associated with traveling (such as infection with Plasmodium falciparum) and unusual infections (ie, dog bites).

 

 

Methods

Hospital and Patient Inclusion

This study was approved by the medical ethics committee of the Academic Medical Center, Amsterdam, the Netherlands. After approval, we composed a representative sample out of the total of 93 Dutch hospitals, by including hospitals through a blind drawing. Hospitals were divided into 3 categories: (1) university hospitals, (2) nonuniversity teaching hospitals and (3) nonteaching hospitals. The teaching status of nonuniversity hospitals was based on the (non) presence of an internal or surgical medicine residency training program. After the drawing, each group contained 30% of the total number of Dutch hospitals in its category (source: RIVM, Nationale Atlas Volksgezondheid, 2007).

Subsequently, splenectomized patients were included retrospectively using the Dutch Pathology Registry, since spleens are routinely sent to pathology after removal. In this Registry, a search query *milt* (spleen) was performed, after which all splenectomies performed from 1997 to 2008 were selected and nonrelevant hits such as partial splenectomies or spleen biopsies were removed.

Data Collection

After hospitals and patients were identified, the medical file and all discharge correspondence were assessed on site. All data were collected separately for each hospital by the same 2 investigators (DV, JL) using a standardized survey form. To investigate discharge correspondence, discharge letters as well as all other correspondence up to at least 1 year after splenectomy were included, for example from follow‐up out‐patient visits.

After hospital category was documented, we registered for each hospital the size of the surgical staff at the time of inclusion, the availability of any form of protocol of the surgical department reflecting hospital post‐splenectomy policy, and the practice of systematically registering (surgical) complications by the department of surgery. Patient data included demographics, documentation of vaccine administration and documentation of the prescription of antibiotics. Furthermore, discharge correspondence was checked for mentioning of each of the following: performed splenectomy, vaccination status, the need for revaccination, prescribed prophylactic antibiotics, the need of urgent use of antibiotics in case of suspected infection, and the advice for annual flu‐vaccination.

Data Analysis

When computing vaccination rates, we included only those patients who survived the first 2 weeks after surgery, since correct vaccination is considered by the British Committee to be given 2 weeks prior to or at least 2 or more weeks after surgery. Pneumococcal vaccination was defined as immunization with either the 23‐valent pneumococcal polysaccharides vaccine (PPV‐23, Pneumovax), the 7‐valent pneumococcal conjugate vaccine (PCV‐7, Prevenar), or both.

Prophylactic antibiotics were defined as a prescription of antibiotics for the first 2 years after splenectomy. On demand antibiotics were defined as a prescription to be given to the patient at discharge, to use in case of suspected infection. When investigating prescription rates of prophylactic antibiotics, we excluded patients deceased in the first 2 weeks after surgery, regarding their death as a complication of surgery. In case of on demand antibiotics, patients who died in the hospital before their discharge were excluded as well. When investigating discharge information to the general practitioner (GP), only those patients alive at time of discharge were excluded.

Statistical Analysis

First, we have described the study sample using standard descriptive statistics. Second, to explore differences in performance and calculate P values, we used a chi‐square test between the 3 categories of hospitals (Table 2), between presence or absence of a protocol (Table 3) and complication registry. The influence of surgical staff size (divided into 1‐8 surgeons or >8 surgeons) was calculated using multivariate logistic regression analysis, where surgical staff size and hospital teaching status were used as covariates in the analysis. All statistical analysis of data was performed in SPSS 16.0.

Hospital Demographics
 UniversityNonuniversity TeachingNonteaching
Hospitals, n (number of patients)2 (40)15 (287)11 (209)
Mean number of surgical staff per hospital (range)20 (1822)9.2 (316)5.5 (47)
Presence of splenectomy protocol at surgical department, n (%)2 (100)14 (93)7 (64)
Presence of complication registry at surgical department, n (%)2 (100)15 (100)9 (82)
Guideline Compliance in Relation to Hospital Teaching Status
 Hospital (n = Number of Patients)University (n = 33)Nonuniversity Teaching (n = 268)Nonteaching (n = 197)P Value
  • NOTE: P value calculated by means of chi‐square testing of 3 categories of hospitals.

  • Prophylaxis: prescription of continuous antibiotic therapy for 2 years after surgery.

  • On‐demand: prescription for antibiotics to be used in case of (suspected) infection.

  • Only when pneumococcal vaccination was given.

Immunizations (%)Pneumococcal9085.584.30.559
 H. influenzae B66.740.333.50.001
 Meningococcal C63.630.629.4<0.001
Antibiotics (%)Prophylaxis*21.214.18.60.056
 On‐demand6.38.59.50.812
 Both18.83.60<0.001
 None53.172.681.50.001
Discharge letters mentioning (%)Splenectomy1009896.80.425
 Immunization83.38180.50.609
 Booster immunization40.622.222.80.113
 Influenza vaccination259.814.30.021
 On‐demand antibiotics37.517.723.30.015
Guideline Compliance in Relation to the Availability of a Protocol
 Protocol PresentNo ProtocolP Value
  • NOTE: P value calculated by means of chi‐square testing.

  • Prophylaxis: prescription for continuous antibiotic therapy for 2 years after splenectomy.

  • On‐demand: prescription for antibiotics to be used in case of (suspected) infection.

  • Only when pneumococcal vaccination was given.

Immunizations (%)   
Pneumococcal85.385.90.671
H. influenzae B40.235.30.970
Meningococcal C33.725.90.188
Antibiotics (%)   
Prophylaxis*13.86.3<0.001
On‐demand9.55.50.001
Both3.900.062
None7287.70.230
Discharge letters mentioning (%)   
Splenectomy97.798.80.096
Immunization81.478.60.321
Booster immunization25.513.80.048
Influenza vaccination14.450.024
On‐demand antibiotics23.212.50.213

Results

We included 28 of 93 Dutch hospitals (30%), containing a total of 536 splenectomized patients (Table 1.) Five hospitals were excluded because they refused cooperation, and were subsequently replaced by comparable hospitals in their category.

Differences Between University and Nonteaching Hospitals

Hospital performance of Dutch university, nonuniversity teaching, and nonteaching hospitals is shown in Table 2. Admission to a university hospital is associated with better guideline adherence: 22 of 33 of patients (66.7%) in university hospitals were immunized with H. influenzae B as compared to 108 of 268 patients (40.3%) in nonuniversity teaching and 66 of 197 (33.5%) in nonteaching hospitals. Vaccination with N. meningitidis C occurred in 21 of 33 patients (63.6%) as compared to 82 of 268 patients (30.6%) in nonuniversity teaching and 58 of 197 (29.4%) in nonteaching hospitals. In 53.1% of patients no antibiotics were prescribed in university hospitals, as compared to 72.6% in nonuniversity teaching and 82.5% in nonteaching hospitals. Differences between nonuniversity teaching hospitals and nonteaching hospitals were small.

Presence of a Post‐Splenectomy Protocol

The availability of a protocol at the surgical department was not associated with higher vaccination rates (Table 3). It did however show a positive relation on the prescription of prophylactic antibiotics. The effect of a protocol on the quality of discharge information to the GP was minimal.

Size of Surgical Staff

Performance in relation to the size of surgical staff was determined (data not shown). There were no differences in vaccination rates or quality of discharge information between the groups of different sizes (less or more than 8 surgeons). Larger surgical groups seemed to perform better in prescribing antibiotics, however when adjusting for hospital category in multivariate analysis these differences were not significant.

Complication Registry

Complications were systematically registered by all but 2 surgical departments in nonteaching hospitals, composing a cohort of 27 patients.

Although numbers are low, it demonstrates that in the absence of a registry, the guideline adherence for this group of patients was similar, and only prophylactic antibiotics were significantly less prescribed: 62 of 473 patients (13.1%) in the presence of a registry, as compared to 0 of 27 patients in absence of a registry (P value = 0.044) (data not shown). The precise role of the registry herein remains unclear, since both hospitals also lacked a hospital post‐splenectomy protocol.

Discussion

Main Findings

The aim of the present study was to investigate quality of care for splenectomized patients in Dutch hospitals with different teaching status. In general, beneficial effects of teaching status only extended to university hospitals in the Netherlands. Other teaching hospitals performed similarly to nonteaching hospitals in the Netherlands. Hospitals in which the surgical department developed a local protocol with recommendations for managing patients after splenectomy did not achieve higher vaccination rates. There was, however, an improvement in prescription of antibiotics and in the quality of discharge correspondence from the hospital to the GP. Surgical staff size was not related to hospital performance.

Explanation of Results

In the Netherlands, all categories of hospitals provided over 80% of their post‐splenectomy patients with pneumococcal immunization, reflecting that Dutch physicians in general are aware of the need for pneumococcal protection after splenectomy. However, university hospitals had better performance results regarding immunizing patients with all 3 recommended vaccines, as well as prescribing prophylactic antibiotics in combination with a prescription for on‐demand antibiotics. Collectively, university hospitals offered their patients a more complete post‐splenectomy treatment.

It has been described elsewhere that minor teaching and nonteaching hospitals show small differences, and that nonteaching hospitals even perform better at certain indicators than minor teaching hospitals.13 We indeed found small differences between nonuniversity teaching hospitals and nonteaching hospitals, where nonuniversity teaching hospitals performed better at prescribing antibiotics, and nonteaching hospitals did better at giving recommendations to the GP on booster immunization and use of on‐demand antibiotics.

Hospital characteristics have been shown to have important effects on hospital outcomes.10, 14, 15 We hypothesized this would also be the case regarding the adherence to post‐splenectomy management recommendations. In particular, we were expecting to find that the availability of a protocol at the department of surgery would be associated with better compliance with all key recommendations in the British Standards, however, vaccination rates did not differ form departments without a protocol. The items that were generally most eligible for improvement seemed to benefit most from the presence of a protocol.

Neither the presence of a protocol nor the size of the surgical staff were related to better performance in university hospitals. We can therefore only speculate about the explanation for the differences found between university and other hospitals. Organizational differences may not be disregarded; it has been described elsewhere that better quality and processes of care are delivered in major teaching hospitals.16, 9, 12 Most prior studies have reported a lower risk‐adjusted mortality in major teaching hospitals as compared with minor teaching or nonteaching hospitals.9, 12 It is also possible that residency and fellowship programs contribute to better compliance of guidelines and have a favorable impact on the delivery of patient care in teaching hospitals.12

Limitations

In absence of a Dutch guideline we chose to investigate adherence to the recommendations by the British Committee for Standards in Haematology, assuming that Dutch professionals have some knowledge of these recommendations. Although these recommendations are internationally considered to reflect current best practice and patients should therefore be managed according to at least comparable standards, the extent of familiarity and use of the British standards by Dutch physicians remains to be investigated in the future. Furthermore, we investigated the availability of a locally designed protocol on the management of post‐splenectomy patients by the surgical department. Checking the contents of each of these local protocols was not part of our study and thus we can not exclude that these protocols are lacking certain recommendations. It also remains unclear how hospitals have implemented their protocols.

Implications for Future Research and Policy

In the Netherlands, hospitals could offer better quality of care for hyposplenic and asplenic patients in the prevention of infections by increasing immunization rates. Furthermore, although academic centers performed better than the other hospital categories, only a minority of patients were given or advised to receive on demand antibiotics. Here lies a tremendous opportunity to improve patient care in the prevention of severe infections.

Potential barriers that exist for delivering optimal care to these patients remain to be investigated. Furthermore, although teaching status is related to performance, the explanation for this difference remains unclear. The results of this study suggest that there is a relation between characteristics of practice organization and performance, but these characteristics should be further elucidated.

Conclusion

University hospitals offer higher guideline adherence in preventing infections after splenectomy than other teaching and nonteaching hospitals. For all Dutch hospitals there is room for improving the quality of post‐splenectomy patient care. The results of this study suggest that the difference in performance may be related to several characteristics of hospital practice organization. Future research should further investigate these hospital characteristics and their influence on performance.

Acknowledgements

The authors would like to thank all participating hospitals.

References
  1. Mebius RE, Kraal G.Structure and function of the spleen.Nat Rev Immunol.2005;5:606616.
  2. Holdsworth RJ, Irving AD, Cuschieri A.Postsplenectomy sepsis and its mortality rate: actual versus perceived risks.Br J Surg.1991;78:10311038.
  3. Mourtzoukou EG, Pappas G, Peppas G, Falagas ME.Vaccination of asplenic or hyposplenic adults.Br J Surg.2008;95:273280.
  4. Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen.Working Party of the British Committee for Standards in Haematology Clinical Haematology Task Force.BMJ.1996;312:430434.
  5. Davies JM, Barnes R, Milligan D.Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen.Clin Med.2002;2:440443.
  6. Cabana MD, Rand CS, Powe NR, et al.Why don't physicians follow clinical practice guidelines? A framework for improvement.JAMA.1999;282:14581465.
  7. Grimshaw J, Eccles M, Tetroe J.Implementing clinical guidelines: current evidence and future implications.J Contin Educ Health Prof.2004;24 Suppl 1:S31S37.
  8. Grol R, Grimshaw J.From best evidence to best practice: effective implementation of change in patients' care.Lancet.2003;362:12251230.
  9. Allison JJ, Kiefe CI, Weissman NW, et al.Relationship of hospital teaching status with quality of care and mortality for Medicare patients with acute MI.JAMA.2000;284:12561262.
  10. Chen J, Radford MJ, Wang Y, Marciniak TA, Krumholz HM.Do “America's Best Hospitals” perform better for acute myocardial infarction?N Engl J Med.1999;340:286292.
  11. Lingsma HF, Dippel DW, Hoeks SE, et al.Variation between hospitals in patient outcome after stroke is only partly explained by differences in quality of care: results from the Netherlands Stroke Survey.J Neurol Neurosurg Psychiatry.2008;79:888894.
  12. Polanczyk CA, Lane A, Coburn M, Philbin EF, Dec GW, DiSalvo TG.Hospital outcomes in major teaching, minor teaching, and nonteaching hospitals in New York state.Am J Med.2002;112:255261.
  13. Ayanian JZ, Weissman JS.Teaching hospitals and quality of care: a review of the literature.Milbank Q.2002;80:569593, v.
  14. Thiemann DR, Coresh J, Oetgen WJ, Powe NR.The association between hospital volume and survival after acute myocardial infarction in elderly patients.N Engl J Med.1999;340:16401648.
  15. Yuan Z, Cooper GS, Einstadter D, Cebul RD, Rimm AA.The association between hospital type and mortality and length of stay: a study of 16.9 million hospitalized Medicare beneficiaries.Med Care.2000;38:231245.
  16. Kupersmith J.Quality of care in teaching hospitals: a literature review.Acad Med.2005;80:458466.
References
  1. Mebius RE, Kraal G.Structure and function of the spleen.Nat Rev Immunol.2005;5:606616.
  2. Holdsworth RJ, Irving AD, Cuschieri A.Postsplenectomy sepsis and its mortality rate: actual versus perceived risks.Br J Surg.1991;78:10311038.
  3. Mourtzoukou EG, Pappas G, Peppas G, Falagas ME.Vaccination of asplenic or hyposplenic adults.Br J Surg.2008;95:273280.
  4. Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen.Working Party of the British Committee for Standards in Haematology Clinical Haematology Task Force.BMJ.1996;312:430434.
  5. Davies JM, Barnes R, Milligan D.Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen.Clin Med.2002;2:440443.
  6. Cabana MD, Rand CS, Powe NR, et al.Why don't physicians follow clinical practice guidelines? A framework for improvement.JAMA.1999;282:14581465.
  7. Grimshaw J, Eccles M, Tetroe J.Implementing clinical guidelines: current evidence and future implications.J Contin Educ Health Prof.2004;24 Suppl 1:S31S37.
  8. Grol R, Grimshaw J.From best evidence to best practice: effective implementation of change in patients' care.Lancet.2003;362:12251230.
  9. Allison JJ, Kiefe CI, Weissman NW, et al.Relationship of hospital teaching status with quality of care and mortality for Medicare patients with acute MI.JAMA.2000;284:12561262.
  10. Chen J, Radford MJ, Wang Y, Marciniak TA, Krumholz HM.Do “America's Best Hospitals” perform better for acute myocardial infarction?N Engl J Med.1999;340:286292.
  11. Lingsma HF, Dippel DW, Hoeks SE, et al.Variation between hospitals in patient outcome after stroke is only partly explained by differences in quality of care: results from the Netherlands Stroke Survey.J Neurol Neurosurg Psychiatry.2008;79:888894.
  12. Polanczyk CA, Lane A, Coburn M, Philbin EF, Dec GW, DiSalvo TG.Hospital outcomes in major teaching, minor teaching, and nonteaching hospitals in New York state.Am J Med.2002;112:255261.
  13. Ayanian JZ, Weissman JS.Teaching hospitals and quality of care: a review of the literature.Milbank Q.2002;80:569593, v.
  14. Thiemann DR, Coresh J, Oetgen WJ, Powe NR.The association between hospital volume and survival after acute myocardial infarction in elderly patients.N Engl J Med.1999;340:16401648.
  15. Yuan Z, Cooper GS, Einstadter D, Cebul RD, Rimm AA.The association between hospital type and mortality and length of stay: a study of 16.9 million hospitalized Medicare beneficiaries.Med Care.2000;38:231245.
  16. Kupersmith J.Quality of care in teaching hospitals: a literature review.Acad Med.2005;80:458466.
Issue
Journal of Hospital Medicine - 5(8)
Issue
Journal of Hospital Medicine - 5(8)
Page Number
466-470
Page Number
466-470
Article Type
Display Headline
Performance of Dutch hospitals in the management of splenectomized patients
Display Headline
Performance of Dutch hospitals in the management of splenectomized patients
Legacy Keywords
hospital, management, performance, post‐splenectomy, teaching status
Legacy Keywords
hospital, management, performance, post‐splenectomy, teaching status
Sections
Article Source

Copyright © 2010 Society of Hospital Medicine

Disallow All Ads
Correspondence Location
Meibergdreef 9, Amsterdam, Amsterdam Zuid‐Oost, The Netherlands
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Article PDF Media

Electrocardiographic changes of severe hyperkalemia

Article Type
Changed
Display Headline
Electrocardiographic changes of severe hyperkalemia

A 62‐year‐old woman with an extensive medical and surgical history presented with complaints of 2 days of weakness. Physical examination demonstrated a lethargic, but arousable woman in no distress. Her lower extremity motor strength was 4/5 bilaterally. The patient's electrocardiogram (ECG) demonstrated peaked T waves (Figure 1, arrow), absence of P waves, poor R wave progression and QRS interval widening (Figure 1, 2‐headed arrow.) Serum chemistries revealed a potassium level of 10.4 mmol/L and a creatinine of 0.9 mg/dL.

Figure 1
Initial ECG. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]

One ampule of D50, 10 units of insulin, 1 ampule of Calcium gluconate and 1 ampule of sodium bicarbonate were given intravenously along with oral Kayexalate. A repeat ECG showed a return of P waves, narrowing of the QRS interval, improved R wave progression and less peaking of the T waves (Figure 2). A repeat potassium level at that time was 9.2 mmol/L.

Figure 2
ECG after initial medical treatment. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]

Despite continued therapy to lower the potassium, another ECG showed a return of peaked T waves, a prolonged PR interval and marked widening of the QRS interval to 205 msec; the potassium level was now 10.0 mmol/L (Figure 3).

Figure 3
Worsening of ECG changes despite medical treatment. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]

Despite the patient's renal function being normal, she was emergently dialyzed. After a single dialysis, the patient's potassium level remained normal for the remainder of the hospitalization and a follow‐up ECG returned to baseline (Figure 4). No physiologic explanation was found for her hyperkalemia and it was concluded, despite her denials, that she had taken large quantities of exogenous potassium she had available from previous prescriptions.

Figure 4
Return to baseline ECG after dialysis. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
Article PDF
Issue
Journal of Hospital Medicine - 6(4)
Page Number
240-240
Sections
Article PDF
Article PDF

A 62‐year‐old woman with an extensive medical and surgical history presented with complaints of 2 days of weakness. Physical examination demonstrated a lethargic, but arousable woman in no distress. Her lower extremity motor strength was 4/5 bilaterally. The patient's electrocardiogram (ECG) demonstrated peaked T waves (Figure 1, arrow), absence of P waves, poor R wave progression and QRS interval widening (Figure 1, 2‐headed arrow.) Serum chemistries revealed a potassium level of 10.4 mmol/L and a creatinine of 0.9 mg/dL.

Figure 1
Initial ECG. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]

One ampule of D50, 10 units of insulin, 1 ampule of Calcium gluconate and 1 ampule of sodium bicarbonate were given intravenously along with oral Kayexalate. A repeat ECG showed a return of P waves, narrowing of the QRS interval, improved R wave progression and less peaking of the T waves (Figure 2). A repeat potassium level at that time was 9.2 mmol/L.

Figure 2
ECG after initial medical treatment. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]

Despite continued therapy to lower the potassium, another ECG showed a return of peaked T waves, a prolonged PR interval and marked widening of the QRS interval to 205 msec; the potassium level was now 10.0 mmol/L (Figure 3).

Figure 3
Worsening of ECG changes despite medical treatment. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]

Despite the patient's renal function being normal, she was emergently dialyzed. After a single dialysis, the patient's potassium level remained normal for the remainder of the hospitalization and a follow‐up ECG returned to baseline (Figure 4). No physiologic explanation was found for her hyperkalemia and it was concluded, despite her denials, that she had taken large quantities of exogenous potassium she had available from previous prescriptions.

Figure 4
Return to baseline ECG after dialysis. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]

A 62‐year‐old woman with an extensive medical and surgical history presented with complaints of 2 days of weakness. Physical examination demonstrated a lethargic, but arousable woman in no distress. Her lower extremity motor strength was 4/5 bilaterally. The patient's electrocardiogram (ECG) demonstrated peaked T waves (Figure 1, arrow), absence of P waves, poor R wave progression and QRS interval widening (Figure 1, 2‐headed arrow.) Serum chemistries revealed a potassium level of 10.4 mmol/L and a creatinine of 0.9 mg/dL.

Figure 1
Initial ECG. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]

One ampule of D50, 10 units of insulin, 1 ampule of Calcium gluconate and 1 ampule of sodium bicarbonate were given intravenously along with oral Kayexalate. A repeat ECG showed a return of P waves, narrowing of the QRS interval, improved R wave progression and less peaking of the T waves (Figure 2). A repeat potassium level at that time was 9.2 mmol/L.

Figure 2
ECG after initial medical treatment. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]

Despite continued therapy to lower the potassium, another ECG showed a return of peaked T waves, a prolonged PR interval and marked widening of the QRS interval to 205 msec; the potassium level was now 10.0 mmol/L (Figure 3).

Figure 3
Worsening of ECG changes despite medical treatment. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]

Despite the patient's renal function being normal, she was emergently dialyzed. After a single dialysis, the patient's potassium level remained normal for the remainder of the hospitalization and a follow‐up ECG returned to baseline (Figure 4). No physiologic explanation was found for her hyperkalemia and it was concluded, despite her denials, that she had taken large quantities of exogenous potassium she had available from previous prescriptions.

Figure 4
Return to baseline ECG after dialysis. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
Issue
Journal of Hospital Medicine - 6(4)
Issue
Journal of Hospital Medicine - 6(4)
Page Number
240-240
Page Number
240-240
Article Type
Display Headline
Electrocardiographic changes of severe hyperkalemia
Display Headline
Electrocardiographic changes of severe hyperkalemia
Sections
Article Source
Copyright © 2010 Society of Hospital Medicine
Disallow All Ads
Correspondence Location
2333 Buchanan, San Francisco, CA 94115
Content Gating
Gated (full article locked unless allowed per User)
Gating Strategy
First Peek Free
Article PDF Media

Iliac vein compression syndrome: An underdiagnosed cause of lower extremity deep venous thrombosis

Article Type
Changed
Display Headline
Iliac vein compression syndrome: An underdiagnosed cause of lower extremity deep venous thrombosis

Hospitalists frequently diagnose and treat lower extremity deep venous thrombosis (DVT). Patients presenting with acute DVT or chronic venous stasis of the left leg can have an underlying anatomic anomaly known as iliac vein compression syndrome (ICS), May‐Thurner syndrome, or Cockett syndrome in Europe. In this condition, the right iliac artery overlies the left iliac vein, causing extrinsic compression of the vein (Figure 1). 1 This compression and accompanying intraluminal changes predisposes patients to left‐sided lower extremity DVT.2 Failure to recognize and treat this anomaly in patients with acute thrombosis can result in serious vascular sequelae and chronic left leg symptoms.3 A high clinical suspicion should be maintained in young individuals presenting with proximal left leg DVT with or without hypercoagulable risk factors. The following report is a case of ICS in a young male recognized and treated early by aggressive diagnostic and therapeutic interventions.

Figure 1
Illustration of the anatomic anomaly present in ICS. The right common iliac artery is shown overlying the left common iliac vein creating a site of compression. Reference
11‐ Grunwald et al.

Case Report

A 19‐year‐old man presented to the ER with sudden onset of left lower extremity swelling and pain 5 days after a fall. He had no known risk factors for DVT. On physical examination his left leg was dusky, swollen, and tender from his groin to his ankle, with good arterial pulses. Duplex ultra‐sonogram of the leg showed a clot in the femoral vein extending up the popliteal vein. Following a venogram, he underwent mechanical thrombectomy and regional thrombolysis. A repeat venogram showed an irregular narrowing of the left iliac vein and a tubular filling defect at the junction of the inferior vena cava and common iliac veins, suggestive of external compression from the right common iliac artery. The patient underwent successful angioplasty and stenting of the common iliac vein. He was treated with intravenous heparin, warfarin and clopidogrel. His hypercoagulable work‐up was inconclusive.

Discussion

In 1956, May and Thurner 1 brought clinical attention to ICS. They hypothesized that an abnormal compression of the left iliac vein by an overriding right iliac arterypresent in 22% of a series of 430 cadaversled to an intraluminal filling defect in the vein. The chronic extrinsic compression and pulsing force from the overlying artery results in endothelial irritation and formation of venous spurs (fibrous vascular lesions) in the intimal layer of the vein.1 Following the principles of Virchow's triad, this endothelial injury propagates the formation of a thrombus. Subsequent studies by Kim et al.4 suggest that there are 3 stages involved in the pathogenesis of thrombosis in ICS: asymptomatic vein compression, venous spur formation, and finally DVT formation.4, 5 It is estimated that 1 to 3 out of 1000 individuals with this malformation develop DVT each year.5, 6

Patients with ICS may present to the emergency or ambulatory setting in either an acute or chronic phase. The acute phase is the actual episode of thrombosis. Symptoms include left leg pain and swelling up to the groin. In rare cases, pulmonary emboli may be the initial presentation. A lifelong chronic phase can follow if undiagnosed, resulting in pain and swelling of the entire left leg, venous claudication, recurrent thrombosis, pigmentation changes, and ulceration. 3

The typical ICS patient is a woman between 18 and 30 years old, 3 possibly due to the developmental changes in the pelvic structures in preparation for child‐bearing.2 Many patients also present after pregnancy; increased lordosis during pregnancy may put additional strain on the anatomic lesion.3 Nevertheless, Steinberg and Jacocks7 reported that out of 127 patients, 38 (30%) were male. Thus, it is critical not to overlook ICS as a possible cause of thrombosis in male patients.

The urgency in diagnosing this anatomic variation lies in the distinct need for more aggressive treatment than that required for a typical DVT. While Doppler ultrasound is typically the first diagnostic test performed in this patient population, it is not specific. For patients with physical exam findings highly suspicious of ICS, venography and magnetic resonance venography are superior modalities to make a definitive diagnosis of the syndrome. 8 In ICS, these studies will reveal left common iliac vein narrowing with intraluminal changes suggestive of spur formation.2

Due to the mechanical nature of ICS pathology, anticoagulation therapy alone is ineffective. ICS prevents recanalization in 70% to 80% of patients and up to 40% will have continued clot propagation. 5, 7 More aggressive treatment using endovascular techniques such as the combination of thrombectomy, angioplasty, and intraluminal stenting have proven to be the most efficacious treatment modality for ICS.9 A study by AbuRahma et al.10 demonstrated that one year following this aggressive combination, patency rate was 83% (vs. 24% following thrombectomy alone).

Conclusion

The anatomic anomaly present in ICS was identified by CT in as many as two‐thirds of an asymptomatic patient population studied by Kibbe et al. 12 Although a common structural anomaly, it is important to note that only 1 to 3 out of 1000 individuals with this malformation develop DVT annually. ICS should be included in the differential diagnosis of all young individuals presenting with proximal left leg DVT with or without hypercoagulable risk factors. If the mechanical compression is not diagnosed and treated, the syndrome can develop into a life‐long chronic phase with multiple complications.2 It is therefore critical that aggressive diagnostic and therapeutic interventions be implemented immediately upon suspicion of ICS.

References
  1. May R, Thurner J. A vascular spur in the vena iliaca communis sinistra as a cause of predominantly left‐sided thrombosis of the pelvic veins. Z Kreislaufforsch. 1956;45:912922.
  2. Oguzkurt L, Ozkan U, Ulusan S, Koc Z, Tercan F. Compression of the left common iliac vein in asymptomatic subjects and patients with left iliofemoral deep vein thrombosis. J Vasc Interv Radiol. 2008;19:366370; quiz 71.
  3. Cockett FB. The iliac compression syndrome alias ‘Iliofemoral thrombosis’ or ‘white leg’. Proc R Soc Med. 1966;59:360361.
  4. Kim D, Orron DE, Porter DH. Venographic anatomy, technique and interpretation. Pheripheral Vascular Imaging and Intervention. St. Louis (MO): Mosby‐Year Book; 1992. p. 269349.
  5. Murphy EH, Davis CM, Journeycake JM, DeMuth P, Arko FR. Symptomatic ileofemoral DVT after onset of oral contraceptive use in women with previously undiagnosed May‐Thurner Syndrome. J Vasc Surg. 2009;49:697703.
  6. Nordstrom M, Wheeler HB, Goldberg RJ. A prospective study of the incidence of deep vein thrombosis within a defined urban population. J Intern Med. 1992;232:152160.
  7. Steinberg JB, Jacocks MA. May‐Thurner syndrome: a previously unreported variant. Ann Vasc Surg. 1993;7:577581.
  8. Hurst D, Forauer A, Bloom J, Greenfield L, Wakefield T, Williams D. Diagnosis and endovascular treatment of iliocaval compression syndrome. J Vasc Surg. 2001;34:106113.
  9. O'sullivan GJ, Semba CP, Bittner CA, et al. Endovascular management of iliac vein compression (May‐Thurner) syndrome. J Vasc Interv Radiol. 2000;11:823836.
  10. AbuRahma AF, Perkins SE, Wulu JT, Ng HK. Iliofemoral deep vein thrombosis: conventional therapy versus lysis and percutaneous transluminal angioplasty and stenting. Ann Surg. 2001;233:752760.
  11. Grunwald MR, Goldberg MJ, Hofmann LV. Endovascular management of May‐Thurner Syndrome. Am J Roentgenol. 2004;183:15231524.
  12. Kibbe M, Ujiki M, Goodwin L, Eskandar M, Yao J, Matsumura J. Iliac vein compression in an asymptomatic patient population. J Vasc Surg. 2004:39:937943.
Article PDF
Issue
Journal of Hospital Medicine - 5(7)
Page Number
E12-E13
Legacy Keywords
Cockett Syndrome, deep venous thrombosis, iliac vein compression syndrome, May‐Thurner syndrome
Sections
Article PDF
Article PDF

Hospitalists frequently diagnose and treat lower extremity deep venous thrombosis (DVT). Patients presenting with acute DVT or chronic venous stasis of the left leg can have an underlying anatomic anomaly known as iliac vein compression syndrome (ICS), May‐Thurner syndrome, or Cockett syndrome in Europe. In this condition, the right iliac artery overlies the left iliac vein, causing extrinsic compression of the vein (Figure 1). 1 This compression and accompanying intraluminal changes predisposes patients to left‐sided lower extremity DVT.2 Failure to recognize and treat this anomaly in patients with acute thrombosis can result in serious vascular sequelae and chronic left leg symptoms.3 A high clinical suspicion should be maintained in young individuals presenting with proximal left leg DVT with or without hypercoagulable risk factors. The following report is a case of ICS in a young male recognized and treated early by aggressive diagnostic and therapeutic interventions.

Figure 1
Illustration of the anatomic anomaly present in ICS. The right common iliac artery is shown overlying the left common iliac vein creating a site of compression. Reference
11‐ Grunwald et al.

Case Report

A 19‐year‐old man presented to the ER with sudden onset of left lower extremity swelling and pain 5 days after a fall. He had no known risk factors for DVT. On physical examination his left leg was dusky, swollen, and tender from his groin to his ankle, with good arterial pulses. Duplex ultra‐sonogram of the leg showed a clot in the femoral vein extending up the popliteal vein. Following a venogram, he underwent mechanical thrombectomy and regional thrombolysis. A repeat venogram showed an irregular narrowing of the left iliac vein and a tubular filling defect at the junction of the inferior vena cava and common iliac veins, suggestive of external compression from the right common iliac artery. The patient underwent successful angioplasty and stenting of the common iliac vein. He was treated with intravenous heparin, warfarin and clopidogrel. His hypercoagulable work‐up was inconclusive.

Discussion

In 1956, May and Thurner 1 brought clinical attention to ICS. They hypothesized that an abnormal compression of the left iliac vein by an overriding right iliac arterypresent in 22% of a series of 430 cadaversled to an intraluminal filling defect in the vein. The chronic extrinsic compression and pulsing force from the overlying artery results in endothelial irritation and formation of venous spurs (fibrous vascular lesions) in the intimal layer of the vein.1 Following the principles of Virchow's triad, this endothelial injury propagates the formation of a thrombus. Subsequent studies by Kim et al.4 suggest that there are 3 stages involved in the pathogenesis of thrombosis in ICS: asymptomatic vein compression, venous spur formation, and finally DVT formation.4, 5 It is estimated that 1 to 3 out of 1000 individuals with this malformation develop DVT each year.5, 6

Patients with ICS may present to the emergency or ambulatory setting in either an acute or chronic phase. The acute phase is the actual episode of thrombosis. Symptoms include left leg pain and swelling up to the groin. In rare cases, pulmonary emboli may be the initial presentation. A lifelong chronic phase can follow if undiagnosed, resulting in pain and swelling of the entire left leg, venous claudication, recurrent thrombosis, pigmentation changes, and ulceration. 3

The typical ICS patient is a woman between 18 and 30 years old, 3 possibly due to the developmental changes in the pelvic structures in preparation for child‐bearing.2 Many patients also present after pregnancy; increased lordosis during pregnancy may put additional strain on the anatomic lesion.3 Nevertheless, Steinberg and Jacocks7 reported that out of 127 patients, 38 (30%) were male. Thus, it is critical not to overlook ICS as a possible cause of thrombosis in male patients.

The urgency in diagnosing this anatomic variation lies in the distinct need for more aggressive treatment than that required for a typical DVT. While Doppler ultrasound is typically the first diagnostic test performed in this patient population, it is not specific. For patients with physical exam findings highly suspicious of ICS, venography and magnetic resonance venography are superior modalities to make a definitive diagnosis of the syndrome. 8 In ICS, these studies will reveal left common iliac vein narrowing with intraluminal changes suggestive of spur formation.2

Due to the mechanical nature of ICS pathology, anticoagulation therapy alone is ineffective. ICS prevents recanalization in 70% to 80% of patients and up to 40% will have continued clot propagation. 5, 7 More aggressive treatment using endovascular techniques such as the combination of thrombectomy, angioplasty, and intraluminal stenting have proven to be the most efficacious treatment modality for ICS.9 A study by AbuRahma et al.10 demonstrated that one year following this aggressive combination, patency rate was 83% (vs. 24% following thrombectomy alone).

Conclusion

The anatomic anomaly present in ICS was identified by CT in as many as two‐thirds of an asymptomatic patient population studied by Kibbe et al. 12 Although a common structural anomaly, it is important to note that only 1 to 3 out of 1000 individuals with this malformation develop DVT annually. ICS should be included in the differential diagnosis of all young individuals presenting with proximal left leg DVT with or without hypercoagulable risk factors. If the mechanical compression is not diagnosed and treated, the syndrome can develop into a life‐long chronic phase with multiple complications.2 It is therefore critical that aggressive diagnostic and therapeutic interventions be implemented immediately upon suspicion of ICS.

Hospitalists frequently diagnose and treat lower extremity deep venous thrombosis (DVT). Patients presenting with acute DVT or chronic venous stasis of the left leg can have an underlying anatomic anomaly known as iliac vein compression syndrome (ICS), May‐Thurner syndrome, or Cockett syndrome in Europe. In this condition, the right iliac artery overlies the left iliac vein, causing extrinsic compression of the vein (Figure 1). 1 This compression and accompanying intraluminal changes predisposes patients to left‐sided lower extremity DVT.2 Failure to recognize and treat this anomaly in patients with acute thrombosis can result in serious vascular sequelae and chronic left leg symptoms.3 A high clinical suspicion should be maintained in young individuals presenting with proximal left leg DVT with or without hypercoagulable risk factors. The following report is a case of ICS in a young male recognized and treated early by aggressive diagnostic and therapeutic interventions.

Figure 1
Illustration of the anatomic anomaly present in ICS. The right common iliac artery is shown overlying the left common iliac vein creating a site of compression. Reference
11‐ Grunwald et al.

Case Report

A 19‐year‐old man presented to the ER with sudden onset of left lower extremity swelling and pain 5 days after a fall. He had no known risk factors for DVT. On physical examination his left leg was dusky, swollen, and tender from his groin to his ankle, with good arterial pulses. Duplex ultra‐sonogram of the leg showed a clot in the femoral vein extending up the popliteal vein. Following a venogram, he underwent mechanical thrombectomy and regional thrombolysis. A repeat venogram showed an irregular narrowing of the left iliac vein and a tubular filling defect at the junction of the inferior vena cava and common iliac veins, suggestive of external compression from the right common iliac artery. The patient underwent successful angioplasty and stenting of the common iliac vein. He was treated with intravenous heparin, warfarin and clopidogrel. His hypercoagulable work‐up was inconclusive.

Discussion

In 1956, May and Thurner 1 brought clinical attention to ICS. They hypothesized that an abnormal compression of the left iliac vein by an overriding right iliac arterypresent in 22% of a series of 430 cadaversled to an intraluminal filling defect in the vein. The chronic extrinsic compression and pulsing force from the overlying artery results in endothelial irritation and formation of venous spurs (fibrous vascular lesions) in the intimal layer of the vein.1 Following the principles of Virchow's triad, this endothelial injury propagates the formation of a thrombus. Subsequent studies by Kim et al.4 suggest that there are 3 stages involved in the pathogenesis of thrombosis in ICS: asymptomatic vein compression, venous spur formation, and finally DVT formation.4, 5 It is estimated that 1 to 3 out of 1000 individuals with this malformation develop DVT each year.5, 6

Patients with ICS may present to the emergency or ambulatory setting in either an acute or chronic phase. The acute phase is the actual episode of thrombosis. Symptoms include left leg pain and swelling up to the groin. In rare cases, pulmonary emboli may be the initial presentation. A lifelong chronic phase can follow if undiagnosed, resulting in pain and swelling of the entire left leg, venous claudication, recurrent thrombosis, pigmentation changes, and ulceration. 3

The typical ICS patient is a woman between 18 and 30 years old, 3 possibly due to the developmental changes in the pelvic structures in preparation for child‐bearing.2 Many patients also present after pregnancy; increased lordosis during pregnancy may put additional strain on the anatomic lesion.3 Nevertheless, Steinberg and Jacocks7 reported that out of 127 patients, 38 (30%) were male. Thus, it is critical not to overlook ICS as a possible cause of thrombosis in male patients.

The urgency in diagnosing this anatomic variation lies in the distinct need for more aggressive treatment than that required for a typical DVT. While Doppler ultrasound is typically the first diagnostic test performed in this patient population, it is not specific. For patients with physical exam findings highly suspicious of ICS, venography and magnetic resonance venography are superior modalities to make a definitive diagnosis of the syndrome. 8 In ICS, these studies will reveal left common iliac vein narrowing with intraluminal changes suggestive of spur formation.2

Due to the mechanical nature of ICS pathology, anticoagulation therapy alone is ineffective. ICS prevents recanalization in 70% to 80% of patients and up to 40% will have continued clot propagation. 5, 7 More aggressive treatment using endovascular techniques such as the combination of thrombectomy, angioplasty, and intraluminal stenting have proven to be the most efficacious treatment modality for ICS.9 A study by AbuRahma et al.10 demonstrated that one year following this aggressive combination, patency rate was 83% (vs. 24% following thrombectomy alone).

Conclusion

The anatomic anomaly present in ICS was identified by CT in as many as two‐thirds of an asymptomatic patient population studied by Kibbe et al. 12 Although a common structural anomaly, it is important to note that only 1 to 3 out of 1000 individuals with this malformation develop DVT annually. ICS should be included in the differential diagnosis of all young individuals presenting with proximal left leg DVT with or without hypercoagulable risk factors. If the mechanical compression is not diagnosed and treated, the syndrome can develop into a life‐long chronic phase with multiple complications.2 It is therefore critical that aggressive diagnostic and therapeutic interventions be implemented immediately upon suspicion of ICS.

References
  1. May R, Thurner J. A vascular spur in the vena iliaca communis sinistra as a cause of predominantly left‐sided thrombosis of the pelvic veins. Z Kreislaufforsch. 1956;45:912922.
  2. Oguzkurt L, Ozkan U, Ulusan S, Koc Z, Tercan F. Compression of the left common iliac vein in asymptomatic subjects and patients with left iliofemoral deep vein thrombosis. J Vasc Interv Radiol. 2008;19:366370; quiz 71.
  3. Cockett FB. The iliac compression syndrome alias ‘Iliofemoral thrombosis’ or ‘white leg’. Proc R Soc Med. 1966;59:360361.
  4. Kim D, Orron DE, Porter DH. Venographic anatomy, technique and interpretation. Pheripheral Vascular Imaging and Intervention. St. Louis (MO): Mosby‐Year Book; 1992. p. 269349.
  5. Murphy EH, Davis CM, Journeycake JM, DeMuth P, Arko FR. Symptomatic ileofemoral DVT after onset of oral contraceptive use in women with previously undiagnosed May‐Thurner Syndrome. J Vasc Surg. 2009;49:697703.
  6. Nordstrom M, Wheeler HB, Goldberg RJ. A prospective study of the incidence of deep vein thrombosis within a defined urban population. J Intern Med. 1992;232:152160.
  7. Steinberg JB, Jacocks MA. May‐Thurner syndrome: a previously unreported variant. Ann Vasc Surg. 1993;7:577581.
  8. Hurst D, Forauer A, Bloom J, Greenfield L, Wakefield T, Williams D. Diagnosis and endovascular treatment of iliocaval compression syndrome. J Vasc Surg. 2001;34:106113.
  9. O'sullivan GJ, Semba CP, Bittner CA, et al. Endovascular management of iliac vein compression (May‐Thurner) syndrome. J Vasc Interv Radiol. 2000;11:823836.
  10. AbuRahma AF, Perkins SE, Wulu JT, Ng HK. Iliofemoral deep vein thrombosis: conventional therapy versus lysis and percutaneous transluminal angioplasty and stenting. Ann Surg. 2001;233:752760.
  11. Grunwald MR, Goldberg MJ, Hofmann LV. Endovascular management of May‐Thurner Syndrome. Am J Roentgenol. 2004;183:15231524.
  12. Kibbe M, Ujiki M, Goodwin L, Eskandar M, Yao J, Matsumura J. Iliac vein compression in an asymptomatic patient population. J Vasc Surg. 2004:39:937943.
References
  1. May R, Thurner J. A vascular spur in the vena iliaca communis sinistra as a cause of predominantly left‐sided thrombosis of the pelvic veins. Z Kreislaufforsch. 1956;45:912922.
  2. Oguzkurt L, Ozkan U, Ulusan S, Koc Z, Tercan F. Compression of the left common iliac vein in asymptomatic subjects and patients with left iliofemoral deep vein thrombosis. J Vasc Interv Radiol. 2008;19:366370; quiz 71.
  3. Cockett FB. The iliac compression syndrome alias ‘Iliofemoral thrombosis’ or ‘white leg’. Proc R Soc Med. 1966;59:360361.
  4. Kim D, Orron DE, Porter DH. Venographic anatomy, technique and interpretation. Pheripheral Vascular Imaging and Intervention. St. Louis (MO): Mosby‐Year Book; 1992. p. 269349.
  5. Murphy EH, Davis CM, Journeycake JM, DeMuth P, Arko FR. Symptomatic ileofemoral DVT after onset of oral contraceptive use in women with previously undiagnosed May‐Thurner Syndrome. J Vasc Surg. 2009;49:697703.
  6. Nordstrom M, Wheeler HB, Goldberg RJ. A prospective study of the incidence of deep vein thrombosis within a defined urban population. J Intern Med. 1992;232:152160.
  7. Steinberg JB, Jacocks MA. May‐Thurner syndrome: a previously unreported variant. Ann Vasc Surg. 1993;7:577581.
  8. Hurst D, Forauer A, Bloom J, Greenfield L, Wakefield T, Williams D. Diagnosis and endovascular treatment of iliocaval compression syndrome. J Vasc Surg. 2001;34:106113.
  9. O'sullivan GJ, Semba CP, Bittner CA, et al. Endovascular management of iliac vein compression (May‐Thurner) syndrome. J Vasc Interv Radiol. 2000;11:823836.
  10. AbuRahma AF, Perkins SE, Wulu JT, Ng HK. Iliofemoral deep vein thrombosis: conventional therapy versus lysis and percutaneous transluminal angioplasty and stenting. Ann Surg. 2001;233:752760.
  11. Grunwald MR, Goldberg MJ, Hofmann LV. Endovascular management of May‐Thurner Syndrome. Am J Roentgenol. 2004;183:15231524.
  12. Kibbe M, Ujiki M, Goodwin L, Eskandar M, Yao J, Matsumura J. Iliac vein compression in an asymptomatic patient population. J Vasc Surg. 2004:39:937943.
Issue
Journal of Hospital Medicine - 5(7)
Issue
Journal of Hospital Medicine - 5(7)
Page Number
E12-E13
Page Number
E12-E13
Article Type
Display Headline
Iliac vein compression syndrome: An underdiagnosed cause of lower extremity deep venous thrombosis
Display Headline
Iliac vein compression syndrome: An underdiagnosed cause of lower extremity deep venous thrombosis
Legacy Keywords
Cockett Syndrome, deep venous thrombosis, iliac vein compression syndrome, May‐Thurner syndrome
Legacy Keywords
Cockett Syndrome, deep venous thrombosis, iliac vein compression syndrome, May‐Thurner syndrome
Sections
Article Source
Copyright © 2010 Society of Hospital Medicine
Disallow All Ads
Content Gating
Gated (full article locked unless allowed per User)
Gating Strategy
First Peek Free
Article PDF Media

Stevens‐Johnson and mycoplasma pneumoniae: A scary duo

Article Type
Changed
Display Headline
Stevens‐Johnson and mycoplasma pneumoniae: A scary duo

A 15‐year‐old male was hospitalized with painful blisters on the lips and ulcers in the oral mucosa that were preceded by upper respiratory infection symptoms for 1 week. He had not been treated with antimicrobials. He subsequently developed conjunctival injection and painful blisters at the urethral meatus and symmetric scattered target lesions in the extremities. Examination demonstrated low‐grade fever, mild conjunctival injection (Figure 2), and oral vesicular lesions affecting the lips (Figure 1) and both the hard and soft palate; he had vesicular lesions affecting the glans penis, a ruptured vesicle at the urethral meatus and target lesions in the arms (Figure 3) and legs (Figure 4). His cardiopulmonary exam was normal. He was started on acyclovir and azithromycin, and symptomatic treatment with oral lidocaine and morphine. Serologies for Epstein‐Barr virus (EBV), cytomegalovirus (CMV) and Coxsackievirus and cultures for herpes simplex virus (HSV) were negative. Mycoplasma pneumoniae immunoglobulin G (IgG) and IgM titers were significantly elevated (>4‐fold) and the diagnosis made of Stevens‐Johnson syndrome (SJS) secondary to Mycoplasma pneumoniae infection. He was able to tolerate oral intake after a 1‐week hospital course.

M. pneumoniae infection can cause mucocutaneous involvement varying from mild mucositis to SJS with significant morbidity and mortality, 1, 2 mostly in the pediatric population. The differential diagnosis includes HSV, Kawasaki, and Streptococcal toxic shock syndrome, as well as other viral infections (eg, Coxsackievirus).3 Pharmacologic causesespecially antibiotics, non steroidal anti‐inflammatory drug (NSAIDS) and anticonvulsantsshould also be considered in the etiology of SJS4 especially in the adult population.

Figure 1
Oral vesicular lesions and mucositis. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
Figure 2
Mild conjunctival injection. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
Figure 3
Target lesions. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
Figure 4
Target lesions. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
References
  1. Schalock PC. Erythema multiforme due to Mycoplasma pneumoniae infection in two children. Pediatr Dermatol. 2006;23(6):546555.
  2. Sendi P. Mycoplasma pneumoniae infection complicated by severe mucocutaneous lesions. Lancet Infect Dis. 2008;8:268.
  3. Ravin KA, Rappaport LD, Zuckerbraun NS, Wadowsky RM, Wald ER, Michaels MM. Mycoplasma pneumoniae and atypical Stevens‐Johnson syndrome: a case series. Pediatrics. 2007;119:e1002e1005.
  4. Mulvey JM, Padowitz A, Lindley‐Jones M, Nickels R. Mycoplasma pneumoniae associated with Stevens Johnson syndrome. Anaesth Intensive Care. 2007;35:414417.
Article PDF
Issue
Journal of Hospital Medicine - 5(9)
Page Number
567-568
Sections
Article PDF
Article PDF

A 15‐year‐old male was hospitalized with painful blisters on the lips and ulcers in the oral mucosa that were preceded by upper respiratory infection symptoms for 1 week. He had not been treated with antimicrobials. He subsequently developed conjunctival injection and painful blisters at the urethral meatus and symmetric scattered target lesions in the extremities. Examination demonstrated low‐grade fever, mild conjunctival injection (Figure 2), and oral vesicular lesions affecting the lips (Figure 1) and both the hard and soft palate; he had vesicular lesions affecting the glans penis, a ruptured vesicle at the urethral meatus and target lesions in the arms (Figure 3) and legs (Figure 4). His cardiopulmonary exam was normal. He was started on acyclovir and azithromycin, and symptomatic treatment with oral lidocaine and morphine. Serologies for Epstein‐Barr virus (EBV), cytomegalovirus (CMV) and Coxsackievirus and cultures for herpes simplex virus (HSV) were negative. Mycoplasma pneumoniae immunoglobulin G (IgG) and IgM titers were significantly elevated (>4‐fold) and the diagnosis made of Stevens‐Johnson syndrome (SJS) secondary to Mycoplasma pneumoniae infection. He was able to tolerate oral intake after a 1‐week hospital course.

M. pneumoniae infection can cause mucocutaneous involvement varying from mild mucositis to SJS with significant morbidity and mortality, 1, 2 mostly in the pediatric population. The differential diagnosis includes HSV, Kawasaki, and Streptococcal toxic shock syndrome, as well as other viral infections (eg, Coxsackievirus).3 Pharmacologic causesespecially antibiotics, non steroidal anti‐inflammatory drug (NSAIDS) and anticonvulsantsshould also be considered in the etiology of SJS4 especially in the adult population.

Figure 1
Oral vesicular lesions and mucositis. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
Figure 2
Mild conjunctival injection. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
Figure 3
Target lesions. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
Figure 4
Target lesions. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]

A 15‐year‐old male was hospitalized with painful blisters on the lips and ulcers in the oral mucosa that were preceded by upper respiratory infection symptoms for 1 week. He had not been treated with antimicrobials. He subsequently developed conjunctival injection and painful blisters at the urethral meatus and symmetric scattered target lesions in the extremities. Examination demonstrated low‐grade fever, mild conjunctival injection (Figure 2), and oral vesicular lesions affecting the lips (Figure 1) and both the hard and soft palate; he had vesicular lesions affecting the glans penis, a ruptured vesicle at the urethral meatus and target lesions in the arms (Figure 3) and legs (Figure 4). His cardiopulmonary exam was normal. He was started on acyclovir and azithromycin, and symptomatic treatment with oral lidocaine and morphine. Serologies for Epstein‐Barr virus (EBV), cytomegalovirus (CMV) and Coxsackievirus and cultures for herpes simplex virus (HSV) were negative. Mycoplasma pneumoniae immunoglobulin G (IgG) and IgM titers were significantly elevated (>4‐fold) and the diagnosis made of Stevens‐Johnson syndrome (SJS) secondary to Mycoplasma pneumoniae infection. He was able to tolerate oral intake after a 1‐week hospital course.

M. pneumoniae infection can cause mucocutaneous involvement varying from mild mucositis to SJS with significant morbidity and mortality, 1, 2 mostly in the pediatric population. The differential diagnosis includes HSV, Kawasaki, and Streptococcal toxic shock syndrome, as well as other viral infections (eg, Coxsackievirus).3 Pharmacologic causesespecially antibiotics, non steroidal anti‐inflammatory drug (NSAIDS) and anticonvulsantsshould also be considered in the etiology of SJS4 especially in the adult population.

Figure 1
Oral vesicular lesions and mucositis. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
Figure 2
Mild conjunctival injection. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
Figure 3
Target lesions. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
Figure 4
Target lesions. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
References
  1. Schalock PC. Erythema multiforme due to Mycoplasma pneumoniae infection in two children. Pediatr Dermatol. 2006;23(6):546555.
  2. Sendi P. Mycoplasma pneumoniae infection complicated by severe mucocutaneous lesions. Lancet Infect Dis. 2008;8:268.
  3. Ravin KA, Rappaport LD, Zuckerbraun NS, Wadowsky RM, Wald ER, Michaels MM. Mycoplasma pneumoniae and atypical Stevens‐Johnson syndrome: a case series. Pediatrics. 2007;119:e1002e1005.
  4. Mulvey JM, Padowitz A, Lindley‐Jones M, Nickels R. Mycoplasma pneumoniae associated with Stevens Johnson syndrome. Anaesth Intensive Care. 2007;35:414417.
References
  1. Schalock PC. Erythema multiforme due to Mycoplasma pneumoniae infection in two children. Pediatr Dermatol. 2006;23(6):546555.
  2. Sendi P. Mycoplasma pneumoniae infection complicated by severe mucocutaneous lesions. Lancet Infect Dis. 2008;8:268.
  3. Ravin KA, Rappaport LD, Zuckerbraun NS, Wadowsky RM, Wald ER, Michaels MM. Mycoplasma pneumoniae and atypical Stevens‐Johnson syndrome: a case series. Pediatrics. 2007;119:e1002e1005.
  4. Mulvey JM, Padowitz A, Lindley‐Jones M, Nickels R. Mycoplasma pneumoniae associated with Stevens Johnson syndrome. Anaesth Intensive Care. 2007;35:414417.
Issue
Journal of Hospital Medicine - 5(9)
Issue
Journal of Hospital Medicine - 5(9)
Page Number
567-568
Page Number
567-568
Article Type
Display Headline
Stevens‐Johnson and mycoplasma pneumoniae: A scary duo
Display Headline
Stevens‐Johnson and mycoplasma pneumoniae: A scary duo
Sections
Article Source
Copyright © 2010 Society of Hospital Medicine
Disallow All Ads
Correspondence Location
9500 Euclid Ave. S70, Cleveland, Ohio 44130
Content Gating
Gated (full article locked unless allowed per User)
Gating Strategy
First Peek Free
Article PDF Media

New Research Target

Article Type
Changed
Display Headline
New Research Target

A report in this month’s Journal of Hospital Medicine shows macrolide and quinolone antibiotics are associated with similar rates of treatment failure in acute exacerbation of chronic pulmonary disease (AECOPD). The lead author says the study could be a precursor to, say, an intrepid HM researcher working on a randomized trial of the antibiotics’ effectiveness.

“It’s a perfect thing for hospitalists to study because they’re the ones treating it,” says Michael Rothberg, MD, MPH, associate professor of medicine at Tufts University School of Medicine in Boston, and lead author of "Comparative Effectiveness of Macrolides and Quinolones for Patients Hospitalized with Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD)."

The retrospective cohort review reported that out of nearly 20,000 patients, 6,139 (31%) were treated initially with a macrolide and 13,469 (69%) with a quinolone. “Those who received macrolides had a lower risk of treatment failure (6.8% vs. 8.1%, p<0.01), a finding that was attenuated after multivariable adjustment (OR=0.89, 95% CI 0.78-1.01), and disappeared in a grouped-treatment analysis (OR=1.01, 95% CI 0.75-1.35),” the authors wrote. The study found no differences in adjusted length of stay or cost. However, antibiotic-associated diarrhea was more common with quinolones (1.2% vs. 0.6%, p<0.001).

Dr. Rothberg, who is affiliated with the Center for Quality of Care Research at Baystate Medical Center in Springfield, Mass., says the data, while a point in the right direction, should be viewed as a first step in doing more search to determine the best treatment for AECOPD.

“If you look at the guidelines, the recommendations are all over the map,” Dr. Rothberg says. “This is really because there are no randomized trials in COPD patients. … There are so many unanswered questions. There’s been so much focus on pneumonia, heart failure, and acute myocardial infarction. COPD kind of has a dearth of research.”

Dr. Rothberg hopes to further that research via the COPD Outcomes-Based Network for Clinical Effectiveness & Research Translation (CONCERT), a team of physicians and researchers from centers around the country who are advocating for improvements to COPD treatment. Baystate is one of CONCERT’s outposts.

Issue
The Hospitalist - 2010(06)
Publications
Sections

A report in this month’s Journal of Hospital Medicine shows macrolide and quinolone antibiotics are associated with similar rates of treatment failure in acute exacerbation of chronic pulmonary disease (AECOPD). The lead author says the study could be a precursor to, say, an intrepid HM researcher working on a randomized trial of the antibiotics’ effectiveness.

“It’s a perfect thing for hospitalists to study because they’re the ones treating it,” says Michael Rothberg, MD, MPH, associate professor of medicine at Tufts University School of Medicine in Boston, and lead author of "Comparative Effectiveness of Macrolides and Quinolones for Patients Hospitalized with Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD)."

The retrospective cohort review reported that out of nearly 20,000 patients, 6,139 (31%) were treated initially with a macrolide and 13,469 (69%) with a quinolone. “Those who received macrolides had a lower risk of treatment failure (6.8% vs. 8.1%, p<0.01), a finding that was attenuated after multivariable adjustment (OR=0.89, 95% CI 0.78-1.01), and disappeared in a grouped-treatment analysis (OR=1.01, 95% CI 0.75-1.35),” the authors wrote. The study found no differences in adjusted length of stay or cost. However, antibiotic-associated diarrhea was more common with quinolones (1.2% vs. 0.6%, p<0.001).

Dr. Rothberg, who is affiliated with the Center for Quality of Care Research at Baystate Medical Center in Springfield, Mass., says the data, while a point in the right direction, should be viewed as a first step in doing more search to determine the best treatment for AECOPD.

“If you look at the guidelines, the recommendations are all over the map,” Dr. Rothberg says. “This is really because there are no randomized trials in COPD patients. … There are so many unanswered questions. There’s been so much focus on pneumonia, heart failure, and acute myocardial infarction. COPD kind of has a dearth of research.”

Dr. Rothberg hopes to further that research via the COPD Outcomes-Based Network for Clinical Effectiveness & Research Translation (CONCERT), a team of physicians and researchers from centers around the country who are advocating for improvements to COPD treatment. Baystate is one of CONCERT’s outposts.

A report in this month’s Journal of Hospital Medicine shows macrolide and quinolone antibiotics are associated with similar rates of treatment failure in acute exacerbation of chronic pulmonary disease (AECOPD). The lead author says the study could be a precursor to, say, an intrepid HM researcher working on a randomized trial of the antibiotics’ effectiveness.

“It’s a perfect thing for hospitalists to study because they’re the ones treating it,” says Michael Rothberg, MD, MPH, associate professor of medicine at Tufts University School of Medicine in Boston, and lead author of "Comparative Effectiveness of Macrolides and Quinolones for Patients Hospitalized with Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD)."

The retrospective cohort review reported that out of nearly 20,000 patients, 6,139 (31%) were treated initially with a macrolide and 13,469 (69%) with a quinolone. “Those who received macrolides had a lower risk of treatment failure (6.8% vs. 8.1%, p<0.01), a finding that was attenuated after multivariable adjustment (OR=0.89, 95% CI 0.78-1.01), and disappeared in a grouped-treatment analysis (OR=1.01, 95% CI 0.75-1.35),” the authors wrote. The study found no differences in adjusted length of stay or cost. However, antibiotic-associated diarrhea was more common with quinolones (1.2% vs. 0.6%, p<0.001).

Dr. Rothberg, who is affiliated with the Center for Quality of Care Research at Baystate Medical Center in Springfield, Mass., says the data, while a point in the right direction, should be viewed as a first step in doing more search to determine the best treatment for AECOPD.

“If you look at the guidelines, the recommendations are all over the map,” Dr. Rothberg says. “This is really because there are no randomized trials in COPD patients. … There are so many unanswered questions. There’s been so much focus on pneumonia, heart failure, and acute myocardial infarction. COPD kind of has a dearth of research.”

Dr. Rothberg hopes to further that research via the COPD Outcomes-Based Network for Clinical Effectiveness & Research Translation (CONCERT), a team of physicians and researchers from centers around the country who are advocating for improvements to COPD treatment. Baystate is one of CONCERT’s outposts.

Issue
The Hospitalist - 2010(06)
Issue
The Hospitalist - 2010(06)
Publications
Publications
Article Type
Display Headline
New Research Target
Display Headline
New Research Target
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)

In the Literature: Research You Need to Know

Article Type
Changed
Display Headline
In the Literature: Research You Need to Know

Clinical question: Is glucose variability associated with increased mortality independent of mean glucose values in intensive-care-unit (ICU) patients on a strict glucose-control algorithm?

Background: Initial studies demonstrating that strict glycemic control in the ICU improves mortality have not been reproduced in more recent trials and meta-analyses. This inconsistency may be due to unstudied aspects of glycemic control, such as glucose variability.

Study design: Retrospective cohort.

Setting: Eighteen-bed medical/surgical ICU in a teaching hospital in Amsterdam, Netherlands.

Synopsis: Data were collected on 5,728 patients admitted to the ICU from January 2004 to December 2007, all of whom were treated with a computerized intensive insulin protocol. Mean glucose, standard deviation in glucose, and mean absolute glucose change per hour (glucose variability) were calculated for each patient stay in the ICU. The results from these three calculated values were divided into quartiles and evaluated for their predictive value of ICU death and in-hospital death.

Within each mean glucose quartile, the uppermost glucose variability quartile was associated with increased risk of death. Compared with the lowest glucose variability quartile, the highest quartile had a 3.3-fold increased risk of ICU death and a 2.8-fold increased risk of in-hospital death. Patients in the highest glucose quartile with the highest glucose variability had a 12.4-fold increased risk of ICU death.

Bottom line: High glucose variability is associated with increased ICU and in-hospital mortality independent of mean glucose values in patients on a strict glucose control algorithm.

Citation: Hermanides J, Vriesendorp TM, Bosman RJ, et al. Glucose variability is associated with intensive care unit mortality. Crit Care Med. 2010;38(3):838-842..

Reviewed for TH eWire by Dimitriy Levin, MD, Jeffrey Carter, MD, Erin Egan, MD, JD, Jonathan Pell, MD, Laura Rosenthal, MSN, ACNP, Nichole Zehnder, MD, Hospital Medicine Group, University of Colorado Denver

For more reviews of HM-related literature, visit our website.

Issue
The Hospitalist - 2010(06)
Publications
Sections

Clinical question: Is glucose variability associated with increased mortality independent of mean glucose values in intensive-care-unit (ICU) patients on a strict glucose-control algorithm?

Background: Initial studies demonstrating that strict glycemic control in the ICU improves mortality have not been reproduced in more recent trials and meta-analyses. This inconsistency may be due to unstudied aspects of glycemic control, such as glucose variability.

Study design: Retrospective cohort.

Setting: Eighteen-bed medical/surgical ICU in a teaching hospital in Amsterdam, Netherlands.

Synopsis: Data were collected on 5,728 patients admitted to the ICU from January 2004 to December 2007, all of whom were treated with a computerized intensive insulin protocol. Mean glucose, standard deviation in glucose, and mean absolute glucose change per hour (glucose variability) were calculated for each patient stay in the ICU. The results from these three calculated values were divided into quartiles and evaluated for their predictive value of ICU death and in-hospital death.

Within each mean glucose quartile, the uppermost glucose variability quartile was associated with increased risk of death. Compared with the lowest glucose variability quartile, the highest quartile had a 3.3-fold increased risk of ICU death and a 2.8-fold increased risk of in-hospital death. Patients in the highest glucose quartile with the highest glucose variability had a 12.4-fold increased risk of ICU death.

Bottom line: High glucose variability is associated with increased ICU and in-hospital mortality independent of mean glucose values in patients on a strict glucose control algorithm.

Citation: Hermanides J, Vriesendorp TM, Bosman RJ, et al. Glucose variability is associated with intensive care unit mortality. Crit Care Med. 2010;38(3):838-842..

Reviewed for TH eWire by Dimitriy Levin, MD, Jeffrey Carter, MD, Erin Egan, MD, JD, Jonathan Pell, MD, Laura Rosenthal, MSN, ACNP, Nichole Zehnder, MD, Hospital Medicine Group, University of Colorado Denver

For more reviews of HM-related literature, visit our website.

Clinical question: Is glucose variability associated with increased mortality independent of mean glucose values in intensive-care-unit (ICU) patients on a strict glucose-control algorithm?

Background: Initial studies demonstrating that strict glycemic control in the ICU improves mortality have not been reproduced in more recent trials and meta-analyses. This inconsistency may be due to unstudied aspects of glycemic control, such as glucose variability.

Study design: Retrospective cohort.

Setting: Eighteen-bed medical/surgical ICU in a teaching hospital in Amsterdam, Netherlands.

Synopsis: Data were collected on 5,728 patients admitted to the ICU from January 2004 to December 2007, all of whom were treated with a computerized intensive insulin protocol. Mean glucose, standard deviation in glucose, and mean absolute glucose change per hour (glucose variability) were calculated for each patient stay in the ICU. The results from these three calculated values were divided into quartiles and evaluated for their predictive value of ICU death and in-hospital death.

Within each mean glucose quartile, the uppermost glucose variability quartile was associated with increased risk of death. Compared with the lowest glucose variability quartile, the highest quartile had a 3.3-fold increased risk of ICU death and a 2.8-fold increased risk of in-hospital death. Patients in the highest glucose quartile with the highest glucose variability had a 12.4-fold increased risk of ICU death.

Bottom line: High glucose variability is associated with increased ICU and in-hospital mortality independent of mean glucose values in patients on a strict glucose control algorithm.

Citation: Hermanides J, Vriesendorp TM, Bosman RJ, et al. Glucose variability is associated with intensive care unit mortality. Crit Care Med. 2010;38(3):838-842..

Reviewed for TH eWire by Dimitriy Levin, MD, Jeffrey Carter, MD, Erin Egan, MD, JD, Jonathan Pell, MD, Laura Rosenthal, MSN, ACNP, Nichole Zehnder, MD, Hospital Medicine Group, University of Colorado Denver

For more reviews of HM-related literature, visit our website.

Issue
The Hospitalist - 2010(06)
Issue
The Hospitalist - 2010(06)
Publications
Publications
Article Type
Display Headline
In the Literature: Research You Need to Know
Display Headline
In the Literature: Research You Need to Know
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)

Insurance Status and Hospital Care

Article Type
Changed
Display Headline
Insurance status and hospital care for myocardial infarction, stroke, and pneumonia

With about 1 in 5 working‐age Americans (age 18‐64 years) currently uninsured and a large number relying on Medicaid, adequate access to quality health care services is becoming increasingly difficult.1 Substantial literature has accumulated over the years suggesting that access and quality in health care are closely linked to an individual's health insurance status.211 Some studies indicate that being uninsured or publicly insured is associated with negative health consequences.12, 13 Although the Medicaid program has improved access for qualifying low‐income individuals, significant gaps in access and quality remain.2, 5, 11, 1419 These issues are likely to become more pervasive should there be further modifications to state Medicaid funding in response to the unfolding economic crisis.

Although numerous studies have focused on insurance‐related disparities in the outpatient setting, few nationally representative studies have examined such disparities among hospitalized patients. A cross‐sectional study of a large hospital database from 1987 reported higher risk‐adjusted in‐hospital mortality, shorter length of stay (LOS), and lower procedure use among uninsured patients.9 A more recent analysis, limited to patients admitted with stroke, reported significant variation in hospital care associated with insurance status.15 Other studies reporting myocardial infarction registry and quality improvement program data are biased by the self‐selection of large urban teaching hospitals.1618 To our knowledge, no nationally representative study has focused on the impact of insurance coverage on hospital care for common medical conditions among working‐age Americans, the fastest growing segment of the uninsured population.

To address this gap in knowledge, we analyzed a nationally representative hospital database to determine whether there are significant insurance‐related disparities in in‐hospital mortality, LOS, and cost per hospitalization for 3 common medical conditions among working‐age adults, and, if present, to determine whether these disparities are due to differences in disease severity and comorbidities, and whether these disparities are affected by the proportion of uninsured and Medicaid patients receiving care in each hospital.

Methods

Design and Subjects

We examined data from the 2005 Nationwide Inpatient Sample (NIS), a nationally representative database of hospital inpatient stays maintained by the Agency for Healthcare Research and Quality (AHRQ) as part of the Healthcare Cost and Utilization Project (HCUP).20, 21 The NIS is a stratified probability sample of 20% of all US community hospitals, including public hospitals, academic medical centers, and specialty hospitals. Long‐term care hospitals, psychiatric hospitals, and alcoholism/chemical‐dependency treatment facilities are excluded. The 2005 NIS contains data on 7,995,048 discharges from 1054 hospitals located in 37 States and is designed to be representative of all acute care discharges from all US community hospitals.21

We identified discharges with a principal diagnosis of acute myocardial infarction (AMI), stroke, and pneumonia using International Classification of Diseases, 9th Revision, Clinical Modification (ICD‐9‐CM) codes specified in the AHRQ definitions of Inpatient Quality Indicators (Supporting Information Appendix).22 These 3 conditions are among the leading causes of noncancer inpatient deaths in patients under 65 years old,23 and evidence suggests that high mortality may be associated with deficiencies in the quality of inpatient care.24

We confined our analysis to patients 18 to 64 years of age, since this population is most at risk of being uninsured or underinsured.25 We excluded pregnant women because they account for an unusually high proportion of uninsured discharges and were relatively few in our cohort.26 In addition, we excluded patients transferred to another acute care hospital and patients missing payer source and discharge disposition. Our study protocol was approved by the Partners Human Research Committee.

Study Variables

We categorized insurance status as privately insured, uninsured, Medicaid, or Medicare. We defined privately insured patients as those having either Blue Cross or another commercial carrier listed as the primary payer and uninsured patients as those having either no charge or self‐pay listed as the primary payer.27 Other governmental payer categories were noted to share several characteristics with Medicare patients and comprised only a small proportion of the sample, and were thus included with Medicare. In order to account for NIS's sampling scheme and accurately apply sample weights in our analysis, we used Medicare as a separate category. However, since Medicare patients age 18 to 64 years represent a fundamentally different population that is primarily disabled or very ill, only results of privately insured, uninsured, and Medicaid patients are reported.

We selected in‐hospital mortality as the outcome measure and LOS and cost per hospitalization as measures of resource utilization. The NIS includes a binary indicator variable for in‐hospital mortality and specifies inpatient LOS in integers, with same‐day stays coded as 0. NIS's cost estimates are based on hospital cost reports submitted to the Centers for Medicare and Medicaid Services. To test the validity of our cost analyses, we performed parallel analyses using hospital charges as a measure of utilization (charges include hospital overhead, charity care, and bad debt). The resulting adjusted ratios differed little from cost ratios and we opted to report only the details of our cost analyses.

In order to assess the independent association between insurance status and the outcome measures listed above, we selected covariates for inclusion in multivariable models based on the existing literature. Patient covariates included: age group (18‐34 years, 35‐49 years, 50‐64 years), sex (male/female), race/ethnicity (non‐Hispanic white, non‐Hispanic black, Hispanic, other, missing), median income by zip code of residence (less than $37,000, $37,000‐$45,999, $46,000‐$60,999, $61,000 or more), admission through the emergency department (yes/no), admission on a weekend (yes/no), measures of disease severity, and comorbidity indicators. Measures of disease severity specific to each outcome are assigned in the NIS using criteria developed by Medstat (Medstat Disease Staging Software Version 5.2, Thomson Medstat Inc., Ann Arbor, MI). Severity is categorized into 5 levels, with a higher level indicating greater risk. We recorded comorbidities for each patient in our sample using HCUP Comorbidity Software, Version 3.2 (www.hcup‐us.ahrq.gov/tools_software.jsp) based on comorbidity measures reported by Elixhauser et al.28

Hospital covariates included: bed size (small, medium, large), ownership/control (private, government, private or government), geographic region (northeast, midwest, south, west), teaching status (teaching, non‐teaching), and the proportion of uninsured and Medicaid patients (combined) admitted to each hospital for AMI, stroke, or pneumonia. The actual number of hospital beds in each bed size category varies according to a hospital's geographic region and teaching status.27 Ownership/control, geographic region, and teaching status are assigned according to information from the American Hospital Association Annual Survey of Hospitals. The proportion of uninsured and Medicaid patients admitted to each hospital was found to have a nonmonotonic relationship with the outcomes being assessed and was thus treated as a 6‐level categorical variable with the following levels: 0% to 10%, 11% to 20%, 21% to 30%, 31% to 40%, 41% to 50%, and 51% to 100%.

Statistical Analysis

Summary statistics were constructed at the patient level and differences in proportions were evaluated with the chi‐square test. We employed direct standardization, using the age and sex distribution of the entire cohort, to compute age‐standardized and sex‐standardized estimates for each insurance group and compared them using the chi‐square test for in‐hospital mortality and t test for log transformed LOS and cost per hospitalization. For each condition, we developed multivariable logistic regression models for in‐hospital mortality and multivariable linear regression models for log transformed LOS and cost. The patient was the unit of analysis in all models.

In order to elucidate the contribution of disease severity and comorbidities and the proportion of uninsured and Medicaid patients admitted to each hospital, we fitted 3 sequential models for each outcome measure: Model 1 adjusted for patient sociodemographic characteristics and hospital characteristics with the exception of the covariate for the proportion of uninsured and Medicaid patients, Model 2 adjusted for all covariates in the preceding model as well as patients' comorbidities and severity of principal diagnosis, and Model 3 adjusted for all previously mentioned covariates as well as the proportion of uninsured and Medicaid patients admitted to each hospital. We excluded patients who died during hospitalization from the models for LOS and cost. We exponentiated the effect estimates from the log transformed linear regression models so that the adjusted ratio represents the percentage change in the mean LOS or mean cost.

To determine whether the association between patients' insurance status and in‐hospital mortality was modified by seeking care in hospitals treating a smaller or larger proportion of uninsured and Medicaid patients, we entered an interaction term for insurance status and proportion of uninsured and Medicaid patients in the final models (Model 3) for our primary outcome of in‐hospital mortality. However, since no significant interaction was found for any of the 3 conditions, this term was removed from the models and results from the interaction models are not described. In order to assess model specification for the linear regression models, we evaluated the normality of model residuals and found that these were approximately normally distributed. Lastly, we attempted to test the robustness of our analyses by creating fixed effects models that controlled for hospital site but were unable to do so due to the computational limitations of available software packages that could not render fixed effects models with more than 1000 hospital sites.

For all variables except race/ethnicity, data were missing for less than 3% of patients, so we excluded these individuals from adjusted analyses. However, race/ethnicity data were missing for 29% of the sample and were analyzed in 3 different ways, namely, with the missing data treated as a separate covariate level, with the missing data removed from the analysis, and with the missing data assigned to the majority covariate level (white race). The results of our analysis were unchanged no matter how the missing values were assigned. As a result, missing values for race/ethnicity were treated as a separate covariate level in the final analysis.15 Sociodemographic characteristics of patients with missing race/ethnicity information were similar to those with complete data.

We used SUDAAN (Release 9.0.1, Research Triangle Institute, NC) to account for NIS's sampling scheme and generalized estimating equations to adjust for the clustering of patients within hospitals and hospitals within sampling strata.29 In order to account for NIS's stratified probability sampling scheme, SUDAAN uses Taylor series linearization for robust variance estimation of descriptive statistics and regression parameters.30, 31 We present 2‐tailed P values or 95% confidence intervals (CIs) for all statistical comparisons.

Results

Patient and Hospital Characteristics

The final cohort comprised of 154,381 patients discharged from 1018 hospitals in 37 states during calendar year 2005 (Table 1). This cohort was representative of 755,346 working‐age Americans, representing approximately 225,947 cases of AMI (29.9%), 151,812 cases of stroke (20.1%), and 377,588 cases of pneumonia (50.0%). Of these patients, 47.5% were privately insured, 12.0% were uninsured, 17.0% received Medicaid, and 23.5% were assigned to Medicare. Compared with the privately insured, uninsured and Medicaid patients were generally younger, less likely to be white, more likely to have lower income, and more likely to be admitted through the emergency department. Of the 1018 hospitals included in our study, close to half (44.3%) were small, with bedsize ranging from 24 to 249. A large number of hospitals were located in the South (39.9%), and 14.9% were designated teaching hospitals.

Characteristics of Patients With Acute Myocardial Infarction, Stroke, and Pneumonia by Insurance Category, 2005 Nationwide Inpatient Sample
Characteristic*Privately insured (n = 73,256)Uninsured (n = 18,531)Medicaid (n = 26,222)
  • NOTE: Because of rounding, percentages may not equal 100.

  • For all comparisons, differences are significant at P < 0.01 using the chi‐square test.

Principal diagnosis (%)   
Acute myocardial infarction36.731.219.7
Stroke20.623.719.9
Pneumonia42.745.260.4
Age group (%)   
18‐34 years6.813.013.7
35‐49 years27.636.933.2
50‐64 years65.750.153.2
Male sex (%)59.362.346.6
Race or ethnicity (%)   
White55.741.538.0
Black7.614.816.6
Hispanic4.810.510.4
Other race3.64.75.2
Missing28.429.029.7
Median income by ZIP code (%)   
<$37,00021.536.743.0
$37,000‐$45,99925.227.827.1
$46,000‐$60,99926.320.317.6
$61,00024.811.58.4
Emergency admission (%)63.375.672.9
Weekend admission (%)24.526.225.1
Hospital bed size (%)   
Small8.910.311.4
Medium24.022.325.9
Large67.167.562.8
Hospital control (%)   
Private33.834.834.4
Government (nonfederal)6.79.78.3
Private or government59.555.557.3
Hospital region (%)   
Northeast17.412.517.6
Midwest25.719.420.9
South39.556.842.4
West17.411.319.2
Teaching hospital (%)41.743.843.3

Compared with privately insured patients, a larger proportion of uninsured and Medicaid patients had higher predicted mortality levels (Table 2). Medicaid patients had a disproportionately higher predicted LOS, whereas predicted resource demand was higher among privately insured patients. Hypertension (48%), chronic pulmonary disease (29.5%), and uncomplicated diabetes (21.5%) were the 3 most common comorbidities in the study cohort, with a generally higher prevalence of comorbidities among Medicaid patients.

Measures of Disease Severity and Comorbid Conditions in Patients With Acute Myocardial Infarction, Stroke, and Pneumonia by Insurance Category, 2005 Nationwide Inpatient Sample
Characteristic*Privately insured (n = 73,256)Uninsured (n = 18,531)Medicaid (n = 26,222)
  • NOTE: Because of rounding, percentages may not equal 100.

  • Abbreviation: AIDS, acquired immune deficiency syndrome.

  • For all comparisons, differences are significant at P < 0.01 using the chi‐square test.

  • The original Medstat disease staging system comprised 5 levels. Due to the small number of patients in levels 1, 2, and 3, we collapsed these into a single level and named it as level 1; we subsequently renamed levels 4 and 5 as levels 2 and 3, respectively. These levels correspond with the severity of the principal diagnosis, with higher levels indicating more severe disease on admission.

Medstat disease staging (%)   
Mortality level 150.845.436.7
Mortality level 244.049.156.7
Mortality level 35.35.56.7
Length of stay level 166.871.653.8
Length of stay level 228.524.539.3
Length of stay level 34.83.86.9
Resource demand level 145.254.248.5
Resource demand level 240.534.239.2
Resource demand level 314.211.712.3
Coexisting medical conditions (%)   
Congestive heart failure4.74.810.1
Valvular disease2.82.02.7
Pulmonary circulation disease0.80.61.5
Peripheral vascular disease3.22.23.2
Paralysis1.20.83.5
Other neurological disorders2.41.97.3
Chronic pulmonary disease23.622.437.7
Uncomplicated diabetes19.618.623.4
Complicated diabetes3.32.14.9
Hypothyroidism5.62.74.7
Renal failure3.01.95.6
Liver disease1.62.54.4
Peptic ulcer disease<0.5<0.5<0.5
AIDS0.10.10.4
Lymphoma1.10.40.6
Metastatic cancer2.10.72.2
Non‐metastatic solid tumor1.50.82.1
Collagen vascular diseases2.30.92.3
Coagulopathy2.72.43.4
Obesity10.38.29.3
Weight loss1.61.83.3
Fluid and electrolyte disorders18.319.423.8
Chronic blood loss anemia0.60.60.8
Deficiency anemias8.68.513.4
Alcohol abuse3.39.88.3
Drug abuse1.910.29.8
Psychoses1.51.96.8
Depression7.24.89.9
Hypertension48.044.145.7

In‐Hospital Mortality

Compared with the privately insured, age‐standardized and sex‐standardized in‐hospital mortality for AMI and stroke was significantly higher for uninsured and Medicaid patients (Table 3). Among pneumonia patients, Medicaid recipients had significantly higher in‐hospital mortality compared with privately insured and uninsured patients.

Age‐Standardized and Sex‐Standardized In‐Hospital Mortality and Resource Use for 3 Common Medical Conditions by Insurance Category, 2005 Nationwide Inpatient Sample
 Privately InsuredUninsuredMedicaid
  • NOTE: Age‐standardized and sex‐standardized using the age and sex distribution of the entire cohort for direct standardization. These are unadjusted figures.

  • Abbreviations: SE, standard error.

  • Significantly different from privately insured at P < 0.001 using the chi‐square test.

  • Significantly different from privately insured at P < 0.05 using the t‐test; log transformations were used to approximate normal distribution.

In‐hospital mortality, rate per 100 discharges (SE)   
Acute myocardial infarction2.22 (0.10)4.03 (0.31)*4.57 (0.34)*
Stroke7.49 (0.27)10.46 (0.64)*9.89 (0.45)*
Pneumonia1.75 (0.09)1.74 (0.18)2.48 (0.14)*
Length of stay, mean (SE), days   
Acute myocardial infarction4.17 (0.06)4.46 (0.09)5.85 (0.16)
Stroke6.37 (0.13)7.15 (0.25)9.28 (0.30)
Pneumonia4.89 (0.05)4.64 (0.10)5.80 (0.08)
Cost per episode, mean (SE), dollars   
Acute myocardial infarction21,077 (512)19,977 (833)22,452 (841)
Stroke16,022 (679)14,571 (1,036)18,462 (824)
Pneumonia8,223 (192)7,086 (293)9,479 (271)

After multivariable adjustment for additional patient and hospital characteristics, uninsured AMI and stroke patients continued to have significantly higher in‐hospital mortality compared with the privately insured (Table 4). Among pneumonia patients, Medicaid recipients persisted in having significantly higher in‐hospital mortality than the privately insured.

Multivariable‐Adjusted In‐Hospital Mortality and Resource Use for 3 Common Medical Conditions by Insurance Category, 2005 Nationwide Inpatient Sample
 Model 1*Model 2Model 3
  • NOTE: Using multivariable logistic regression models for in‐hospital mortality and

  • multivariable linear regression models for log transformed length of stay and cost per episode.

  • Abbreviation: CI, confidence interval.

  • Model 1 adjusted for patients' age group, sex, race, income, emergency admission, and weekend admission and for hospitals' bed size, control, region, and teaching status.

  • Model 2 adjusted for all the covariates in model 1 and comorbidities and severity of principal diagnosis.

  • Model 3 adjusted for all the covariates in model 2 and the proportion of uninsured and Medicaid patients in each hospital. Interaction terms were not included in any of these 3 models.

  • Patients who died were excluded from models for length of stay and cost. Ratios are the antilog of the beta coefficients and can be interpreted in the original scale of the data as the impact relative to the reference level. Log transformations were used to approximate normal distribution.

In‐hospital mortality, adjusted odds ratio (95% CI)   
Acute Myocardial Infarction   
Uninsured vs. privately insured1.59 (1.35‐1.88)1.58 (1.30‐1.93)1.52 (1.24‐1.85)
Medicaid vs. privately insured1.83 (1.54‐2.18)1.22 (0.99‐1.50)1.15 (0.94‐1.42)
Stroke   
Uninsured vs. privately insured1.56 (1.35‐1.80)1.50 (1.30‐1.73)1.49 (1.29‐1.72)
Medicaid vs. privately insured1.32 (1.15‐1.52)1.09 (0.93‐1.27)1.08 (0.93‐1.26)
Pneumonia   
Uninsured vs. privately insured0.99 (0.81‐1.21)1.12 (0.91‐1.39)1.10 (0.89‐1.36)
Medicaid vs. privately insured1.41 (1.20‐1.65)1.24 (1.04‐1.48)1.21 (1.01‐1.45)
Length of stay, adjusted ratio (95% CI)|   
Acute Myocardial Infarction   
Uninsured vs. privately insured1.00 (0.98‐1.02)1.00 (0.98‐1.02)1.00 (0.98‐1.02)
Medicaid vs. privately insured1.17 (1.14‐1.21)1.07 (1.05‐1.09)1.07 (1.05‐1.09)
Stroke   
Uninsured vs. privately insured1.06 (1.02‐1.10)1.08 (1.04‐1.11)1.07 (1.04‐1.11)
Medicaid vs. privately insured1.30 (1.26‐1.34)1.17 (1.14‐1.20)1.17 (1.14‐1.20)
Pneumonia   
Uninsured vs. privately insured0.95 (0.93‐0.97)0.96 (0.94‐0.99)0.96 (0.94‐0.98)
Medicaid vs. privately insured1.15 (1.13‐1.17)1.04 (1.03‐1.06)1.04 (1.03‐1.06)
Cost per episode, adjusted ratio (95% CI)|   
Acute Myocardial Infarction   
Uninsured vs. privately insured0.97 (0.95‐0.99)0.99 (0.97‐1.00)0.99 (0.97‐1.00)
Medicaid vs. privately insured1.01 (0.98‐1.04)0.99 (0.97‐1.01)0.99 (0.97‐1.01)
Stroke   
Uninsured vs. privately insured0.97 (0.93‐1.02)1.00 (0.96‐1.03)1.00 (0.97‐1.03)
Medicaid vs. privately insured1.17 (1.13‐1.21)1.06 (1.04‐1.09)1.06 (1.04‐1.09)
Pneumonia   
Uninsured vs. privately insured0.95 (0.92‐0.97)0.98 (0.96‐1.00)0.98 (0.96‐1.00)
Medicaid vs. privately insured1.17 (1.15‐1.19)1.05 (1.04‐1.07)1.05 (1.04‐1.07)

LOS

Among AMI and stroke patients, age‐standardized and sex‐standardized mean LOS was significantly longer for the uninsured and Medicaid recipients compared with the privately insured (Table 3). Among pneumonia patients, the uninsured had a slightly shorter mean LOS compared with the privately insured whereas Medicaid recipients averaged the longest LOS.

These insurance‐related disparities in LOS among pneumonia patients persisted after multivariable adjustment (Table 4). Among AMI patients, only Medicaid recipients persisted in having a significantly longer LOS than the privately insured. Among stroke patients, both the uninsured and Medicaid recipients averaged a longer LOS compared with the privately insured.

Cost per Episode

For all 3 conditions, the uninsured had significantly lower age‐standardized and sex‐standardized costs compared with the privately insured (Table 3). However, Medicaid patients had higher costs than the privately insured for all three conditions, significantly so among patients with stroke and pneumonia.

These insurance‐related disparities in costs persisted in multivariable analyses (Table 4). The uninsured continued to have lower costs compared with the privately insured, significantly so for patients with AMI and pneumonia. Among stroke and pneumonia patients, Medicaid recipients continued to accrue higher costs than the uninsured or privately insured.

Discussion

In this nationally representative study of working‐age Americans hospitalized for 3 common medical conditions, we found that insurance status was associated with significant variations in in‐hospital mortality and resource use. Whereas privately insured patients experienced comparatively lower in‐hospital mortality in most cases, mortality risk was highest among the uninsured for 2 of the 3 common causes of noncancer inpatient deaths. Although previous studies have examined insurance‐related disparities in inpatient care for individual diagnoses and specific populations, no broad overview of this important issue has been published in the past decade. In light of the current economic recession and national healthcare debate, these findings may be a prescient indication of a widening insurance gap in the quality of hospital care.

There are several potential mechanisms for these disparities. For instance, Hadley et al.9 reported significant underuse of high‐cost or high‐discretion procedures among the uninsured in their analysis of a nationally representative sample of 592,598 hospitalized patients. Similarly, Burstin et al.10 found that among a population of 30,195 hospitalized patients with diverse diagnoses, the uninsured were at greater risk for receiving substandard care regardless of hospital characteristics. These, and other similar findings,7, 8, 19 are suggestive of differences in the way uninsured patients are generally managed in the hospital that may partly explain the disparities reported herein.

More specifically, analyses of national registries of AMI have documented lower rates of utilization of invasive, potentially life‐saving, cardiac interventions among the uninsured.16, 17 Similarly, a lower rate of carotid endarterectomy was reported among uninsured stroke patients from an analysis of the 2002 NIS.15 Other differences in inpatient management unmeasured by administrative data, such as the use of subspecialists and allied health professionals, may also contribute.32 Unfortunately, limitations in the available data prevented us from being able to appropriately address the important issue of insurance related differences in the utilization of specific inpatient procedures.

These disparities may also be indicative of differences in severity of illness that are not captured fully by the MedStat disease staging criteria. The uninsured might have more severe illness at admission, either due to the presence of more advanced chronic disease or delay in seeking care for the acute episode. AMI and stroke are usually the culmination of longstanding atherosclerosis that is amenable to improvement through timely and consistent risk‐factor modification. Not having a usual source of medical care,6, 33 inadequate screening and management of known risk‐factors,3, 34 and difficulties in obtaining specialty care5 among the uninsured likely increases their risk of being hospitalized with more advanced disease. The higher likelihood of being admitted through the emergency department19 and on weekends9 among the uninsured lends credence to the possibility of delays in seeking care. All of these are potential mediators of higher AMI and stroke mortality in uninsured patients.

Finally, these mortality differences could also be due to the additional risks imposed by poorly managed comorbidities among uninsured patients. Although we controlled for the presence of comorbidities in our analysis, we lacked data about the severity of individual comorbidities. A recent study reported significant lapses in follow‐up care after the onset of a chronic condition in uninsured individuals under 65 years of age.34 Other studies have also documented insurance related disparities in the care of chronic diseases3, 35 that were among the most common comorbidities in our cohort.

Most of the reasons for insurance‐related disparities noted above for the uninsured are also applicable to Medicaid patients. Differences in the intensity of inpatient care,7, 8, 1519 limited access to health care services,2, 14 unmet health needs,5 and suboptimal management of chronic medical conditions35 were also reported for Medicaid patients in prior research. These factors likely contributed to the higher in‐hospital mortality in this patient population, evidenced by the sequential decrease in odds after adjusting for comorbidities and disease severity. Medicaid patients hospitalized for stroke were noted to have significantly longer LOS, which could plausibly be due to difficulties with arranging appropriate discharge disposition; the higher likelihood of paralysis among these patients15 would likely necessitate a higher frequency of rehabilitation facility placement. The higher costs for Medicaid patients with stroke and pneumonia may potentially be the result of these patients longer LOS. Although cost differences between the uninsured and privately insured were statistically significant, these were not large enough to be of material significance.

Limitations

Our study has several limitations. Since the NIS does not assign unique patient identifiers that would permit tracking of readmissions, we excluded patients transferred to another acute‐care hospital from our study to avoid counting the same patient twice. However, only 10% of hospitalized patients underwent transfer for cardiac procedures in the National Registry of Myocardial Infarction, with privately insured patients more likely to be transferred than other insurance groups.17 Since these patients are also more likely to have better survival, their exclusion likely biased our study toward the null. The same is probable for stroke patients as well.

Some uninsured patients begin Medicaid coverage during hospitalization and should ideally be counted as uninsured but were included under Medicaid in our analysis. They are also likely to be state‐ and plan‐specific variations in Medicaid and private payer coverage that we could not incorporate into our analysis. In addition, we were unable to include deaths that may have occurred shortly after discharge, even though these may have been related to the quality of hospital care. Furthermore, although the 3 conditions we studied are common and responsible for a large number of hospital deaths, they make up about 8% of total annual hospital discharges,23 and caution should be exercised in generalizing our findings to the full spectrum of hospitalizations. Lastly, it is possible that unmeasured confounding could be responsible for the observed associations. Uninsured and Medicaid patients are likely to have more severe disease, which may not be adequately captured by the administrative data available in the NIS. If so, this would explain the mortality association rather than insurance status.36, 37

Conclusions

Significant insurance‐related differences in mortality exist for 2 of the leading causes of noncancer inpatient deaths among working‐age Americans. Further studies are needed to determine whether provider sensitivity to insurance status or unmeasured sociodemographic and clinical prognostic factors are responsible for these disparities. Policy makers, hospital administrators, and physicians should be cognizant of these disparities and consider policies to address potential insurance related gaps in the quality of inpatient care.

References
  1. Holahan J, Cook A.The U.S. economy and changes in health insurance coverage, 2000‐2006.Health Aff (Millwood).2008;27(2):w135w144.
  2. Weissman JS, Gatsonis C, Epstein AM.Rates of avoidable hospitalization by insurance status in Massachusetts and Maryland.JAMA.1992;268(17):2388‐2394.
  3. Ayanian JZ, Weissman JS, Schneider EC, et al.Unmet health needs of uninsured adults in the United States.JAMA.2000;284(16):20612069.
  4. Baker DW, Shapiro MF, Schur CL.Health insurance and access to care for symptomatic conditions.Arch Intern Med.2000;160(9):12691274.
  5. Cook NL, Hicks LS, O'Malley AJ, et al.Access to specialty care and medical services in community health centers.Health Aff (Millwood).2007;26(5):14591468.
  6. Wilper AP, Woolhandler S, Lasser KE, et al.A national study of chronic disease prevalence and access to care in uninsured U.S. adults.Ann Intern Med.2008;149:170176.
  7. Yergan J, Flood AB, Diehr P, LoGerfo JP.Relationship between patient source of payment and the intensity of hospital services.Med Care.1988;26(11):11111114.
  8. Wenneker MB, Weissman JS, Epstein AM.The association of payer with utilization of cardiac procedures in Massachusetts.JAMA.1990;264(10):12551260.
  9. Hadley J, Steinberg EP, Feder J.Comparison of uninsured and privately insured hospital patients: condition on admission, resource use, and outcome.JAMA.1991;265:374379.
  10. Burstin HR, Lipsitz SR, Brennan TA.Socioeconomic status and risk for substandard medical care.JAMA.1992;268(17):23832387.
  11. Ayanian JZ, Kohler BA, Abe T, Epstein AM.The relation between health insurance coverage and clinical outcomes among women with breast cancer.N Engl J Med.1993;329(5):326331.
  12. Franks P, Clancy CM, Gold MR.Health insurance and mortality. Evidence from a national cohort.JAMA.1993;270(6):737741.
  13. Sorlie PD, Johnson NJ, Backlund E, Bradham DD.Mortality in the uninsured compared with that in persons with public and private health insurance.Arch Intern Med.1994;154(21):24092416.
  14. Cohen JW.Medicaid policy and the substitution of hospital outpatient care for physician care.Health Serv Res.1989;24:3366.
  15. Shen JJ, Washington EL.Disparities in outcomes among patients with stroke associated with insurance status.Stroke.2007;38(3):10101016.
  16. Sada MJ, French WJ, Carlisle DM, et al.Influence of payor on use of invasive cardiac procedures and patient outcome after myocardial infarction in the United States. Participants in the National Registry of Myocardial Infarction.J Am Coll Cardiol.1998;31(7):14741480.
  17. Canto JG, Rogers WJ, French WJ, et al.Payer status and the utilization of hospital resources in acute myocardial infarction: a report from the National Registry of Myocardial Infarction 2.Arch Intern Med.2000;160(6):817823.
  18. Calvin JE, Roe MT, Chen AY, et al.Insurance coverage and care of patients with non‐ST‐segment elevation acute coronary syndromes.Ann Intern Med.2006;145(10):739748.
  19. Bradbury RC, Golec JH, Steen PM.Comparing uninsured and privately insured hospital patients: Admission severity, health outcomes and resource use.Health Serv Manage Res.2001;14(3):203210.
  20. Healthcare Cost and Utilization Project. Introduction to the HCUP Nationwide Inpatient Sample (NIS) 2005. Rockville, MD: Agency for Healthcare Research and Quality; 2007:6. Available at: www.hcup‐us.ahrq.gov/db/nation/nis/NIS_Introduction_2005.pdf. Accessed February2010.
  21. Healthcare Cost and Utilization Project. Design of the Nationwide Inpatient Sample (NIS) 2005. Rockville, MD: Agency for Healthcare Research and Quality; 2007. Available at: www.hcup‐us.ahrq.gov/db/nation/nis/reports/NIS_2005_Design_Report.pdf. Accessed February2010.
  22. AHRQ Quality Indicators. Inpatient Quality Indicators: Technical Specifications. Version 3.1 (March 12, 2007). Available at: www.qualityindicators.ahrq.gov/downloads/iqi/iqi_technical_specs_v31.pdf. Accessed February2010.
  23. DeFrances CJ, Cullen KA, Kozak LJ. National Hospital Discharge Survey: 2005 annual summary with detailed diagnosis and procedure data. Washington, DC: National Center for Health Statistics; 2007. Vital and Health Statistics 13(165). Available at: www.cdc.gov/nchs/data/series/sr_13/sr13_165.pdf. Accessed February2010.
  24. AHRQ Quality Indicators. Guide to Inpatient Quality Indicators: Quality of Care in Hospitals—Volume, Mortality, and Utilization. Version 3.1 (March 12, 2007). Available at: www.qualityindicators.ahrq.gov/downloads/iqi/iqi_guide_v31.pdf. Accessed February2010.
  25. DeNavas‐Walt C, Proctor BD, Smith J.Income, poverty, and health insurance coverage in the United States: 2006.Washington, DC:US Census Bureau. Current Population Reports;2007:60233.
  26. Elixhauser A, Russo CA. Conditions Related to Uninsured Hospitalizations, 2003. HCUP Statistical Brief #8. Rockville, MD: Agency for Healthcare Research and Quality; 2006:6. Available at: www.hcup‐us.ahrq.gov/reports/statbriefs/sb8.pdf. Accessed February2010.
  27. Healthcare Cost and Utilization Project. NIS Description of Data Elements. Available at: www.hcup‐us.ahrq.gov/db/nation/nis/nisdde.jsp. Accessed February2010.
  28. Elixhauser A, Steiner C, Harris DR, Coffey RM.Comorbidity measures for use with administrative data.Med Care.1998;36:827.
  29. SUDAAN User's Manual, Release 9.0. Research TrianglePark, NC:Research Triangle Institute;2006.
  30. Houchens R, Elixhauser A. Final Report on Calculating Nationwide Inpatient Sample (NIS) Variances, 2001. HCUP Methods Series Report #2003‐2. Online June 2005 (revised June 6, 2005). U.S. Agency for Healthcare Research and Quality. Available at: www.hcup‐us.ahrq.gov/reports/CalculatingNISVariances200106092005.pdf. Accessed February2010.
  31. Binder DA.On the variances of asymptotically normal estimators from complex surveys.Int Stat Rev.1983;51:279292.
  32. Auerbach AD, Hamel MB, Califf RM, et al.Patient characteristics associated with care by a cardiologist among adults hospitalized with severe congestive heart failure.J Am Coll Cardiol.2000;36:21192125.
  33. Pleis JR, Lethbridge‐Çejku M. Summary health statistics for U.S. adults: National Health Interview Survey, 2006. Washington, DC: National Center for Health Statistics; 2007:12. Vital and Health Statistics 10(235). Available at: www.cdc.gov/nchs/data/series/sr_10/sr10_235.pdf. Accessed February2010.
  34. Hadley J.Insurance coverage, medical care use, and short‐term health changes following an unintentional injury or the onset of a chronic condition.JAMA.2007;297(10):10731084.
  35. Hicks LS, O'Malley AJ, Lieu TA, et al.The quality of chronic disease care in U.S. community health centers.Health Aff (Millwood).2006;25(6):17121723.
  36. Escobar GJ, Greene JD, Scheirer P, Gardner MN, Draper D, Kipnis P.Risk‐adjusting hospital inpatient mortality using automated inpatient, outpatient, and laboratory databases.Med Care.2008;46(3):232239.
  37. van Walraven C, Escobar GJ, Greene JD, Forster AJ.The Kaiser Permanente inpatient risk adjustment methodology was valid in an external patient population.J Clin Epidemiol. [E‐pub ahead of print].
Article PDF
Issue
Journal of Hospital Medicine - 5(8)
Page Number
452-459
Legacy Keywords
hospital cost, in‐hospital mortality, insurance status, length of stay, uninsured
Sections
Article PDF
Article PDF

With about 1 in 5 working‐age Americans (age 18‐64 years) currently uninsured and a large number relying on Medicaid, adequate access to quality health care services is becoming increasingly difficult.1 Substantial literature has accumulated over the years suggesting that access and quality in health care are closely linked to an individual's health insurance status.211 Some studies indicate that being uninsured or publicly insured is associated with negative health consequences.12, 13 Although the Medicaid program has improved access for qualifying low‐income individuals, significant gaps in access and quality remain.2, 5, 11, 1419 These issues are likely to become more pervasive should there be further modifications to state Medicaid funding in response to the unfolding economic crisis.

Although numerous studies have focused on insurance‐related disparities in the outpatient setting, few nationally representative studies have examined such disparities among hospitalized patients. A cross‐sectional study of a large hospital database from 1987 reported higher risk‐adjusted in‐hospital mortality, shorter length of stay (LOS), and lower procedure use among uninsured patients.9 A more recent analysis, limited to patients admitted with stroke, reported significant variation in hospital care associated with insurance status.15 Other studies reporting myocardial infarction registry and quality improvement program data are biased by the self‐selection of large urban teaching hospitals.1618 To our knowledge, no nationally representative study has focused on the impact of insurance coverage on hospital care for common medical conditions among working‐age Americans, the fastest growing segment of the uninsured population.

To address this gap in knowledge, we analyzed a nationally representative hospital database to determine whether there are significant insurance‐related disparities in in‐hospital mortality, LOS, and cost per hospitalization for 3 common medical conditions among working‐age adults, and, if present, to determine whether these disparities are due to differences in disease severity and comorbidities, and whether these disparities are affected by the proportion of uninsured and Medicaid patients receiving care in each hospital.

Methods

Design and Subjects

We examined data from the 2005 Nationwide Inpatient Sample (NIS), a nationally representative database of hospital inpatient stays maintained by the Agency for Healthcare Research and Quality (AHRQ) as part of the Healthcare Cost and Utilization Project (HCUP).20, 21 The NIS is a stratified probability sample of 20% of all US community hospitals, including public hospitals, academic medical centers, and specialty hospitals. Long‐term care hospitals, psychiatric hospitals, and alcoholism/chemical‐dependency treatment facilities are excluded. The 2005 NIS contains data on 7,995,048 discharges from 1054 hospitals located in 37 States and is designed to be representative of all acute care discharges from all US community hospitals.21

We identified discharges with a principal diagnosis of acute myocardial infarction (AMI), stroke, and pneumonia using International Classification of Diseases, 9th Revision, Clinical Modification (ICD‐9‐CM) codes specified in the AHRQ definitions of Inpatient Quality Indicators (Supporting Information Appendix).22 These 3 conditions are among the leading causes of noncancer inpatient deaths in patients under 65 years old,23 and evidence suggests that high mortality may be associated with deficiencies in the quality of inpatient care.24

We confined our analysis to patients 18 to 64 years of age, since this population is most at risk of being uninsured or underinsured.25 We excluded pregnant women because they account for an unusually high proportion of uninsured discharges and were relatively few in our cohort.26 In addition, we excluded patients transferred to another acute care hospital and patients missing payer source and discharge disposition. Our study protocol was approved by the Partners Human Research Committee.

Study Variables

We categorized insurance status as privately insured, uninsured, Medicaid, or Medicare. We defined privately insured patients as those having either Blue Cross or another commercial carrier listed as the primary payer and uninsured patients as those having either no charge or self‐pay listed as the primary payer.27 Other governmental payer categories were noted to share several characteristics with Medicare patients and comprised only a small proportion of the sample, and were thus included with Medicare. In order to account for NIS's sampling scheme and accurately apply sample weights in our analysis, we used Medicare as a separate category. However, since Medicare patients age 18 to 64 years represent a fundamentally different population that is primarily disabled or very ill, only results of privately insured, uninsured, and Medicaid patients are reported.

We selected in‐hospital mortality as the outcome measure and LOS and cost per hospitalization as measures of resource utilization. The NIS includes a binary indicator variable for in‐hospital mortality and specifies inpatient LOS in integers, with same‐day stays coded as 0. NIS's cost estimates are based on hospital cost reports submitted to the Centers for Medicare and Medicaid Services. To test the validity of our cost analyses, we performed parallel analyses using hospital charges as a measure of utilization (charges include hospital overhead, charity care, and bad debt). The resulting adjusted ratios differed little from cost ratios and we opted to report only the details of our cost analyses.

In order to assess the independent association between insurance status and the outcome measures listed above, we selected covariates for inclusion in multivariable models based on the existing literature. Patient covariates included: age group (18‐34 years, 35‐49 years, 50‐64 years), sex (male/female), race/ethnicity (non‐Hispanic white, non‐Hispanic black, Hispanic, other, missing), median income by zip code of residence (less than $37,000, $37,000‐$45,999, $46,000‐$60,999, $61,000 or more), admission through the emergency department (yes/no), admission on a weekend (yes/no), measures of disease severity, and comorbidity indicators. Measures of disease severity specific to each outcome are assigned in the NIS using criteria developed by Medstat (Medstat Disease Staging Software Version 5.2, Thomson Medstat Inc., Ann Arbor, MI). Severity is categorized into 5 levels, with a higher level indicating greater risk. We recorded comorbidities for each patient in our sample using HCUP Comorbidity Software, Version 3.2 (www.hcup‐us.ahrq.gov/tools_software.jsp) based on comorbidity measures reported by Elixhauser et al.28

Hospital covariates included: bed size (small, medium, large), ownership/control (private, government, private or government), geographic region (northeast, midwest, south, west), teaching status (teaching, non‐teaching), and the proportion of uninsured and Medicaid patients (combined) admitted to each hospital for AMI, stroke, or pneumonia. The actual number of hospital beds in each bed size category varies according to a hospital's geographic region and teaching status.27 Ownership/control, geographic region, and teaching status are assigned according to information from the American Hospital Association Annual Survey of Hospitals. The proportion of uninsured and Medicaid patients admitted to each hospital was found to have a nonmonotonic relationship with the outcomes being assessed and was thus treated as a 6‐level categorical variable with the following levels: 0% to 10%, 11% to 20%, 21% to 30%, 31% to 40%, 41% to 50%, and 51% to 100%.

Statistical Analysis

Summary statistics were constructed at the patient level and differences in proportions were evaluated with the chi‐square test. We employed direct standardization, using the age and sex distribution of the entire cohort, to compute age‐standardized and sex‐standardized estimates for each insurance group and compared them using the chi‐square test for in‐hospital mortality and t test for log transformed LOS and cost per hospitalization. For each condition, we developed multivariable logistic regression models for in‐hospital mortality and multivariable linear regression models for log transformed LOS and cost. The patient was the unit of analysis in all models.

In order to elucidate the contribution of disease severity and comorbidities and the proportion of uninsured and Medicaid patients admitted to each hospital, we fitted 3 sequential models for each outcome measure: Model 1 adjusted for patient sociodemographic characteristics and hospital characteristics with the exception of the covariate for the proportion of uninsured and Medicaid patients, Model 2 adjusted for all covariates in the preceding model as well as patients' comorbidities and severity of principal diagnosis, and Model 3 adjusted for all previously mentioned covariates as well as the proportion of uninsured and Medicaid patients admitted to each hospital. We excluded patients who died during hospitalization from the models for LOS and cost. We exponentiated the effect estimates from the log transformed linear regression models so that the adjusted ratio represents the percentage change in the mean LOS or mean cost.

To determine whether the association between patients' insurance status and in‐hospital mortality was modified by seeking care in hospitals treating a smaller or larger proportion of uninsured and Medicaid patients, we entered an interaction term for insurance status and proportion of uninsured and Medicaid patients in the final models (Model 3) for our primary outcome of in‐hospital mortality. However, since no significant interaction was found for any of the 3 conditions, this term was removed from the models and results from the interaction models are not described. In order to assess model specification for the linear regression models, we evaluated the normality of model residuals and found that these were approximately normally distributed. Lastly, we attempted to test the robustness of our analyses by creating fixed effects models that controlled for hospital site but were unable to do so due to the computational limitations of available software packages that could not render fixed effects models with more than 1000 hospital sites.

For all variables except race/ethnicity, data were missing for less than 3% of patients, so we excluded these individuals from adjusted analyses. However, race/ethnicity data were missing for 29% of the sample and were analyzed in 3 different ways, namely, with the missing data treated as a separate covariate level, with the missing data removed from the analysis, and with the missing data assigned to the majority covariate level (white race). The results of our analysis were unchanged no matter how the missing values were assigned. As a result, missing values for race/ethnicity were treated as a separate covariate level in the final analysis.15 Sociodemographic characteristics of patients with missing race/ethnicity information were similar to those with complete data.

We used SUDAAN (Release 9.0.1, Research Triangle Institute, NC) to account for NIS's sampling scheme and generalized estimating equations to adjust for the clustering of patients within hospitals and hospitals within sampling strata.29 In order to account for NIS's stratified probability sampling scheme, SUDAAN uses Taylor series linearization for robust variance estimation of descriptive statistics and regression parameters.30, 31 We present 2‐tailed P values or 95% confidence intervals (CIs) for all statistical comparisons.

Results

Patient and Hospital Characteristics

The final cohort comprised of 154,381 patients discharged from 1018 hospitals in 37 states during calendar year 2005 (Table 1). This cohort was representative of 755,346 working‐age Americans, representing approximately 225,947 cases of AMI (29.9%), 151,812 cases of stroke (20.1%), and 377,588 cases of pneumonia (50.0%). Of these patients, 47.5% were privately insured, 12.0% were uninsured, 17.0% received Medicaid, and 23.5% were assigned to Medicare. Compared with the privately insured, uninsured and Medicaid patients were generally younger, less likely to be white, more likely to have lower income, and more likely to be admitted through the emergency department. Of the 1018 hospitals included in our study, close to half (44.3%) were small, with bedsize ranging from 24 to 249. A large number of hospitals were located in the South (39.9%), and 14.9% were designated teaching hospitals.

Characteristics of Patients With Acute Myocardial Infarction, Stroke, and Pneumonia by Insurance Category, 2005 Nationwide Inpatient Sample
Characteristic*Privately insured (n = 73,256)Uninsured (n = 18,531)Medicaid (n = 26,222)
  • NOTE: Because of rounding, percentages may not equal 100.

  • For all comparisons, differences are significant at P < 0.01 using the chi‐square test.

Principal diagnosis (%)   
Acute myocardial infarction36.731.219.7
Stroke20.623.719.9
Pneumonia42.745.260.4
Age group (%)   
18‐34 years6.813.013.7
35‐49 years27.636.933.2
50‐64 years65.750.153.2
Male sex (%)59.362.346.6
Race or ethnicity (%)   
White55.741.538.0
Black7.614.816.6
Hispanic4.810.510.4
Other race3.64.75.2
Missing28.429.029.7
Median income by ZIP code (%)   
<$37,00021.536.743.0
$37,000‐$45,99925.227.827.1
$46,000‐$60,99926.320.317.6
$61,00024.811.58.4
Emergency admission (%)63.375.672.9
Weekend admission (%)24.526.225.1
Hospital bed size (%)   
Small8.910.311.4
Medium24.022.325.9
Large67.167.562.8
Hospital control (%)   
Private33.834.834.4
Government (nonfederal)6.79.78.3
Private or government59.555.557.3
Hospital region (%)   
Northeast17.412.517.6
Midwest25.719.420.9
South39.556.842.4
West17.411.319.2
Teaching hospital (%)41.743.843.3

Compared with privately insured patients, a larger proportion of uninsured and Medicaid patients had higher predicted mortality levels (Table 2). Medicaid patients had a disproportionately higher predicted LOS, whereas predicted resource demand was higher among privately insured patients. Hypertension (48%), chronic pulmonary disease (29.5%), and uncomplicated diabetes (21.5%) were the 3 most common comorbidities in the study cohort, with a generally higher prevalence of comorbidities among Medicaid patients.

Measures of Disease Severity and Comorbid Conditions in Patients With Acute Myocardial Infarction, Stroke, and Pneumonia by Insurance Category, 2005 Nationwide Inpatient Sample
Characteristic*Privately insured (n = 73,256)Uninsured (n = 18,531)Medicaid (n = 26,222)
  • NOTE: Because of rounding, percentages may not equal 100.

  • Abbreviation: AIDS, acquired immune deficiency syndrome.

  • For all comparisons, differences are significant at P < 0.01 using the chi‐square test.

  • The original Medstat disease staging system comprised 5 levels. Due to the small number of patients in levels 1, 2, and 3, we collapsed these into a single level and named it as level 1; we subsequently renamed levels 4 and 5 as levels 2 and 3, respectively. These levels correspond with the severity of the principal diagnosis, with higher levels indicating more severe disease on admission.

Medstat disease staging (%)   
Mortality level 150.845.436.7
Mortality level 244.049.156.7
Mortality level 35.35.56.7
Length of stay level 166.871.653.8
Length of stay level 228.524.539.3
Length of stay level 34.83.86.9
Resource demand level 145.254.248.5
Resource demand level 240.534.239.2
Resource demand level 314.211.712.3
Coexisting medical conditions (%)   
Congestive heart failure4.74.810.1
Valvular disease2.82.02.7
Pulmonary circulation disease0.80.61.5
Peripheral vascular disease3.22.23.2
Paralysis1.20.83.5
Other neurological disorders2.41.97.3
Chronic pulmonary disease23.622.437.7
Uncomplicated diabetes19.618.623.4
Complicated diabetes3.32.14.9
Hypothyroidism5.62.74.7
Renal failure3.01.95.6
Liver disease1.62.54.4
Peptic ulcer disease<0.5<0.5<0.5
AIDS0.10.10.4
Lymphoma1.10.40.6
Metastatic cancer2.10.72.2
Non‐metastatic solid tumor1.50.82.1
Collagen vascular diseases2.30.92.3
Coagulopathy2.72.43.4
Obesity10.38.29.3
Weight loss1.61.83.3
Fluid and electrolyte disorders18.319.423.8
Chronic blood loss anemia0.60.60.8
Deficiency anemias8.68.513.4
Alcohol abuse3.39.88.3
Drug abuse1.910.29.8
Psychoses1.51.96.8
Depression7.24.89.9
Hypertension48.044.145.7

In‐Hospital Mortality

Compared with the privately insured, age‐standardized and sex‐standardized in‐hospital mortality for AMI and stroke was significantly higher for uninsured and Medicaid patients (Table 3). Among pneumonia patients, Medicaid recipients had significantly higher in‐hospital mortality compared with privately insured and uninsured patients.

Age‐Standardized and Sex‐Standardized In‐Hospital Mortality and Resource Use for 3 Common Medical Conditions by Insurance Category, 2005 Nationwide Inpatient Sample
 Privately InsuredUninsuredMedicaid
  • NOTE: Age‐standardized and sex‐standardized using the age and sex distribution of the entire cohort for direct standardization. These are unadjusted figures.

  • Abbreviations: SE, standard error.

  • Significantly different from privately insured at P < 0.001 using the chi‐square test.

  • Significantly different from privately insured at P < 0.05 using the t‐test; log transformations were used to approximate normal distribution.

In‐hospital mortality, rate per 100 discharges (SE)   
Acute myocardial infarction2.22 (0.10)4.03 (0.31)*4.57 (0.34)*
Stroke7.49 (0.27)10.46 (0.64)*9.89 (0.45)*
Pneumonia1.75 (0.09)1.74 (0.18)2.48 (0.14)*
Length of stay, mean (SE), days   
Acute myocardial infarction4.17 (0.06)4.46 (0.09)5.85 (0.16)
Stroke6.37 (0.13)7.15 (0.25)9.28 (0.30)
Pneumonia4.89 (0.05)4.64 (0.10)5.80 (0.08)
Cost per episode, mean (SE), dollars   
Acute myocardial infarction21,077 (512)19,977 (833)22,452 (841)
Stroke16,022 (679)14,571 (1,036)18,462 (824)
Pneumonia8,223 (192)7,086 (293)9,479 (271)

After multivariable adjustment for additional patient and hospital characteristics, uninsured AMI and stroke patients continued to have significantly higher in‐hospital mortality compared with the privately insured (Table 4). Among pneumonia patients, Medicaid recipients persisted in having significantly higher in‐hospital mortality than the privately insured.

Multivariable‐Adjusted In‐Hospital Mortality and Resource Use for 3 Common Medical Conditions by Insurance Category, 2005 Nationwide Inpatient Sample
 Model 1*Model 2Model 3
  • NOTE: Using multivariable logistic regression models for in‐hospital mortality and

  • multivariable linear regression models for log transformed length of stay and cost per episode.

  • Abbreviation: CI, confidence interval.

  • Model 1 adjusted for patients' age group, sex, race, income, emergency admission, and weekend admission and for hospitals' bed size, control, region, and teaching status.

  • Model 2 adjusted for all the covariates in model 1 and comorbidities and severity of principal diagnosis.

  • Model 3 adjusted for all the covariates in model 2 and the proportion of uninsured and Medicaid patients in each hospital. Interaction terms were not included in any of these 3 models.

  • Patients who died were excluded from models for length of stay and cost. Ratios are the antilog of the beta coefficients and can be interpreted in the original scale of the data as the impact relative to the reference level. Log transformations were used to approximate normal distribution.

In‐hospital mortality, adjusted odds ratio (95% CI)   
Acute Myocardial Infarction   
Uninsured vs. privately insured1.59 (1.35‐1.88)1.58 (1.30‐1.93)1.52 (1.24‐1.85)
Medicaid vs. privately insured1.83 (1.54‐2.18)1.22 (0.99‐1.50)1.15 (0.94‐1.42)
Stroke   
Uninsured vs. privately insured1.56 (1.35‐1.80)1.50 (1.30‐1.73)1.49 (1.29‐1.72)
Medicaid vs. privately insured1.32 (1.15‐1.52)1.09 (0.93‐1.27)1.08 (0.93‐1.26)
Pneumonia   
Uninsured vs. privately insured0.99 (0.81‐1.21)1.12 (0.91‐1.39)1.10 (0.89‐1.36)
Medicaid vs. privately insured1.41 (1.20‐1.65)1.24 (1.04‐1.48)1.21 (1.01‐1.45)
Length of stay, adjusted ratio (95% CI)|   
Acute Myocardial Infarction   
Uninsured vs. privately insured1.00 (0.98‐1.02)1.00 (0.98‐1.02)1.00 (0.98‐1.02)
Medicaid vs. privately insured1.17 (1.14‐1.21)1.07 (1.05‐1.09)1.07 (1.05‐1.09)
Stroke   
Uninsured vs. privately insured1.06 (1.02‐1.10)1.08 (1.04‐1.11)1.07 (1.04‐1.11)
Medicaid vs. privately insured1.30 (1.26‐1.34)1.17 (1.14‐1.20)1.17 (1.14‐1.20)
Pneumonia   
Uninsured vs. privately insured0.95 (0.93‐0.97)0.96 (0.94‐0.99)0.96 (0.94‐0.98)
Medicaid vs. privately insured1.15 (1.13‐1.17)1.04 (1.03‐1.06)1.04 (1.03‐1.06)
Cost per episode, adjusted ratio (95% CI)|   
Acute Myocardial Infarction   
Uninsured vs. privately insured0.97 (0.95‐0.99)0.99 (0.97‐1.00)0.99 (0.97‐1.00)
Medicaid vs. privately insured1.01 (0.98‐1.04)0.99 (0.97‐1.01)0.99 (0.97‐1.01)
Stroke   
Uninsured vs. privately insured0.97 (0.93‐1.02)1.00 (0.96‐1.03)1.00 (0.97‐1.03)
Medicaid vs. privately insured1.17 (1.13‐1.21)1.06 (1.04‐1.09)1.06 (1.04‐1.09)
Pneumonia   
Uninsured vs. privately insured0.95 (0.92‐0.97)0.98 (0.96‐1.00)0.98 (0.96‐1.00)
Medicaid vs. privately insured1.17 (1.15‐1.19)1.05 (1.04‐1.07)1.05 (1.04‐1.07)

LOS

Among AMI and stroke patients, age‐standardized and sex‐standardized mean LOS was significantly longer for the uninsured and Medicaid recipients compared with the privately insured (Table 3). Among pneumonia patients, the uninsured had a slightly shorter mean LOS compared with the privately insured whereas Medicaid recipients averaged the longest LOS.

These insurance‐related disparities in LOS among pneumonia patients persisted after multivariable adjustment (Table 4). Among AMI patients, only Medicaid recipients persisted in having a significantly longer LOS than the privately insured. Among stroke patients, both the uninsured and Medicaid recipients averaged a longer LOS compared with the privately insured.

Cost per Episode

For all 3 conditions, the uninsured had significantly lower age‐standardized and sex‐standardized costs compared with the privately insured (Table 3). However, Medicaid patients had higher costs than the privately insured for all three conditions, significantly so among patients with stroke and pneumonia.

These insurance‐related disparities in costs persisted in multivariable analyses (Table 4). The uninsured continued to have lower costs compared with the privately insured, significantly so for patients with AMI and pneumonia. Among stroke and pneumonia patients, Medicaid recipients continued to accrue higher costs than the uninsured or privately insured.

Discussion

In this nationally representative study of working‐age Americans hospitalized for 3 common medical conditions, we found that insurance status was associated with significant variations in in‐hospital mortality and resource use. Whereas privately insured patients experienced comparatively lower in‐hospital mortality in most cases, mortality risk was highest among the uninsured for 2 of the 3 common causes of noncancer inpatient deaths. Although previous studies have examined insurance‐related disparities in inpatient care for individual diagnoses and specific populations, no broad overview of this important issue has been published in the past decade. In light of the current economic recession and national healthcare debate, these findings may be a prescient indication of a widening insurance gap in the quality of hospital care.

There are several potential mechanisms for these disparities. For instance, Hadley et al.9 reported significant underuse of high‐cost or high‐discretion procedures among the uninsured in their analysis of a nationally representative sample of 592,598 hospitalized patients. Similarly, Burstin et al.10 found that among a population of 30,195 hospitalized patients with diverse diagnoses, the uninsured were at greater risk for receiving substandard care regardless of hospital characteristics. These, and other similar findings,7, 8, 19 are suggestive of differences in the way uninsured patients are generally managed in the hospital that may partly explain the disparities reported herein.

More specifically, analyses of national registries of AMI have documented lower rates of utilization of invasive, potentially life‐saving, cardiac interventions among the uninsured.16, 17 Similarly, a lower rate of carotid endarterectomy was reported among uninsured stroke patients from an analysis of the 2002 NIS.15 Other differences in inpatient management unmeasured by administrative data, such as the use of subspecialists and allied health professionals, may also contribute.32 Unfortunately, limitations in the available data prevented us from being able to appropriately address the important issue of insurance related differences in the utilization of specific inpatient procedures.

These disparities may also be indicative of differences in severity of illness that are not captured fully by the MedStat disease staging criteria. The uninsured might have more severe illness at admission, either due to the presence of more advanced chronic disease or delay in seeking care for the acute episode. AMI and stroke are usually the culmination of longstanding atherosclerosis that is amenable to improvement through timely and consistent risk‐factor modification. Not having a usual source of medical care,6, 33 inadequate screening and management of known risk‐factors,3, 34 and difficulties in obtaining specialty care5 among the uninsured likely increases their risk of being hospitalized with more advanced disease. The higher likelihood of being admitted through the emergency department19 and on weekends9 among the uninsured lends credence to the possibility of delays in seeking care. All of these are potential mediators of higher AMI and stroke mortality in uninsured patients.

Finally, these mortality differences could also be due to the additional risks imposed by poorly managed comorbidities among uninsured patients. Although we controlled for the presence of comorbidities in our analysis, we lacked data about the severity of individual comorbidities. A recent study reported significant lapses in follow‐up care after the onset of a chronic condition in uninsured individuals under 65 years of age.34 Other studies have also documented insurance related disparities in the care of chronic diseases3, 35 that were among the most common comorbidities in our cohort.

Most of the reasons for insurance‐related disparities noted above for the uninsured are also applicable to Medicaid patients. Differences in the intensity of inpatient care,7, 8, 1519 limited access to health care services,2, 14 unmet health needs,5 and suboptimal management of chronic medical conditions35 were also reported for Medicaid patients in prior research. These factors likely contributed to the higher in‐hospital mortality in this patient population, evidenced by the sequential decrease in odds after adjusting for comorbidities and disease severity. Medicaid patients hospitalized for stroke were noted to have significantly longer LOS, which could plausibly be due to difficulties with arranging appropriate discharge disposition; the higher likelihood of paralysis among these patients15 would likely necessitate a higher frequency of rehabilitation facility placement. The higher costs for Medicaid patients with stroke and pneumonia may potentially be the result of these patients longer LOS. Although cost differences between the uninsured and privately insured were statistically significant, these were not large enough to be of material significance.

Limitations

Our study has several limitations. Since the NIS does not assign unique patient identifiers that would permit tracking of readmissions, we excluded patients transferred to another acute‐care hospital from our study to avoid counting the same patient twice. However, only 10% of hospitalized patients underwent transfer for cardiac procedures in the National Registry of Myocardial Infarction, with privately insured patients more likely to be transferred than other insurance groups.17 Since these patients are also more likely to have better survival, their exclusion likely biased our study toward the null. The same is probable for stroke patients as well.

Some uninsured patients begin Medicaid coverage during hospitalization and should ideally be counted as uninsured but were included under Medicaid in our analysis. They are also likely to be state‐ and plan‐specific variations in Medicaid and private payer coverage that we could not incorporate into our analysis. In addition, we were unable to include deaths that may have occurred shortly after discharge, even though these may have been related to the quality of hospital care. Furthermore, although the 3 conditions we studied are common and responsible for a large number of hospital deaths, they make up about 8% of total annual hospital discharges,23 and caution should be exercised in generalizing our findings to the full spectrum of hospitalizations. Lastly, it is possible that unmeasured confounding could be responsible for the observed associations. Uninsured and Medicaid patients are likely to have more severe disease, which may not be adequately captured by the administrative data available in the NIS. If so, this would explain the mortality association rather than insurance status.36, 37

Conclusions

Significant insurance‐related differences in mortality exist for 2 of the leading causes of noncancer inpatient deaths among working‐age Americans. Further studies are needed to determine whether provider sensitivity to insurance status or unmeasured sociodemographic and clinical prognostic factors are responsible for these disparities. Policy makers, hospital administrators, and physicians should be cognizant of these disparities and consider policies to address potential insurance related gaps in the quality of inpatient care.

With about 1 in 5 working‐age Americans (age 18‐64 years) currently uninsured and a large number relying on Medicaid, adequate access to quality health care services is becoming increasingly difficult.1 Substantial literature has accumulated over the years suggesting that access and quality in health care are closely linked to an individual's health insurance status.211 Some studies indicate that being uninsured or publicly insured is associated with negative health consequences.12, 13 Although the Medicaid program has improved access for qualifying low‐income individuals, significant gaps in access and quality remain.2, 5, 11, 1419 These issues are likely to become more pervasive should there be further modifications to state Medicaid funding in response to the unfolding economic crisis.

Although numerous studies have focused on insurance‐related disparities in the outpatient setting, few nationally representative studies have examined such disparities among hospitalized patients. A cross‐sectional study of a large hospital database from 1987 reported higher risk‐adjusted in‐hospital mortality, shorter length of stay (LOS), and lower procedure use among uninsured patients.9 A more recent analysis, limited to patients admitted with stroke, reported significant variation in hospital care associated with insurance status.15 Other studies reporting myocardial infarction registry and quality improvement program data are biased by the self‐selection of large urban teaching hospitals.1618 To our knowledge, no nationally representative study has focused on the impact of insurance coverage on hospital care for common medical conditions among working‐age Americans, the fastest growing segment of the uninsured population.

To address this gap in knowledge, we analyzed a nationally representative hospital database to determine whether there are significant insurance‐related disparities in in‐hospital mortality, LOS, and cost per hospitalization for 3 common medical conditions among working‐age adults, and, if present, to determine whether these disparities are due to differences in disease severity and comorbidities, and whether these disparities are affected by the proportion of uninsured and Medicaid patients receiving care in each hospital.

Methods

Design and Subjects

We examined data from the 2005 Nationwide Inpatient Sample (NIS), a nationally representative database of hospital inpatient stays maintained by the Agency for Healthcare Research and Quality (AHRQ) as part of the Healthcare Cost and Utilization Project (HCUP).20, 21 The NIS is a stratified probability sample of 20% of all US community hospitals, including public hospitals, academic medical centers, and specialty hospitals. Long‐term care hospitals, psychiatric hospitals, and alcoholism/chemical‐dependency treatment facilities are excluded. The 2005 NIS contains data on 7,995,048 discharges from 1054 hospitals located in 37 States and is designed to be representative of all acute care discharges from all US community hospitals.21

We identified discharges with a principal diagnosis of acute myocardial infarction (AMI), stroke, and pneumonia using International Classification of Diseases, 9th Revision, Clinical Modification (ICD‐9‐CM) codes specified in the AHRQ definitions of Inpatient Quality Indicators (Supporting Information Appendix).22 These 3 conditions are among the leading causes of noncancer inpatient deaths in patients under 65 years old,23 and evidence suggests that high mortality may be associated with deficiencies in the quality of inpatient care.24

We confined our analysis to patients 18 to 64 years of age, since this population is most at risk of being uninsured or underinsured.25 We excluded pregnant women because they account for an unusually high proportion of uninsured discharges and were relatively few in our cohort.26 In addition, we excluded patients transferred to another acute care hospital and patients missing payer source and discharge disposition. Our study protocol was approved by the Partners Human Research Committee.

Study Variables

We categorized insurance status as privately insured, uninsured, Medicaid, or Medicare. We defined privately insured patients as those having either Blue Cross or another commercial carrier listed as the primary payer and uninsured patients as those having either no charge or self‐pay listed as the primary payer.27 Other governmental payer categories were noted to share several characteristics with Medicare patients and comprised only a small proportion of the sample, and were thus included with Medicare. In order to account for NIS's sampling scheme and accurately apply sample weights in our analysis, we used Medicare as a separate category. However, since Medicare patients age 18 to 64 years represent a fundamentally different population that is primarily disabled or very ill, only results of privately insured, uninsured, and Medicaid patients are reported.

We selected in‐hospital mortality as the outcome measure and LOS and cost per hospitalization as measures of resource utilization. The NIS includes a binary indicator variable for in‐hospital mortality and specifies inpatient LOS in integers, with same‐day stays coded as 0. NIS's cost estimates are based on hospital cost reports submitted to the Centers for Medicare and Medicaid Services. To test the validity of our cost analyses, we performed parallel analyses using hospital charges as a measure of utilization (charges include hospital overhead, charity care, and bad debt). The resulting adjusted ratios differed little from cost ratios and we opted to report only the details of our cost analyses.

In order to assess the independent association between insurance status and the outcome measures listed above, we selected covariates for inclusion in multivariable models based on the existing literature. Patient covariates included: age group (18‐34 years, 35‐49 years, 50‐64 years), sex (male/female), race/ethnicity (non‐Hispanic white, non‐Hispanic black, Hispanic, other, missing), median income by zip code of residence (less than $37,000, $37,000‐$45,999, $46,000‐$60,999, $61,000 or more), admission through the emergency department (yes/no), admission on a weekend (yes/no), measures of disease severity, and comorbidity indicators. Measures of disease severity specific to each outcome are assigned in the NIS using criteria developed by Medstat (Medstat Disease Staging Software Version 5.2, Thomson Medstat Inc., Ann Arbor, MI). Severity is categorized into 5 levels, with a higher level indicating greater risk. We recorded comorbidities for each patient in our sample using HCUP Comorbidity Software, Version 3.2 (www.hcup‐us.ahrq.gov/tools_software.jsp) based on comorbidity measures reported by Elixhauser et al.28

Hospital covariates included: bed size (small, medium, large), ownership/control (private, government, private or government), geographic region (northeast, midwest, south, west), teaching status (teaching, non‐teaching), and the proportion of uninsured and Medicaid patients (combined) admitted to each hospital for AMI, stroke, or pneumonia. The actual number of hospital beds in each bed size category varies according to a hospital's geographic region and teaching status.27 Ownership/control, geographic region, and teaching status are assigned according to information from the American Hospital Association Annual Survey of Hospitals. The proportion of uninsured and Medicaid patients admitted to each hospital was found to have a nonmonotonic relationship with the outcomes being assessed and was thus treated as a 6‐level categorical variable with the following levels: 0% to 10%, 11% to 20%, 21% to 30%, 31% to 40%, 41% to 50%, and 51% to 100%.

Statistical Analysis

Summary statistics were constructed at the patient level and differences in proportions were evaluated with the chi‐square test. We employed direct standardization, using the age and sex distribution of the entire cohort, to compute age‐standardized and sex‐standardized estimates for each insurance group and compared them using the chi‐square test for in‐hospital mortality and t test for log transformed LOS and cost per hospitalization. For each condition, we developed multivariable logistic regression models for in‐hospital mortality and multivariable linear regression models for log transformed LOS and cost. The patient was the unit of analysis in all models.

In order to elucidate the contribution of disease severity and comorbidities and the proportion of uninsured and Medicaid patients admitted to each hospital, we fitted 3 sequential models for each outcome measure: Model 1 adjusted for patient sociodemographic characteristics and hospital characteristics with the exception of the covariate for the proportion of uninsured and Medicaid patients, Model 2 adjusted for all covariates in the preceding model as well as patients' comorbidities and severity of principal diagnosis, and Model 3 adjusted for all previously mentioned covariates as well as the proportion of uninsured and Medicaid patients admitted to each hospital. We excluded patients who died during hospitalization from the models for LOS and cost. We exponentiated the effect estimates from the log transformed linear regression models so that the adjusted ratio represents the percentage change in the mean LOS or mean cost.

To determine whether the association between patients' insurance status and in‐hospital mortality was modified by seeking care in hospitals treating a smaller or larger proportion of uninsured and Medicaid patients, we entered an interaction term for insurance status and proportion of uninsured and Medicaid patients in the final models (Model 3) for our primary outcome of in‐hospital mortality. However, since no significant interaction was found for any of the 3 conditions, this term was removed from the models and results from the interaction models are not described. In order to assess model specification for the linear regression models, we evaluated the normality of model residuals and found that these were approximately normally distributed. Lastly, we attempted to test the robustness of our analyses by creating fixed effects models that controlled for hospital site but were unable to do so due to the computational limitations of available software packages that could not render fixed effects models with more than 1000 hospital sites.

For all variables except race/ethnicity, data were missing for less than 3% of patients, so we excluded these individuals from adjusted analyses. However, race/ethnicity data were missing for 29% of the sample and were analyzed in 3 different ways, namely, with the missing data treated as a separate covariate level, with the missing data removed from the analysis, and with the missing data assigned to the majority covariate level (white race). The results of our analysis were unchanged no matter how the missing values were assigned. As a result, missing values for race/ethnicity were treated as a separate covariate level in the final analysis.15 Sociodemographic characteristics of patients with missing race/ethnicity information were similar to those with complete data.

We used SUDAAN (Release 9.0.1, Research Triangle Institute, NC) to account for NIS's sampling scheme and generalized estimating equations to adjust for the clustering of patients within hospitals and hospitals within sampling strata.29 In order to account for NIS's stratified probability sampling scheme, SUDAAN uses Taylor series linearization for robust variance estimation of descriptive statistics and regression parameters.30, 31 We present 2‐tailed P values or 95% confidence intervals (CIs) for all statistical comparisons.

Results

Patient and Hospital Characteristics

The final cohort comprised of 154,381 patients discharged from 1018 hospitals in 37 states during calendar year 2005 (Table 1). This cohort was representative of 755,346 working‐age Americans, representing approximately 225,947 cases of AMI (29.9%), 151,812 cases of stroke (20.1%), and 377,588 cases of pneumonia (50.0%). Of these patients, 47.5% were privately insured, 12.0% were uninsured, 17.0% received Medicaid, and 23.5% were assigned to Medicare. Compared with the privately insured, uninsured and Medicaid patients were generally younger, less likely to be white, more likely to have lower income, and more likely to be admitted through the emergency department. Of the 1018 hospitals included in our study, close to half (44.3%) were small, with bedsize ranging from 24 to 249. A large number of hospitals were located in the South (39.9%), and 14.9% were designated teaching hospitals.

Characteristics of Patients With Acute Myocardial Infarction, Stroke, and Pneumonia by Insurance Category, 2005 Nationwide Inpatient Sample
Characteristic*Privately insured (n = 73,256)Uninsured (n = 18,531)Medicaid (n = 26,222)
  • NOTE: Because of rounding, percentages may not equal 100.

  • For all comparisons, differences are significant at P < 0.01 using the chi‐square test.

Principal diagnosis (%)   
Acute myocardial infarction36.731.219.7
Stroke20.623.719.9
Pneumonia42.745.260.4
Age group (%)   
18‐34 years6.813.013.7
35‐49 years27.636.933.2
50‐64 years65.750.153.2
Male sex (%)59.362.346.6
Race or ethnicity (%)   
White55.741.538.0
Black7.614.816.6
Hispanic4.810.510.4
Other race3.64.75.2
Missing28.429.029.7
Median income by ZIP code (%)   
<$37,00021.536.743.0
$37,000‐$45,99925.227.827.1
$46,000‐$60,99926.320.317.6
$61,00024.811.58.4
Emergency admission (%)63.375.672.9
Weekend admission (%)24.526.225.1
Hospital bed size (%)   
Small8.910.311.4
Medium24.022.325.9
Large67.167.562.8
Hospital control (%)   
Private33.834.834.4
Government (nonfederal)6.79.78.3
Private or government59.555.557.3
Hospital region (%)   
Northeast17.412.517.6
Midwest25.719.420.9
South39.556.842.4
West17.411.319.2
Teaching hospital (%)41.743.843.3

Compared with privately insured patients, a larger proportion of uninsured and Medicaid patients had higher predicted mortality levels (Table 2). Medicaid patients had a disproportionately higher predicted LOS, whereas predicted resource demand was higher among privately insured patients. Hypertension (48%), chronic pulmonary disease (29.5%), and uncomplicated diabetes (21.5%) were the 3 most common comorbidities in the study cohort, with a generally higher prevalence of comorbidities among Medicaid patients.

Measures of Disease Severity and Comorbid Conditions in Patients With Acute Myocardial Infarction, Stroke, and Pneumonia by Insurance Category, 2005 Nationwide Inpatient Sample
Characteristic*Privately insured (n = 73,256)Uninsured (n = 18,531)Medicaid (n = 26,222)
  • NOTE: Because of rounding, percentages may not equal 100.

  • Abbreviation: AIDS, acquired immune deficiency syndrome.

  • For all comparisons, differences are significant at P < 0.01 using the chi‐square test.

  • The original Medstat disease staging system comprised 5 levels. Due to the small number of patients in levels 1, 2, and 3, we collapsed these into a single level and named it as level 1; we subsequently renamed levels 4 and 5 as levels 2 and 3, respectively. These levels correspond with the severity of the principal diagnosis, with higher levels indicating more severe disease on admission.

Medstat disease staging (%)   
Mortality level 150.845.436.7
Mortality level 244.049.156.7
Mortality level 35.35.56.7
Length of stay level 166.871.653.8
Length of stay level 228.524.539.3
Length of stay level 34.83.86.9
Resource demand level 145.254.248.5
Resource demand level 240.534.239.2
Resource demand level 314.211.712.3
Coexisting medical conditions (%)   
Congestive heart failure4.74.810.1
Valvular disease2.82.02.7
Pulmonary circulation disease0.80.61.5
Peripheral vascular disease3.22.23.2
Paralysis1.20.83.5
Other neurological disorders2.41.97.3
Chronic pulmonary disease23.622.437.7
Uncomplicated diabetes19.618.623.4
Complicated diabetes3.32.14.9
Hypothyroidism5.62.74.7
Renal failure3.01.95.6
Liver disease1.62.54.4
Peptic ulcer disease<0.5<0.5<0.5
AIDS0.10.10.4
Lymphoma1.10.40.6
Metastatic cancer2.10.72.2
Non‐metastatic solid tumor1.50.82.1
Collagen vascular diseases2.30.92.3
Coagulopathy2.72.43.4
Obesity10.38.29.3
Weight loss1.61.83.3
Fluid and electrolyte disorders18.319.423.8
Chronic blood loss anemia0.60.60.8
Deficiency anemias8.68.513.4
Alcohol abuse3.39.88.3
Drug abuse1.910.29.8
Psychoses1.51.96.8
Depression7.24.89.9
Hypertension48.044.145.7

In‐Hospital Mortality

Compared with the privately insured, age‐standardized and sex‐standardized in‐hospital mortality for AMI and stroke was significantly higher for uninsured and Medicaid patients (Table 3). Among pneumonia patients, Medicaid recipients had significantly higher in‐hospital mortality compared with privately insured and uninsured patients.

Age‐Standardized and Sex‐Standardized In‐Hospital Mortality and Resource Use for 3 Common Medical Conditions by Insurance Category, 2005 Nationwide Inpatient Sample
 Privately InsuredUninsuredMedicaid
  • NOTE: Age‐standardized and sex‐standardized using the age and sex distribution of the entire cohort for direct standardization. These are unadjusted figures.

  • Abbreviations: SE, standard error.

  • Significantly different from privately insured at P < 0.001 using the chi‐square test.

  • Significantly different from privately insured at P < 0.05 using the t‐test; log transformations were used to approximate normal distribution.

In‐hospital mortality, rate per 100 discharges (SE)   
Acute myocardial infarction2.22 (0.10)4.03 (0.31)*4.57 (0.34)*
Stroke7.49 (0.27)10.46 (0.64)*9.89 (0.45)*
Pneumonia1.75 (0.09)1.74 (0.18)2.48 (0.14)*
Length of stay, mean (SE), days   
Acute myocardial infarction4.17 (0.06)4.46 (0.09)5.85 (0.16)
Stroke6.37 (0.13)7.15 (0.25)9.28 (0.30)
Pneumonia4.89 (0.05)4.64 (0.10)5.80 (0.08)
Cost per episode, mean (SE), dollars   
Acute myocardial infarction21,077 (512)19,977 (833)22,452 (841)
Stroke16,022 (679)14,571 (1,036)18,462 (824)
Pneumonia8,223 (192)7,086 (293)9,479 (271)

After multivariable adjustment for additional patient and hospital characteristics, uninsured AMI and stroke patients continued to have significantly higher in‐hospital mortality compared with the privately insured (Table 4). Among pneumonia patients, Medicaid recipients persisted in having significantly higher in‐hospital mortality than the privately insured.

Multivariable‐Adjusted In‐Hospital Mortality and Resource Use for 3 Common Medical Conditions by Insurance Category, 2005 Nationwide Inpatient Sample
 Model 1*Model 2Model 3
  • NOTE: Using multivariable logistic regression models for in‐hospital mortality and

  • multivariable linear regression models for log transformed length of stay and cost per episode.

  • Abbreviation: CI, confidence interval.

  • Model 1 adjusted for patients' age group, sex, race, income, emergency admission, and weekend admission and for hospitals' bed size, control, region, and teaching status.

  • Model 2 adjusted for all the covariates in model 1 and comorbidities and severity of principal diagnosis.

  • Model 3 adjusted for all the covariates in model 2 and the proportion of uninsured and Medicaid patients in each hospital. Interaction terms were not included in any of these 3 models.

  • Patients who died were excluded from models for length of stay and cost. Ratios are the antilog of the beta coefficients and can be interpreted in the original scale of the data as the impact relative to the reference level. Log transformations were used to approximate normal distribution.

In‐hospital mortality, adjusted odds ratio (95% CI)   
Acute Myocardial Infarction   
Uninsured vs. privately insured1.59 (1.35‐1.88)1.58 (1.30‐1.93)1.52 (1.24‐1.85)
Medicaid vs. privately insured1.83 (1.54‐2.18)1.22 (0.99‐1.50)1.15 (0.94‐1.42)
Stroke   
Uninsured vs. privately insured1.56 (1.35‐1.80)1.50 (1.30‐1.73)1.49 (1.29‐1.72)
Medicaid vs. privately insured1.32 (1.15‐1.52)1.09 (0.93‐1.27)1.08 (0.93‐1.26)
Pneumonia   
Uninsured vs. privately insured0.99 (0.81‐1.21)1.12 (0.91‐1.39)1.10 (0.89‐1.36)
Medicaid vs. privately insured1.41 (1.20‐1.65)1.24 (1.04‐1.48)1.21 (1.01‐1.45)
Length of stay, adjusted ratio (95% CI)|   
Acute Myocardial Infarction   
Uninsured vs. privately insured1.00 (0.98‐1.02)1.00 (0.98‐1.02)1.00 (0.98‐1.02)
Medicaid vs. privately insured1.17 (1.14‐1.21)1.07 (1.05‐1.09)1.07 (1.05‐1.09)
Stroke   
Uninsured vs. privately insured1.06 (1.02‐1.10)1.08 (1.04‐1.11)1.07 (1.04‐1.11)
Medicaid vs. privately insured1.30 (1.26‐1.34)1.17 (1.14‐1.20)1.17 (1.14‐1.20)
Pneumonia   
Uninsured vs. privately insured0.95 (0.93‐0.97)0.96 (0.94‐0.99)0.96 (0.94‐0.98)
Medicaid vs. privately insured1.15 (1.13‐1.17)1.04 (1.03‐1.06)1.04 (1.03‐1.06)
Cost per episode, adjusted ratio (95% CI)|   
Acute Myocardial Infarction   
Uninsured vs. privately insured0.97 (0.95‐0.99)0.99 (0.97‐1.00)0.99 (0.97‐1.00)
Medicaid vs. privately insured1.01 (0.98‐1.04)0.99 (0.97‐1.01)0.99 (0.97‐1.01)
Stroke   
Uninsured vs. privately insured0.97 (0.93‐1.02)1.00 (0.96‐1.03)1.00 (0.97‐1.03)
Medicaid vs. privately insured1.17 (1.13‐1.21)1.06 (1.04‐1.09)1.06 (1.04‐1.09)
Pneumonia   
Uninsured vs. privately insured0.95 (0.92‐0.97)0.98 (0.96‐1.00)0.98 (0.96‐1.00)
Medicaid vs. privately insured1.17 (1.15‐1.19)1.05 (1.04‐1.07)1.05 (1.04‐1.07)

LOS

Among AMI and stroke patients, age‐standardized and sex‐standardized mean LOS was significantly longer for the uninsured and Medicaid recipients compared with the privately insured (Table 3). Among pneumonia patients, the uninsured had a slightly shorter mean LOS compared with the privately insured whereas Medicaid recipients averaged the longest LOS.

These insurance‐related disparities in LOS among pneumonia patients persisted after multivariable adjustment (Table 4). Among AMI patients, only Medicaid recipients persisted in having a significantly longer LOS than the privately insured. Among stroke patients, both the uninsured and Medicaid recipients averaged a longer LOS compared with the privately insured.

Cost per Episode

For all 3 conditions, the uninsured had significantly lower age‐standardized and sex‐standardized costs compared with the privately insured (Table 3). However, Medicaid patients had higher costs than the privately insured for all three conditions, significantly so among patients with stroke and pneumonia.

These insurance‐related disparities in costs persisted in multivariable analyses (Table 4). The uninsured continued to have lower costs compared with the privately insured, significantly so for patients with AMI and pneumonia. Among stroke and pneumonia patients, Medicaid recipients continued to accrue higher costs than the uninsured or privately insured.

Discussion

In this nationally representative study of working‐age Americans hospitalized for 3 common medical conditions, we found that insurance status was associated with significant variations in in‐hospital mortality and resource use. Whereas privately insured patients experienced comparatively lower in‐hospital mortality in most cases, mortality risk was highest among the uninsured for 2 of the 3 common causes of noncancer inpatient deaths. Although previous studies have examined insurance‐related disparities in inpatient care for individual diagnoses and specific populations, no broad overview of this important issue has been published in the past decade. In light of the current economic recession and national healthcare debate, these findings may be a prescient indication of a widening insurance gap in the quality of hospital care.

There are several potential mechanisms for these disparities. For instance, Hadley et al.9 reported significant underuse of high‐cost or high‐discretion procedures among the uninsured in their analysis of a nationally representative sample of 592,598 hospitalized patients. Similarly, Burstin et al.10 found that among a population of 30,195 hospitalized patients with diverse diagnoses, the uninsured were at greater risk for receiving substandard care regardless of hospital characteristics. These, and other similar findings,7, 8, 19 are suggestive of differences in the way uninsured patients are generally managed in the hospital that may partly explain the disparities reported herein.

More specifically, analyses of national registries of AMI have documented lower rates of utilization of invasive, potentially life‐saving, cardiac interventions among the uninsured.16, 17 Similarly, a lower rate of carotid endarterectomy was reported among uninsured stroke patients from an analysis of the 2002 NIS.15 Other differences in inpatient management unmeasured by administrative data, such as the use of subspecialists and allied health professionals, may also contribute.32 Unfortunately, limitations in the available data prevented us from being able to appropriately address the important issue of insurance related differences in the utilization of specific inpatient procedures.

These disparities may also be indicative of differences in severity of illness that are not captured fully by the MedStat disease staging criteria. The uninsured might have more severe illness at admission, either due to the presence of more advanced chronic disease or delay in seeking care for the acute episode. AMI and stroke are usually the culmination of longstanding atherosclerosis that is amenable to improvement through timely and consistent risk‐factor modification. Not having a usual source of medical care,6, 33 inadequate screening and management of known risk‐factors,3, 34 and difficulties in obtaining specialty care5 among the uninsured likely increases their risk of being hospitalized with more advanced disease. The higher likelihood of being admitted through the emergency department19 and on weekends9 among the uninsured lends credence to the possibility of delays in seeking care. All of these are potential mediators of higher AMI and stroke mortality in uninsured patients.

Finally, these mortality differences could also be due to the additional risks imposed by poorly managed comorbidities among uninsured patients. Although we controlled for the presence of comorbidities in our analysis, we lacked data about the severity of individual comorbidities. A recent study reported significant lapses in follow‐up care after the onset of a chronic condition in uninsured individuals under 65 years of age.34 Other studies have also documented insurance related disparities in the care of chronic diseases3, 35 that were among the most common comorbidities in our cohort.

Most of the reasons for insurance‐related disparities noted above for the uninsured are also applicable to Medicaid patients. Differences in the intensity of inpatient care,7, 8, 1519 limited access to health care services,2, 14 unmet health needs,5 and suboptimal management of chronic medical conditions35 were also reported for Medicaid patients in prior research. These factors likely contributed to the higher in‐hospital mortality in this patient population, evidenced by the sequential decrease in odds after adjusting for comorbidities and disease severity. Medicaid patients hospitalized for stroke were noted to have significantly longer LOS, which could plausibly be due to difficulties with arranging appropriate discharge disposition; the higher likelihood of paralysis among these patients15 would likely necessitate a higher frequency of rehabilitation facility placement. The higher costs for Medicaid patients with stroke and pneumonia may potentially be the result of these patients longer LOS. Although cost differences between the uninsured and privately insured were statistically significant, these were not large enough to be of material significance.

Limitations

Our study has several limitations. Since the NIS does not assign unique patient identifiers that would permit tracking of readmissions, we excluded patients transferred to another acute‐care hospital from our study to avoid counting the same patient twice. However, only 10% of hospitalized patients underwent transfer for cardiac procedures in the National Registry of Myocardial Infarction, with privately insured patients more likely to be transferred than other insurance groups.17 Since these patients are also more likely to have better survival, their exclusion likely biased our study toward the null. The same is probable for stroke patients as well.

Some uninsured patients begin Medicaid coverage during hospitalization and should ideally be counted as uninsured but were included under Medicaid in our analysis. They are also likely to be state‐ and plan‐specific variations in Medicaid and private payer coverage that we could not incorporate into our analysis. In addition, we were unable to include deaths that may have occurred shortly after discharge, even though these may have been related to the quality of hospital care. Furthermore, although the 3 conditions we studied are common and responsible for a large number of hospital deaths, they make up about 8% of total annual hospital discharges,23 and caution should be exercised in generalizing our findings to the full spectrum of hospitalizations. Lastly, it is possible that unmeasured confounding could be responsible for the observed associations. Uninsured and Medicaid patients are likely to have more severe disease, which may not be adequately captured by the administrative data available in the NIS. If so, this would explain the mortality association rather than insurance status.36, 37

Conclusions

Significant insurance‐related differences in mortality exist for 2 of the leading causes of noncancer inpatient deaths among working‐age Americans. Further studies are needed to determine whether provider sensitivity to insurance status or unmeasured sociodemographic and clinical prognostic factors are responsible for these disparities. Policy makers, hospital administrators, and physicians should be cognizant of these disparities and consider policies to address potential insurance related gaps in the quality of inpatient care.

References
  1. Holahan J, Cook A.The U.S. economy and changes in health insurance coverage, 2000‐2006.Health Aff (Millwood).2008;27(2):w135w144.
  2. Weissman JS, Gatsonis C, Epstein AM.Rates of avoidable hospitalization by insurance status in Massachusetts and Maryland.JAMA.1992;268(17):2388‐2394.
  3. Ayanian JZ, Weissman JS, Schneider EC, et al.Unmet health needs of uninsured adults in the United States.JAMA.2000;284(16):20612069.
  4. Baker DW, Shapiro MF, Schur CL.Health insurance and access to care for symptomatic conditions.Arch Intern Med.2000;160(9):12691274.
  5. Cook NL, Hicks LS, O'Malley AJ, et al.Access to specialty care and medical services in community health centers.Health Aff (Millwood).2007;26(5):14591468.
  6. Wilper AP, Woolhandler S, Lasser KE, et al.A national study of chronic disease prevalence and access to care in uninsured U.S. adults.Ann Intern Med.2008;149:170176.
  7. Yergan J, Flood AB, Diehr P, LoGerfo JP.Relationship between patient source of payment and the intensity of hospital services.Med Care.1988;26(11):11111114.
  8. Wenneker MB, Weissman JS, Epstein AM.The association of payer with utilization of cardiac procedures in Massachusetts.JAMA.1990;264(10):12551260.
  9. Hadley J, Steinberg EP, Feder J.Comparison of uninsured and privately insured hospital patients: condition on admission, resource use, and outcome.JAMA.1991;265:374379.
  10. Burstin HR, Lipsitz SR, Brennan TA.Socioeconomic status and risk for substandard medical care.JAMA.1992;268(17):23832387.
  11. Ayanian JZ, Kohler BA, Abe T, Epstein AM.The relation between health insurance coverage and clinical outcomes among women with breast cancer.N Engl J Med.1993;329(5):326331.
  12. Franks P, Clancy CM, Gold MR.Health insurance and mortality. Evidence from a national cohort.JAMA.1993;270(6):737741.
  13. Sorlie PD, Johnson NJ, Backlund E, Bradham DD.Mortality in the uninsured compared with that in persons with public and private health insurance.Arch Intern Med.1994;154(21):24092416.
  14. Cohen JW.Medicaid policy and the substitution of hospital outpatient care for physician care.Health Serv Res.1989;24:3366.
  15. Shen JJ, Washington EL.Disparities in outcomes among patients with stroke associated with insurance status.Stroke.2007;38(3):10101016.
  16. Sada MJ, French WJ, Carlisle DM, et al.Influence of payor on use of invasive cardiac procedures and patient outcome after myocardial infarction in the United States. Participants in the National Registry of Myocardial Infarction.J Am Coll Cardiol.1998;31(7):14741480.
  17. Canto JG, Rogers WJ, French WJ, et al.Payer status and the utilization of hospital resources in acute myocardial infarction: a report from the National Registry of Myocardial Infarction 2.Arch Intern Med.2000;160(6):817823.
  18. Calvin JE, Roe MT, Chen AY, et al.Insurance coverage and care of patients with non‐ST‐segment elevation acute coronary syndromes.Ann Intern Med.2006;145(10):739748.
  19. Bradbury RC, Golec JH, Steen PM.Comparing uninsured and privately insured hospital patients: Admission severity, health outcomes and resource use.Health Serv Manage Res.2001;14(3):203210.
  20. Healthcare Cost and Utilization Project. Introduction to the HCUP Nationwide Inpatient Sample (NIS) 2005. Rockville, MD: Agency for Healthcare Research and Quality; 2007:6. Available at: www.hcup‐us.ahrq.gov/db/nation/nis/NIS_Introduction_2005.pdf. Accessed February2010.
  21. Healthcare Cost and Utilization Project. Design of the Nationwide Inpatient Sample (NIS) 2005. Rockville, MD: Agency for Healthcare Research and Quality; 2007. Available at: www.hcup‐us.ahrq.gov/db/nation/nis/reports/NIS_2005_Design_Report.pdf. Accessed February2010.
  22. AHRQ Quality Indicators. Inpatient Quality Indicators: Technical Specifications. Version 3.1 (March 12, 2007). Available at: www.qualityindicators.ahrq.gov/downloads/iqi/iqi_technical_specs_v31.pdf. Accessed February2010.
  23. DeFrances CJ, Cullen KA, Kozak LJ. National Hospital Discharge Survey: 2005 annual summary with detailed diagnosis and procedure data. Washington, DC: National Center for Health Statistics; 2007. Vital and Health Statistics 13(165). Available at: www.cdc.gov/nchs/data/series/sr_13/sr13_165.pdf. Accessed February2010.
  24. AHRQ Quality Indicators. Guide to Inpatient Quality Indicators: Quality of Care in Hospitals—Volume, Mortality, and Utilization. Version 3.1 (March 12, 2007). Available at: www.qualityindicators.ahrq.gov/downloads/iqi/iqi_guide_v31.pdf. Accessed February2010.
  25. DeNavas‐Walt C, Proctor BD, Smith J.Income, poverty, and health insurance coverage in the United States: 2006.Washington, DC:US Census Bureau. Current Population Reports;2007:60233.
  26. Elixhauser A, Russo CA. Conditions Related to Uninsured Hospitalizations, 2003. HCUP Statistical Brief #8. Rockville, MD: Agency for Healthcare Research and Quality; 2006:6. Available at: www.hcup‐us.ahrq.gov/reports/statbriefs/sb8.pdf. Accessed February2010.
  27. Healthcare Cost and Utilization Project. NIS Description of Data Elements. Available at: www.hcup‐us.ahrq.gov/db/nation/nis/nisdde.jsp. Accessed February2010.
  28. Elixhauser A, Steiner C, Harris DR, Coffey RM.Comorbidity measures for use with administrative data.Med Care.1998;36:827.
  29. SUDAAN User's Manual, Release 9.0. Research TrianglePark, NC:Research Triangle Institute;2006.
  30. Houchens R, Elixhauser A. Final Report on Calculating Nationwide Inpatient Sample (NIS) Variances, 2001. HCUP Methods Series Report #2003‐2. Online June 2005 (revised June 6, 2005). U.S. Agency for Healthcare Research and Quality. Available at: www.hcup‐us.ahrq.gov/reports/CalculatingNISVariances200106092005.pdf. Accessed February2010.
  31. Binder DA.On the variances of asymptotically normal estimators from complex surveys.Int Stat Rev.1983;51:279292.
  32. Auerbach AD, Hamel MB, Califf RM, et al.Patient characteristics associated with care by a cardiologist among adults hospitalized with severe congestive heart failure.J Am Coll Cardiol.2000;36:21192125.
  33. Pleis JR, Lethbridge‐Çejku M. Summary health statistics for U.S. adults: National Health Interview Survey, 2006. Washington, DC: National Center for Health Statistics; 2007:12. Vital and Health Statistics 10(235). Available at: www.cdc.gov/nchs/data/series/sr_10/sr10_235.pdf. Accessed February2010.
  34. Hadley J.Insurance coverage, medical care use, and short‐term health changes following an unintentional injury or the onset of a chronic condition.JAMA.2007;297(10):10731084.
  35. Hicks LS, O'Malley AJ, Lieu TA, et al.The quality of chronic disease care in U.S. community health centers.Health Aff (Millwood).2006;25(6):17121723.
  36. Escobar GJ, Greene JD, Scheirer P, Gardner MN, Draper D, Kipnis P.Risk‐adjusting hospital inpatient mortality using automated inpatient, outpatient, and laboratory databases.Med Care.2008;46(3):232239.
  37. van Walraven C, Escobar GJ, Greene JD, Forster AJ.The Kaiser Permanente inpatient risk adjustment methodology was valid in an external patient population.J Clin Epidemiol. [E‐pub ahead of print].
References
  1. Holahan J, Cook A.The U.S. economy and changes in health insurance coverage, 2000‐2006.Health Aff (Millwood).2008;27(2):w135w144.
  2. Weissman JS, Gatsonis C, Epstein AM.Rates of avoidable hospitalization by insurance status in Massachusetts and Maryland.JAMA.1992;268(17):2388‐2394.
  3. Ayanian JZ, Weissman JS, Schneider EC, et al.Unmet health needs of uninsured adults in the United States.JAMA.2000;284(16):20612069.
  4. Baker DW, Shapiro MF, Schur CL.Health insurance and access to care for symptomatic conditions.Arch Intern Med.2000;160(9):12691274.
  5. Cook NL, Hicks LS, O'Malley AJ, et al.Access to specialty care and medical services in community health centers.Health Aff (Millwood).2007;26(5):14591468.
  6. Wilper AP, Woolhandler S, Lasser KE, et al.A national study of chronic disease prevalence and access to care in uninsured U.S. adults.Ann Intern Med.2008;149:170176.
  7. Yergan J, Flood AB, Diehr P, LoGerfo JP.Relationship between patient source of payment and the intensity of hospital services.Med Care.1988;26(11):11111114.
  8. Wenneker MB, Weissman JS, Epstein AM.The association of payer with utilization of cardiac procedures in Massachusetts.JAMA.1990;264(10):12551260.
  9. Hadley J, Steinberg EP, Feder J.Comparison of uninsured and privately insured hospital patients: condition on admission, resource use, and outcome.JAMA.1991;265:374379.
  10. Burstin HR, Lipsitz SR, Brennan TA.Socioeconomic status and risk for substandard medical care.JAMA.1992;268(17):23832387.
  11. Ayanian JZ, Kohler BA, Abe T, Epstein AM.The relation between health insurance coverage and clinical outcomes among women with breast cancer.N Engl J Med.1993;329(5):326331.
  12. Franks P, Clancy CM, Gold MR.Health insurance and mortality. Evidence from a national cohort.JAMA.1993;270(6):737741.
  13. Sorlie PD, Johnson NJ, Backlund E, Bradham DD.Mortality in the uninsured compared with that in persons with public and private health insurance.Arch Intern Med.1994;154(21):24092416.
  14. Cohen JW.Medicaid policy and the substitution of hospital outpatient care for physician care.Health Serv Res.1989;24:3366.
  15. Shen JJ, Washington EL.Disparities in outcomes among patients with stroke associated with insurance status.Stroke.2007;38(3):10101016.
  16. Sada MJ, French WJ, Carlisle DM, et al.Influence of payor on use of invasive cardiac procedures and patient outcome after myocardial infarction in the United States. Participants in the National Registry of Myocardial Infarction.J Am Coll Cardiol.1998;31(7):14741480.
  17. Canto JG, Rogers WJ, French WJ, et al.Payer status and the utilization of hospital resources in acute myocardial infarction: a report from the National Registry of Myocardial Infarction 2.Arch Intern Med.2000;160(6):817823.
  18. Calvin JE, Roe MT, Chen AY, et al.Insurance coverage and care of patients with non‐ST‐segment elevation acute coronary syndromes.Ann Intern Med.2006;145(10):739748.
  19. Bradbury RC, Golec JH, Steen PM.Comparing uninsured and privately insured hospital patients: Admission severity, health outcomes and resource use.Health Serv Manage Res.2001;14(3):203210.
  20. Healthcare Cost and Utilization Project. Introduction to the HCUP Nationwide Inpatient Sample (NIS) 2005. Rockville, MD: Agency for Healthcare Research and Quality; 2007:6. Available at: www.hcup‐us.ahrq.gov/db/nation/nis/NIS_Introduction_2005.pdf. Accessed February2010.
  21. Healthcare Cost and Utilization Project. Design of the Nationwide Inpatient Sample (NIS) 2005. Rockville, MD: Agency for Healthcare Research and Quality; 2007. Available at: www.hcup‐us.ahrq.gov/db/nation/nis/reports/NIS_2005_Design_Report.pdf. Accessed February2010.
  22. AHRQ Quality Indicators. Inpatient Quality Indicators: Technical Specifications. Version 3.1 (March 12, 2007). Available at: www.qualityindicators.ahrq.gov/downloads/iqi/iqi_technical_specs_v31.pdf. Accessed February2010.
  23. DeFrances CJ, Cullen KA, Kozak LJ. National Hospital Discharge Survey: 2005 annual summary with detailed diagnosis and procedure data. Washington, DC: National Center for Health Statistics; 2007. Vital and Health Statistics 13(165). Available at: www.cdc.gov/nchs/data/series/sr_13/sr13_165.pdf. Accessed February2010.
  24. AHRQ Quality Indicators. Guide to Inpatient Quality Indicators: Quality of Care in Hospitals—Volume, Mortality, and Utilization. Version 3.1 (March 12, 2007). Available at: www.qualityindicators.ahrq.gov/downloads/iqi/iqi_guide_v31.pdf. Accessed February2010.
  25. DeNavas‐Walt C, Proctor BD, Smith J.Income, poverty, and health insurance coverage in the United States: 2006.Washington, DC:US Census Bureau. Current Population Reports;2007:60233.
  26. Elixhauser A, Russo CA. Conditions Related to Uninsured Hospitalizations, 2003. HCUP Statistical Brief #8. Rockville, MD: Agency for Healthcare Research and Quality; 2006:6. Available at: www.hcup‐us.ahrq.gov/reports/statbriefs/sb8.pdf. Accessed February2010.
  27. Healthcare Cost and Utilization Project. NIS Description of Data Elements. Available at: www.hcup‐us.ahrq.gov/db/nation/nis/nisdde.jsp. Accessed February2010.
  28. Elixhauser A, Steiner C, Harris DR, Coffey RM.Comorbidity measures for use with administrative data.Med Care.1998;36:827.
  29. SUDAAN User's Manual, Release 9.0. Research TrianglePark, NC:Research Triangle Institute;2006.
  30. Houchens R, Elixhauser A. Final Report on Calculating Nationwide Inpatient Sample (NIS) Variances, 2001. HCUP Methods Series Report #2003‐2. Online June 2005 (revised June 6, 2005). U.S. Agency for Healthcare Research and Quality. Available at: www.hcup‐us.ahrq.gov/reports/CalculatingNISVariances200106092005.pdf. Accessed February2010.
  31. Binder DA.On the variances of asymptotically normal estimators from complex surveys.Int Stat Rev.1983;51:279292.
  32. Auerbach AD, Hamel MB, Califf RM, et al.Patient characteristics associated with care by a cardiologist among adults hospitalized with severe congestive heart failure.J Am Coll Cardiol.2000;36:21192125.
  33. Pleis JR, Lethbridge‐Çejku M. Summary health statistics for U.S. adults: National Health Interview Survey, 2006. Washington, DC: National Center for Health Statistics; 2007:12. Vital and Health Statistics 10(235). Available at: www.cdc.gov/nchs/data/series/sr_10/sr10_235.pdf. Accessed February2010.
  34. Hadley J.Insurance coverage, medical care use, and short‐term health changes following an unintentional injury or the onset of a chronic condition.JAMA.2007;297(10):10731084.
  35. Hicks LS, O'Malley AJ, Lieu TA, et al.The quality of chronic disease care in U.S. community health centers.Health Aff (Millwood).2006;25(6):17121723.
  36. Escobar GJ, Greene JD, Scheirer P, Gardner MN, Draper D, Kipnis P.Risk‐adjusting hospital inpatient mortality using automated inpatient, outpatient, and laboratory databases.Med Care.2008;46(3):232239.
  37. van Walraven C, Escobar GJ, Greene JD, Forster AJ.The Kaiser Permanente inpatient risk adjustment methodology was valid in an external patient population.J Clin Epidemiol. [E‐pub ahead of print].
Issue
Journal of Hospital Medicine - 5(8)
Issue
Journal of Hospital Medicine - 5(8)
Page Number
452-459
Page Number
452-459
Article Type
Display Headline
Insurance status and hospital care for myocardial infarction, stroke, and pneumonia
Display Headline
Insurance status and hospital care for myocardial infarction, stroke, and pneumonia
Legacy Keywords
hospital cost, in‐hospital mortality, insurance status, length of stay, uninsured
Legacy Keywords
hospital cost, in‐hospital mortality, insurance status, length of stay, uninsured
Sections
Article Source

Copyright © 2010 Society of Hospital Medicine

Disallow All Ads
Correspondence Location
Division of General Medicine, Brigham and Women's Hospital, 1620 Tremont Street, 3rd Floor, Boston, MA 02120‐1613
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Article PDF Media

Talking the Talk

Article Type
Changed
Display Headline
Talking the Talk

On May 26, members of SHM’s Public Policy Committee visited Capitol Hill to meet with members of Congress and their legislative staffs. Now in their fifth year, the annual “Hill Day” meetings have evolved from explaining “What is a hospitalist?” to substantive discussions about HM’s impact on improving the quality and efficiency of healthcare and reducing preventable rehospitalizations.

“We don’t go in with an agenda to ask for things” or to guard professional turf, says Eric Siegal, MD, SFHM, committee chair and a critical care fellow at the University of Wisconsin School of Medicine in Madison. “People on the Hill who talk to us recognize that we are the experts [on improving the quality of hospital care]. They say to us: ‘You are different than the other medical associations; you really represent the solution.’ ”

The committee highlighted Project BOOST (Better Outcomes for Older Adults through Safe Transitions), SHM’s national quality initiative aimed at helping to improve care transitions and reduce rehospitalizations—–a major focus in the healthcare reform legislation.

Committee members also discussed SHM's support for a permanent repeal of the Sustainable Growth Rate (SGR). Physician reimbursement to Medicare patients technically was cut by 21% on June 1. The House passed another stopgap measure, but the Senate adjourned before a vote and is expected to raise the topic again early next week.

Committee member Patrick Torcson, MD, SFHM, a hospitalist at St. Tammany Parish Hospital in Covington, La., spent 30 minutes with Sen. David Vitter (R-La.), among his other Congressional encounters. “I had to be respectful and mindful of our senators’ and representatives’ different positions on healthcare reform,” Dr. Torcson explains, adding Vitter voted against the Patient Protection and Affordable Care Act, which was passed in March. “But he couldn’t have been more engaging with me. We talked about all aspects of hospital medicine.”

Find out the latest information on SGR reform and contact your legislators in support of permanent repeal through SHM's Legislative Action Center.

Issue
The Hospitalist - 2010(06)
Publications
Sections

On May 26, members of SHM’s Public Policy Committee visited Capitol Hill to meet with members of Congress and their legislative staffs. Now in their fifth year, the annual “Hill Day” meetings have evolved from explaining “What is a hospitalist?” to substantive discussions about HM’s impact on improving the quality and efficiency of healthcare and reducing preventable rehospitalizations.

“We don’t go in with an agenda to ask for things” or to guard professional turf, says Eric Siegal, MD, SFHM, committee chair and a critical care fellow at the University of Wisconsin School of Medicine in Madison. “People on the Hill who talk to us recognize that we are the experts [on improving the quality of hospital care]. They say to us: ‘You are different than the other medical associations; you really represent the solution.’ ”

The committee highlighted Project BOOST (Better Outcomes for Older Adults through Safe Transitions), SHM’s national quality initiative aimed at helping to improve care transitions and reduce rehospitalizations—–a major focus in the healthcare reform legislation.

Committee members also discussed SHM's support for a permanent repeal of the Sustainable Growth Rate (SGR). Physician reimbursement to Medicare patients technically was cut by 21% on June 1. The House passed another stopgap measure, but the Senate adjourned before a vote and is expected to raise the topic again early next week.

Committee member Patrick Torcson, MD, SFHM, a hospitalist at St. Tammany Parish Hospital in Covington, La., spent 30 minutes with Sen. David Vitter (R-La.), among his other Congressional encounters. “I had to be respectful and mindful of our senators’ and representatives’ different positions on healthcare reform,” Dr. Torcson explains, adding Vitter voted against the Patient Protection and Affordable Care Act, which was passed in March. “But he couldn’t have been more engaging with me. We talked about all aspects of hospital medicine.”

Find out the latest information on SGR reform and contact your legislators in support of permanent repeal through SHM's Legislative Action Center.

On May 26, members of SHM’s Public Policy Committee visited Capitol Hill to meet with members of Congress and their legislative staffs. Now in their fifth year, the annual “Hill Day” meetings have evolved from explaining “What is a hospitalist?” to substantive discussions about HM’s impact on improving the quality and efficiency of healthcare and reducing preventable rehospitalizations.

“We don’t go in with an agenda to ask for things” or to guard professional turf, says Eric Siegal, MD, SFHM, committee chair and a critical care fellow at the University of Wisconsin School of Medicine in Madison. “People on the Hill who talk to us recognize that we are the experts [on improving the quality of hospital care]. They say to us: ‘You are different than the other medical associations; you really represent the solution.’ ”

The committee highlighted Project BOOST (Better Outcomes for Older Adults through Safe Transitions), SHM’s national quality initiative aimed at helping to improve care transitions and reduce rehospitalizations—–a major focus in the healthcare reform legislation.

Committee members also discussed SHM's support for a permanent repeal of the Sustainable Growth Rate (SGR). Physician reimbursement to Medicare patients technically was cut by 21% on June 1. The House passed another stopgap measure, but the Senate adjourned before a vote and is expected to raise the topic again early next week.

Committee member Patrick Torcson, MD, SFHM, a hospitalist at St. Tammany Parish Hospital in Covington, La., spent 30 minutes with Sen. David Vitter (R-La.), among his other Congressional encounters. “I had to be respectful and mindful of our senators’ and representatives’ different positions on healthcare reform,” Dr. Torcson explains, adding Vitter voted against the Patient Protection and Affordable Care Act, which was passed in March. “But he couldn’t have been more engaging with me. We talked about all aspects of hospital medicine.”

Find out the latest information on SGR reform and contact your legislators in support of permanent repeal through SHM's Legislative Action Center.

Issue
The Hospitalist - 2010(06)
Issue
The Hospitalist - 2010(06)
Publications
Publications
Article Type
Display Headline
Talking the Talk
Display Headline
Talking the Talk
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)

HM-pedia

Article Type
Changed
Display Headline
HM-pedia

Ever think there has to be a better way to update your group’s 100-plus-page program manual? The HM group at Beth Israel Deaconess Medical Center in Boston offers a solution: Post all of the information on a secure wiki page.

That’s what hospitalist Roger Yu, MD, did a few months ago. He transferred his group’s manual to a wiki that allows members to access, add, and edit information about referring physicians, schedules, and more.

Dr. Yu says the page, hosted by Microsoft’s SharePoint platform, allows the 33-hospitalist group to stay up to date on new policies without forcing them to sift through a barrage of e-mails. “We probably have at least eight to 10 clinical rotations,” Dr. Yu says. “The hospital policy is always changing, the way we do our work constantly changes, and [using a wiki platform] is a way of getting this information across.”

The program was especially helpful, he adds, when his group recently developed a new referral relationship with a large, multispecialty group that had some unique needs. “There are specific ways they want us to consult their specialists, and they have different pager numbers and contact people, so we were able to post all of that in a page on the wiki,” Dr. Yu explains, adding any member of his group can add or edit information on the wiki.

 

Dr. Yu says his group hopes to eventually use the wiki to post calendar events and share teaching materials.

Joe Li, MD, director of the Beth Israel HM program, who tasked Dr. Yu with developing the wiki, says the program has, for the most part, run smoothly: “I wouldn’t say there have been glitches, per se, but I think people in the group have different levels of willingness to adopt new technology,” says Dr. Li, SHM’s president-elect. “Some [of our] people have accessed it less than others.”

Dr. Yu says that while creating a wiki doesn’t require extensive HTML knowledge or even computer savviness, it does involve some initial planning. “I would say if you’re going to start it up, it’s more about thinking about how to organize the table of contents,” he says. Once the table of contents is created, he says, expect to spend a few hours a day plugging in the information. It took him about three days to input the 120-plus-page manual.

For more tips on how to create your own wiki, visit Microsoft's help page.

Issue
The Hospitalist - 2010(06)
Publications
Sections

Ever think there has to be a better way to update your group’s 100-plus-page program manual? The HM group at Beth Israel Deaconess Medical Center in Boston offers a solution: Post all of the information on a secure wiki page.

That’s what hospitalist Roger Yu, MD, did a few months ago. He transferred his group’s manual to a wiki that allows members to access, add, and edit information about referring physicians, schedules, and more.

Dr. Yu says the page, hosted by Microsoft’s SharePoint platform, allows the 33-hospitalist group to stay up to date on new policies without forcing them to sift through a barrage of e-mails. “We probably have at least eight to 10 clinical rotations,” Dr. Yu says. “The hospital policy is always changing, the way we do our work constantly changes, and [using a wiki platform] is a way of getting this information across.”

The program was especially helpful, he adds, when his group recently developed a new referral relationship with a large, multispecialty group that had some unique needs. “There are specific ways they want us to consult their specialists, and they have different pager numbers and contact people, so we were able to post all of that in a page on the wiki,” Dr. Yu explains, adding any member of his group can add or edit information on the wiki.

 

Dr. Yu says his group hopes to eventually use the wiki to post calendar events and share teaching materials.

Joe Li, MD, director of the Beth Israel HM program, who tasked Dr. Yu with developing the wiki, says the program has, for the most part, run smoothly: “I wouldn’t say there have been glitches, per se, but I think people in the group have different levels of willingness to adopt new technology,” says Dr. Li, SHM’s president-elect. “Some [of our] people have accessed it less than others.”

Dr. Yu says that while creating a wiki doesn’t require extensive HTML knowledge or even computer savviness, it does involve some initial planning. “I would say if you’re going to start it up, it’s more about thinking about how to organize the table of contents,” he says. Once the table of contents is created, he says, expect to spend a few hours a day plugging in the information. It took him about three days to input the 120-plus-page manual.

For more tips on how to create your own wiki, visit Microsoft's help page.

Ever think there has to be a better way to update your group’s 100-plus-page program manual? The HM group at Beth Israel Deaconess Medical Center in Boston offers a solution: Post all of the information on a secure wiki page.

That’s what hospitalist Roger Yu, MD, did a few months ago. He transferred his group’s manual to a wiki that allows members to access, add, and edit information about referring physicians, schedules, and more.

Dr. Yu says the page, hosted by Microsoft’s SharePoint platform, allows the 33-hospitalist group to stay up to date on new policies without forcing them to sift through a barrage of e-mails. “We probably have at least eight to 10 clinical rotations,” Dr. Yu says. “The hospital policy is always changing, the way we do our work constantly changes, and [using a wiki platform] is a way of getting this information across.”

The program was especially helpful, he adds, when his group recently developed a new referral relationship with a large, multispecialty group that had some unique needs. “There are specific ways they want us to consult their specialists, and they have different pager numbers and contact people, so we were able to post all of that in a page on the wiki,” Dr. Yu explains, adding any member of his group can add or edit information on the wiki.

 

Dr. Yu says his group hopes to eventually use the wiki to post calendar events and share teaching materials.

Joe Li, MD, director of the Beth Israel HM program, who tasked Dr. Yu with developing the wiki, says the program has, for the most part, run smoothly: “I wouldn’t say there have been glitches, per se, but I think people in the group have different levels of willingness to adopt new technology,” says Dr. Li, SHM’s president-elect. “Some [of our] people have accessed it less than others.”

Dr. Yu says that while creating a wiki doesn’t require extensive HTML knowledge or even computer savviness, it does involve some initial planning. “I would say if you’re going to start it up, it’s more about thinking about how to organize the table of contents,” he says. Once the table of contents is created, he says, expect to spend a few hours a day plugging in the information. It took him about three days to input the 120-plus-page manual.

For more tips on how to create your own wiki, visit Microsoft's help page.

Issue
The Hospitalist - 2010(06)
Issue
The Hospitalist - 2010(06)
Publications
Publications
Article Type
Display Headline
HM-pedia
Display Headline
HM-pedia
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)